{"id":222124,"date":"2024-03-06T18:46:00","date_gmt":"2024-03-06T10:46:00","guid":{"rendered":"https:\/\/pingtungtimes.com.tw\/?p=222124"},"modified":"2024-03-06T18:46:00","modified_gmt":"2024-03-06T10:46:00","slug":"%e7%b6%ad%e4%ba%9e%e7%94%9f%e7%89%a9%e6%8a%95%e8%b3%87%e5%ad%b5%e5%8c%96%e5%85%ac%e5%8f%b8%e8%bf%91%e6%9c%9f%e7%99%bc%e5%b1%95%e5%8b%95%e6%85%8b%e4%b8%80%e8%a6%bd","status":"publish","type":"post","link":"https:\/\/pingtungtimes.com.tw\/?p=222124","title":{"rendered":"\u7dad\u4e9e\u751f\u7269\u6295\u8cc7\u5b75\u5316\u516c\u53f8\u8fd1\u671f\u767c\u5c55\u52d5\u614b\u4e00\u89bd"},"content":{"rendered":"<div>\n<p><span class=\"legendSpanClass\">\u9999\u6e2f<\/span><span class=\"legendSpanClass\">2024\u5e743\u67086\u65e5<\/span> \/\u7f8e\u901a\u793e\/ &#8212; \u9762\u5c0d\u4e0d\u65b7\u8b8a\u5316\u7684\u5c40\u52e2\uff0c\u6280\u8853\u5275\u65b0\u4f9d\u820a\u662f\u751f\u7269\u91ab\u85e5\u4f01\u696d\u9577\u9060\u767c\u5c55\u6c38\u6046\u7684\u4e3b\u65cb\u5f8b\uff0c\u70ba\u4f01\u696d\u6e90\u6e90\u4e0d\u65b7\u5730\u6ce8\u5165\u751f\u547d\u529b\uff0c\u6301\u7e8c\u63a8\u52d5\u7814\u767c\u300c\u5f9e0\u52301\u300d\u8f49\u5316\u4ee5\u53ca\u5546\u696d\u5316\u6210\u529f\u3002\u8fd1\u671f\uff0c\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u4f01\u696d\u53c8\u6709\u65b0\u7684\u52d5\u614b\uff1aAceLink\u3001\u7279\u79d1\u7f85\u7814\u767c\u9032\u5c55\u9806\u5229\uff1b\u535a\u81f4\u751f\u7269\u3001Basking\u3001\u7279\u79d1\u7f85\u3001\u8f3b\u806f\u79d1\u6280\u6210\u529f\u5b8c\u6210\u878d\u8cc7\uff1b\u7dad\u7738\u751f\u7269\u65ac\u7372\u6b8a\u69ae\uff1bAbsci\u9054\u6210\u91cd\u8981\u5408\u4f5c\u3002<\/p>\n<p class=\"prntal\"><b>\u535a\u81f4\u751f\u7269\u5b8c\u62101800\u842c\u7f8e\u5143A\u8f2a\u878d\u8cc7<\/b><\/p>\n<p>\u8fd1\u65e5\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u535a\u81f4\u751f\u7269\uff08Proviva Therapeutics\uff09\u6b23\u7136\u5ba3\u4f48\u5b8c\u62101800\u842c\u7f8e\u5143\u7684A\u8f2a\u878d\u8cc7\uff0c\u4ee5\u63a8\u9032\u5176\u6838\u5fc3\u7522\u54c1PTX-912\u7684\u81e8\u5e8a\u958b\u767c\u3002\u9f8d\u78d0\u6295\u8cc7\uff0c\u6069\u7136\u5275\u6295\u548c\u4ed9\u77b3\u8cc7\u672c\u806f\u5408\u53c3\u52a0\u672c\u8f2a\u878d\u8cc7\u3002<\/p>\n<p>\u535a\u81f4\u751f\u7269\u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\u7684\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u81f4\u529b\u65bc\u958b\u767c\u65b0\u4e00\u4ee3\u7d30\u80de\u56e0\u5b50\u6297\u816b\u7624\u514d\u75ab\u7642\u6cd5\u3002\u91dd\u5c0d\u7d30\u80de\u56e0\u5b50\u5916\u5468\u6bd2\u6027\u7684\u50b3\u7d71\u96e3\u984c\uff0c\u516c\u53f8\u81ea\u4e3b\u958b\u767c\u4e86\u300cCrossover\u300d\u7d30\u80de\u56e0\u5b50\u524d\u85e5\u6280\u8853\u5e73\u53f0\uff0c\u5be6\u73fe\u5728\u816b\u7624\u5fae\u74b0\u5883\u4e2d\u7279\u7570\u6027\u7684\u85e5\u7269\u6d3b\u6027\u91cb\u653e\u3002\u4f9d\u8a17\u300cCrossover\u300d\u6280\u8853\u5e73\u53f0\uff0c\u535a\u81f4\u6210\u529f\u7814\u767c\u51faPTX-912\u2014\u2014\u65b0\u4e00\u4ee3\u514d\u75ab\u7d30\u80de\u9776\u5411\u7684\u767d\u7d30\u80de\u4ecb\u7d20-2\uff08IL-2\uff09\u524d\u85e5\u878d\u5408\u86cb\u767d\u3002<\/p>\n<p class=\"prntal\"><b>AceLink Therapeutics\u767c\u4f48\u5065\u5eb7\u5fd7\u9858\u8005\u53c3\u8207\u8a55\u4f30AL01211\u7684I\u671f\u81e8\u5e8a\u8a66\u9a57\u6578\u64da<\/b><\/p>\n<p>\u7d10\u74e6\u514b\uff0c\u52a0\u5229\u798f\u5c3c\u4e9e\u5dde\u2014\u20142024\u5e742\u670826\u65e5\uff0cAceLink Therapeutics\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u3001\u4e00\u5bb6\u958b\u767c\u4e0b\u4e00\u4ee3\u53e3\u670d\u5e95\u7269\u6e1b\u5c11\u7642\u6cd5\uff08SRTs\uff09\u7684\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u88fd\u85e5\u516c\u53f8\u5ba3\u4f48\uff0c\u5176\u5728\u5065\u5eb7\u5fd7\u9858\u8005\u4e2d\u9032\u884c\u7684AL01211\u7684I\u671f\u7814\u7a76\u7684\u7d50\u679c\u5df2\u7d93\u767c\u8868\u5728\u540c\u884c\u8a55\u5be9\u7684\u7f8e\u570b\u81e8\u5e8a\u85e5\u5b78\u9662\u671f\u520a\u300aClinical Pharmacology in Drug Development\u300b\u4e0a\u3002AL01211\u662f\u4e00\u7a2e\u5f37\u5927\u7684\u53e3\u670d\u8461\u7cd6\u795e\u7d93\u91af\u80fa\u5408\u6210\u9176\uff08GCS\uff09\u6291\u5236\u5291\uff0c\u6b63\u5728\u958b\u767c\u7528\u65bc\u6cbb\u7642\u6cd5\u5e03\u745e\u6c0f\u75c7\u548cI\u578b\u9ad8\u96ea\u6c0f\u75c7\u3002<\/p>\n<p>\u5728\u5df2\u767c\u8868\u7684I\u671f\u7814\u7a76\u4e2d\uff0c\u5c0dAL01211\u9032\u884c\u4e86\u55ae\u5291\u91cf\u905e\u589e\u548c\u591a\u5291\u91cf\u905e\u589e\u7684\u7814\u7a76\uff0c\u4ee5\u78ba\u5b9a\u5176\u5728\u5065\u5eb7\u5fd7\u9858\u8005\u4e2d\u7684\u5b89\u5168\u6027\u3001\u85e5\u4ee3\u52d5\u529b\u5b78\uff08PK\uff09\u548c\u85e5\u6548\u5b78\uff08PD\uff09\u6548\u61c9\u3002\u7e3d\u9ad4\u800c\u8a00\uff0cAL01211\u5177\u6709\u826f\u597d\u7684\u5b89\u5168\u6027\u548c\u8010\u53d7\u6027\uff0c\u7121\u56b4\u91cd\u4e0d\u826f\u4e8b\u4ef6\u3002\u572830mg\u5291\u91cf\u6c34\u5e73\u4e0b\uff0c\u8840\u6f3f\u8461\u7cd6\u57fa\u795e\u7d93\u91af\u80fa\u548c\u7403\u86cb\u767d\u4e09\u7cd6\u795e\u7d93\u91af\u80fa\u5206\u5225\u5f9e\u57fa\u7dda\u6c34\u6e96\u964d\u4f4e\u4e8678%\u548c52%\uff0c\u5f9e\u800c\u652f\u6301AL01211\u7684\u9032\u4e00\u6b65\u81e8\u5e8a\u7814\u7a76\u3002<\/p>\n<p class=\"prntal\"><b>Basking\u5ba3\u4f48\u5b8c\u6210\u7531ARCH\u9818\u6295\u76845500\u842c\u7f8e\u5143\u878d\u8cc7\uff0c\u52a0\u901f\u53ef\u9006\u6eb6\u6813\u5291\u7684\u81e8\u5e8a\u958b\u767c<\/b><\/p>\n<p>\u4fc4\u4ea5\u4fc4\u5dde\u54e5\u502b\u5e03\u2014\u20142024\u5e741\u670830\u65e5\uff0cBasking Biosciences\uff08\u4ee5\u4e0b\u7c21\u7a31\u300cBasking\u300d\uff09\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\uff0c\u4e00\u5bb6\u958b\u767c\u65b0\u578b\u6025\u6027\u6eb6\u6813\u7642\u6cd5\u6cbb\u7642\u5352\u4e2d\u7684\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u88fd\u85e5\u516c\u53f8\uff0c\u5ba3\u4f48\u5b8c\u62105500\u842c\u7f8e\u5143\u7684\u878d\u8cc7\u3002\u65b0\u6295\u8cc7\u8005ARCH Venture Partners\u9818\u6295\uff0c\u5176\u4ed6\u65b0\u6295\u8cc7\u8005Insight Partners\u3001Platanus\u3001Solas BioVentures\u548cRTW Investments\uff0c\u4ee5\u53ca\u73fe\u6709\u6295\u8cc7\u8005\u8ddf\u6295\u3002ARCH Venture Partners\u8463\u4e8b\u7e3d\u7d93\u7406Steven Gillis\u535a\u58eb\u5c07\u64d4\u4efbBasking\u8463\u4e8b\u6703\u4e3b\u5e2d\u3002\u6b64\u524d\u516c\u53f8\u66fe\u5b8c\u6210540\u842c\u7f8e\u5143\u7a2e\u5b50\u8f2a\u878d\u8cc7\uff0c\u6295\u8cc7\u8005\u5305\u62ecRev1 Ventures\u3001Broadview Ventures\u548c\u7dad\u4e9e\u751f\u7269\u3002<\/p>\n<p>Basking\u5c07\u5229\u7528\u878d\u8cc7\u52a0\u901fBB-031\u7684\u81e8\u5e8a\u958b\u767c\u3002\u9019\u662f\u4e00\u7a2e\u9776\u5411von Willebrand\u56e0\u5b50\uff08vWF\uff09\u7684\u540c\u985e\u9996\u5275\u53ef\u9006RNA aptamers\uff0c\u5c08\u70ba\u5feb\u901f\u8d77\u6548\u548c\u77ed\u6301\u7e8c\u6642\u9593\u7684\u7642\u6548\u800c\u8a2d\u8a08\u3002<\/p>\n<p class=\"prntal\"><b>\u7279\u79d1\u7f85\u7372\u842c\u7269\u5275\u6295\u6578\u767e\u842c\u7f8e\u5143Pre-B\u8f2a\u878d\u8cc7\uff0c\u4e14\u5176\u6cbb\u7642\u96c4\u6fc0\u7d20\u6027\u812b\u9aee\u5168\u7403\u9996\u5275\u65b0\u85e5TDM-105795\u81e8\u5e8a\u4e8c\u671fa\u8a66\u9a57\u9806\u5229\u5b8c\u6210\u53ca\u5b8c\u6210\u91dd\u5c0d\u6fd5\u75b9\/\u76ae\u708e\u9069\u61c9\u75c7\u7684TDM-180935\u5291\u91cf\u905e\u589e\u7684\u4e00\u671f\u81e8\u5e8a\u8a66\u9a57<\/b><\/p>\n<p>\u64da\u52d5\u8108\u7db21\u670815\u65e5\u6d88\u606f\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u3001\u4e00\u5bb6\u5c08\u6ce8\u76ae\u819a\u75be\u75c5\u65b0\u85e5\u7814\u767c\u7684\u81e8\u5e8a\u968e\u6bb5\u516c\u53f8\u7279\u79d1\u7f85\u751f\u7269\u79d1\u6280\uff08\u6210\u90fd\uff09\u6709\u9650\u516c\u53f8\uff08\u4ee5\u4e0b\u7c21\u7a31\u300c\u7279\u79d1\u7f85\u300d\uff09\uff0c\u5ba3\u4f48\u5df2\u65bc\u8fd1\u671f\u5b8c\u6210\u6578\u5343\u842c\u4eba\u6c11\u5e63\u7684Pre-B\u8f2a\u878d\u8cc7\uff0c\u672c\u8f2a\u878d\u8cc7\u6295\u8cc7\u65b9\u70ba\u842c\u7269\u5275\u6295\uff0c\u6240\u878d\u8cc7\u91d1\u5c07\u7528\u65bc\u6bdb\u9aee\u9805\u76ee\u7684\u5f8c\u7e8c\u81e8\u5e8a\u958b\u767c\u548c\u6fd5\u75b9\u76ae\u708e\u9805\u76ee\u4e2d\u7f8e\u96d9\u5831\u7684\u4e8c\u671f\u81e8\u5e8a\u8a66\u9a57\uff08\u4e2d\u7f8eIIa\u81e8\u5e8a\uff09\u3002\u96a8\u5f8c2\u67085\u65e5\uff0c\u7279\u79d1\u7f85\u5f88\u9ad8\u8208\u5730\u5ba3\u4f48\uff1a\u5916\u7528\u5857\u62b9\u88fd\u5291TDM-105795\u7528\u65bc\u6cbb\u7642\u96c4\u6fc0\u7d20\u6027\u812b\u9aee\uff08AGA\uff09\u7684\u9996\u500b\u81e8\u5e8a\u4e8c\u671f\u8a66\u9a57\uff08NCT05802173\uff09\u9806\u5229\u5b8c\u6210\u3002<\/p>\n<p>\u6b64\u5916\uff0c2023\u5e7412\u67084\u65e5\uff0c\u7279\u79d1\u7f85\u5ba3\u4f48\u5df2\u7d93\u5b8c\u6210\u91dd\u5c0d\u7279\u61c9\u6027\u76ae\u708e\/\u6fd5\u75b9\u7684TDM-180935\u5916\u7528\u8edf\u818f\u7684\u4e00\u671f\u81e8\u5e8a\u8a66\u9a57\uff08NCT05525468\uff09\uff0c\u8a66\u9a57\u7d50\u679c\u5747\u9054\u5230\u9810\u671f\u3002<\/p>\n<p class=\"prntal\"><b>\u8f3b\u806f\u79d1\u6280\u5ba3\u4f48\u5b8c\u6210B\u8f2a\u7f8e\u5143\u878d\u8cc7\uff0c\u4e14\u5176\u6bd4\u5229\u6642GMP\u751f\u7522\u8a2d\u65bd\u5960\u57fa<\/b><\/p>\n<p>2024\u5e741\u67084\u65e5\uff0c\u4e0a\u6d77\/\u8b93\u5e03\u76e7\/\u6d77\u5fb7\u5821\u2014\u2014\u7dad\u4e9e\u751f\u7269\u88ab\u6295\u4f01\u696d\u3001\u5168\u9762\u6574\u5408\u7684\u570b\u969b\u5316\u653e\u5c04\u6027\u85e5\u7269\u6cbb\u7642\u516c\u53f8\u8f3b\u806f\u79d1\u6280\u6709\u9650\u516c\u53f8\uff08\u4ee5\u4e0b\u7c21\u7a31\u300c\u8f3b\u806f\u79d1\u6280\u300d\uff09\uff0c\u5ba3\u4f48\u5b8c\u62106330\u842c\u7f8e\u5143\u878d\u8cc7\uff0c\u5176\u4e2d\u5305\u62ec4730\u842c\u7f8e\u5143\u7684B\u8f2a\u80a1\u6b0a\u878d\u8cc7\u548c1600\u842c\u7f8e\u5143\u7684\u6388\u4fe1\u984d\u5ea6\u3002\u672c\u6b21\u878d\u8cc7\u5c07\u5e6b\u52a9\u516c\u53f8\u5feb\u901f\u63a8\u9032\u5176\u653e\u5c04\u6027\u85e5\u7269\u7ba1\u7dda\u7684\u958b\u767c\u548c\u85e5\u7269\u751f\u7522\u80fd\u529b\u7684\u5efa\u8a2d\uff0c\u4e26\u512a\u5316\u5176\u5c08\u6709\u767c\u73fe\u5e73\u53f0UniRDC\u2122\u3002\u00a0\u96a8\u8457\u672c\u6b21\u878d\u8cc7\u7684\u5b8c\u6210\uff0c\u8f3b\u806f\u79d1\u6280\u81ea2021\u5e748\u6708\u6210\u7acb\u4ee5\u4f86\u5df2\u7d2f\u8a08\u878d\u8cc7\u8d85\u904e1.1\u5104\u7f8e\u5143\uff0c\u5305\u62ec\u80a1\u6b0a\u878d\u8cc7\u3001\u50b5\u6b0a\u878d\u8cc7\u548c\u653f\u5e9c\u88dc\u8cbc\u3002<\/p>\n<p>\u6b64\u524d12\u67088\u65e5\uff0c\u8f3b\u806f\u79d1\u6280\u9084\u5ba3\u4f48\u4e86\u5728\u6bd4\u5229\u6642\u8b93\u5e03\u76e7\u5e02\u958b\u5de5\u5efa\u8a2d\u5176\u7b26\u5408\u751f\u7522\u8cea\u91cf\u7ba1\u7406\u898f\u7bc4\uff08\u300cGMP\u300d\uff09\u7684\u653e\u5c04\u6027\u85e5\u7269\u751f\u7522\u8a2d\u65bd\uff0c\u4ee5\u9032\u4e00\u6b65\u63a8\u9032\u653e\u5c04\u6027\u85e5\u7269\u7684\u5168\u7522\u696d\u93c8\u89e3\u6c7a\u65b9\u6848\u3002<\/p>\n<p class=\"prntal\"><b>\u7dad\u7738\u751f\u7269\u7372\u9999\u6e2f\u5275\u65b0\u79d1\u6280\u7f72\u300c\u4f01\u696d\u652f\u63f4\u8a08\u5283\u300d\u8cc7\u52a9\uff0c\u4e14\u69ae\u767b\u300a2023\u80e1\u6f64\u5168\u7403\u7375\u8c79\u4f01\u696d\u699c\u300b<\/b><\/p>\n<p>\u8fd1\u671f\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u7dad\u7738\u751f\u7269\u7684\u9999\u6e2f\u5b50\u516c\u53f8\uff0c\u4e00\u5bb6\u805a\u7126\u5dee\u7570\u5316\u548c\u5168\u7403\u65b0\u958b\u767c\u7684\u773c\u79d1\u5275\u65b0\u85e5\u516c\u53f8\uff0c\u5ba3\u4f48\u5176\u5275\u65b0\u773c\u5e95\u85e5\u7269VVN481\u6210\u529f\u7372\u5f97\u9999\u6e2f\u5275\u65b0\u79d1\u6280\u7f72\u300c\u4f01\u696d\u652f\u63f4\u8a08\u5283Enterprise Support Scheme\u300d\uff08ESS\u2014Hong Kong-Israel R&amp;D Cooperation Programme\uff09\u00a0\u8cc7\u52a9\u3002\u6b64\u6b21\u8cc7\u52a9\u5c07\u7528\u65bc\u63a8\u9032\u8a72\u7ba1\u7dda\u7684\u81e8\u5e8a\u524d\u7814\u767c\u5de5\u4f5c\uff0c\u4ee5\u671f\u66f4\u5feb\u63a8\u9032\u5230\u81e8\u5e8a\u968e\u6bb5\u3002\u6b64\u5916\uff0c\u8fd1\u65e5\u7dad\u7738\u751f\u7269\u9084\u69ae\u767b\u300a2023\u80e1\u6f64\u5168\u7403\u7375\u8c79\u4f01\u696d\u699c\u300b\u3002<\/p>\n<p class=\"prntal\"><b>\u7dad\u4e9e\u751f\u7269\u88ab\u6295\u4f01\u696dAbsci\u5ba3\u4f48\u8207\u963f\u65af\u5229\u5eb7\u5408\u4f5c\u958b\u767c\u4eba\u5de5\u667a\u80fd\u9a45\u52d5\u7684\u816b\u7624\u5019\u9078\u85e5\u7269<\/b><\/p>\n<p>\u83ef\u76db\u9813\u5dde\u6eab\u54e5\u83ef\uff0c2023\u5e7412\u67084\u65e5\u2014\u2014\u7dad\u4e9e\u751f\u7269\u88ab\u6295\u4f01\u696d\u3001\u751f\u6210\u5f0f\u4eba\u5de5\u667a\u80fd\u6297\u9ad4\u767c\u73fe\u9818\u57df\u7684\u9818\u5c0e\u8005Absci\u516c\u53f8\uff08NASDAQ:ABSI\uff09\uff0c\u5ba3\u4f48\u8207\u5168\u7403\u751f\u7269\u88fd\u85e5\u516c\u53f8\u963f\u65af\u5229\u5eb7\uff08AstraZeneca\uff09\u5408\u4f5c\uff0c\u91dd\u5c0d\u816b\u7624\u9776\u9ede\u63d0\u4f9b\u4eba\u5de5\u667a\u80fd\u8a2d\u8a08\u7684\u6297\u9ad4\u3002\u6b64\u6b21\u5408\u4f5c\u5c07Absci\u7684Integrated Drug Creation\u2122\u5e73\u53f0\u8207\u963f\u65af\u5229\u5eb7\u5728\u816b\u7624\u5b78\u9818\u57df\u7684\u5c08\u696d\u77e5\u8b58\u76f8\u7d50\u5408\uff0c\u65e8\u5728\u52a0\u901f\u767c\u73fe\u6f5b\u5728\u7684\u65b0\u578b\u764c\u75c7\u6cbb\u7642\u5019\u9078\u85e5\u7269\u3002\u64da\u6089\uff0c\u8a72\u5354\u8b70\u5305\u62ec\u9810\u4ed8\u6b3e\u3001\u7814\u767c\u7d93\u8cbb\u548c\u91cc\u7a0b\u7891\u6b3e\u9805\u7b49\uff0c\u7e3d\u91d1\u984d\u9ad8\u90542.47\u5104\u7f8e\u5143\u3002<\/p>\n<p><b>\u95dc\u65bc\u535a\u81f4\u751f\u7269<\/b><\/p>\n<p>\u535a\u81f4\u751f\u7269\u5275\u7acb\u65bc2019\u5e74\uff0c\u7531\u86cb\u767d\u8cea\u5de5\u7a0b\u548c\u816b\u7624\u514d\u75ab\u9818\u57df\u7684\u9802\u5c16\u5c08\u5bb6\u5718\u968a\u7d44\u5efa\uff0c\u81f4\u529b\u65bc\u958b\u767c\u65b0\u4e00\u4ee3\u7d30\u80de\u56e0\u5b50\u6297\u816b\u7624\u514d\u75ab\u7642\u6cd5\u3002\u516c\u53f8\u81ea\u4e3b\u7814\u767c\u4e86\u300cCrossover\u300d\u524d\u85e5\u6280\u8853\u5e73\u53f0\uff0c\u80fd\u5be6\u73fe\u7d30\u80de\u56e0\u5b50\u5728\u816b\u7624\u5fae\u74b0\u5883\u4e2d\u7279\u7570\u6027\u91cb\u653e\uff0c\u6709\u6548\u89e3\u6c7a\u4e86\u7d30\u80de\u56e0\u5b50\u7684\u5916\u5468\u6bd2\u6027\u554f\u984c\u3002\u4f9d\u8a17\u8a72\u5e73\u53f0\u6280\u8853\uff0c\u516c\u53f8\u6210\u529f\u958b\u767c\u4e86\u81e8\u5e8a\u5019\u9078\u85e5\u7269PTX-912\uff0c\u5df2\u7d93\u555f\u52d5\u7f8e\u570b1\u671f\u81e8\u5e8a\u8a66\u9a57\u3002<\/p>\n<p><b>\u95dc\u65bc<\/b><b>AceLink Therapeutics<\/b><\/p>\n<p>AceLink Therapeutics\u6210\u7acb\u65bc2018\u5e74\uff0c\u662f\u4e00\u5bb6\u5275\u65b0\u578b\u751f\u7269\u88fd\u85e5\u521d\u5275\u516c\u53f8\uff0c\u5c08\u6ce8\u65bc\u958b\u767c\u5b89\u5168\u6709\u6548\u7684\u85e5\u7269\uff0c\u4ee5\u6eff\u8db3\u5b58\u5728\u9ad8\u5ea6\u672a\u6eff\u8db3\u7684\u81e8\u5e8a\u9700\u6c42\u7684\u907a\u50b3\u6027\u75be\u75c5\u3002\u516c\u53f8\u6700\u521d\u7684\u91cd\u9ede\u662f\u958b\u767c\u6cd5\u5e03\u745e\u6c0f\u75c7\u7684\u65b0\u578b\u6cbb\u7642\u65b9\u6cd5\u3002\u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8acb\u8a2a\u554f <a href=\"https:\/\/www.acelinktherapeutics.com\/\" target=\"_blank\" rel=\"nofollow noopener\">www.acelinktherapeutics.com<\/a><\/p>\n<p><b>\u95dc\u65bc<\/b><b>Basking Biosciences<\/b><\/p>\n<p>Basking Biosciences\u662f\u4e00\u5bb6\u8655\u65bc\u81e8\u5e8a\u968e\u6bb5\u7684\u516c\u53f8\uff0c\u65e8\u5728\u89e3\u6c7a\u7f3a\u8840\u6027\u8166\u5352\u4e2d\u6cbb\u7642\u7684\u6700\u5927\u9700\u6c42\u2014\u2014\u4e00\u7a2e\u5feb\u901f\u8d77\u6548\u7684\u77ed\u6548\u6eb6\u6813\u85e5\u7269\uff0c\u80fd\u5920\u63d0\u4f9b\u6bd4\u73fe\u6709\u7642\u6cd5\u5927\u5927\u5ef6\u9577\u7684\u6cbb\u7642\u7a97\u53e3\uff0c\u4e26\u91cd\u65b0\u758f\u901a\u963b\u585e\u7684\u52d5\u8108\uff0c\u4e26\u4e14\u5728\u51fa\u8840\u6642\u53ef\u4ee5\u8fc5\u901f\u88ab\u9006\u8f49\u6d3b\u6027\u3002\u516c\u53f8\u6b63\u5728\u958b\u767c\u7684\u85e5\u7269BB-031\uff0c\u5373\u662f\u9019\u7a2efirst -in-class RNA\u9069\u914d\u9ad4\uff0c\u9776\u5411\u8840\u6813\u7684\u91cd\u8981\u7d50\u69cb\u6210\u5206\u548c\u51dd\u8840\u904e\u7a0b\u7684\u9a45\u52d5\u56e0\u7d20\u8840\u7ba1\u6027\u8840\u53cb\u75c5\u56e0\u5b50\uff08von Willebrand Factor\uff0cvWF\uff09\u3002<\/p>\n<p><b>\u95dc\u65bc\u7279\u79d1\u7f85\u751f\u7269\u79d1\u6280\uff08\u6210\u90fd\uff09\u6709\u9650\u516c\u53f8<\/b>\u00a0<\/p>\n<p>\u7279\u79d1\u7f85\u751f\u7269\u79d1\u6280\uff08\u6210\u90fd\uff09\u6709\u9650\u516c\u53f8\u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\u7684\u751f\u7269\u91ab\u85e5\u516c\u53f8\u3002\u516c\u53f8\u524d\u8eab\u70ba\u5609\u8208\u7279\u79d1\u7f85\u751f\u7269\u79d1\u6280\u6709\u9650\u516c\u53f8\uff0c\u65b0\u8fd1\u65bc2023\u5e743\u6708\u642c\u9077\u81f3\u56db\u5ddd\u7701\u6210\u90fd\u5929\u5e9c\u570b\u969b\u751f\u7269\u57ce\u3002<\/p>\n<p>\u516c\u53f8\u76ee\u524d\u7684\u6838\u5fc3\u7814\u767c\u9805\u76ee\u5305\u62ec\u91dd\u5c0d\u6cbb\u7642\u96c4\u6fc0\u7d20\u6027\u812b\u9aee\u3001\u7279\u61c9\u6027\u76ae\u708e\/\u6fd5\u75b9\u3001\u9280\u5c51\u75c5\u548c\u7d05\u6591\u72fc\u7621\u7b49\u75be\u75c5\u7684\u5275\u65b0\u85e5\u7269\u3002\u516c\u53f8\u5168\u7403\u9818\u5148\u7684\u6cbb\u7642\u96c4\u6fc0\u7d20\u6027\u812b\u9aee\u7684\u5c0f\u5206\u5b50\u5019\u9078\u85e5\u7269TDM-105795\u5373\u5c07\u5b8c\u6210\u4e8c\u671fa\u968e\u6bb5\u81e8\u5e8a\u8a66\u9a57\uff0c\u91dd\u5c0d\u7279\u61c9\u6027\u76ae\u708e\/\u6fd5\u75b9\u7684\u5275\u65b0\u578bJAK1\/TYK2\u6291\u5236\u5291\u4e5f\u5df2\u7d93\u5b8c\u6210\u4e00\u671f\u81e8\u5e8a\u8a66\u9a57\uff0c\u5373\u5c07\u958b\u5c55\u81e8\u5e8a\u4e8c\u671fPOC\u8a66\u9a57\u3002\u516c\u53f8\u5177\u6709\u591a\u500b\u81e8\u5e8a\u524d\u6216\u81e8\u5e8a\u968e\u6bb5\u7684\u5019\u9078\u85e5\u7269\uff0c\u5728\u7814\u7ba1\u7dda\u7522\u54c1\u90fd\u662f\u91dd\u5c0d\u6cbb\u7642\u5404\u7a2e\u76ae\u819a\u9069\u61c9\u75c7\u3002<\/p>\n<p><b>\u95dc\u65bc\u8f3b\u806f\u79d1\u6280<\/b><\/p>\n<p>\u8f3b\u806f\u79d1\u6280\u6709\u9650\u516c\u53f8\uff08\u300c\u8f3b\u806f\u79d1\u6280\u300d\uff09\u662f\u4e00\u5bb6\u5168\u9762\u6574\u5408\u7684\u570b\u969b\u5316\u653e\u5c04\u6027\u85e5\u7269\u6cbb\u7642\u516c\u53f8\uff0c\u5728\u6bd4\u5229\u6642\u3001\u5fb7\u570b\u548c\u4e2d\u570b\u5747\u8a2d\u6709\u8fa6\u4e8b\u8655\u3002\u6211\u5011\u81f4\u529b\u65bc\u6253\u9020\u64c1\u6709\u653e\u5c04\u6027\u85e5\u7269\u7814\u767c\u3001\u751f\u7522\u548c\u5546\u696d\u5316\u7684\u5168\u7522\u696d\u93c8\u7684\u6838\u85e5\u516c\u53f8\u4ee5\u9020\u798f\u5168\u7403\u60a3\u8005\u3002\u6211\u5011\u8a08\u5283\u901a\u904e\u91dd\u5c0d\u672a\u4f86\u6cbb\u7642\u65b9\u6cd5\u7684\u5275\u65b0\u7814\u7a76\u4f86\u89e3\u6c7a\u76ee\u524d\u5f71\u97ff\u653e\u5c04\u6027\u85e5\u7269\u7814\u767c\u7684\u6838\u5fc3\u554f\u984c\u3002\u6211\u5011\u5718\u968a\u4e2d\u4e0d\u4e4f\u7d93\u9a57\u8c50\u5bcc\u7684\u4f01\u696d\u5bb6\u548c\u79d1\u5b78\u5bb6\uff0c\u4ed6\u5011\u65e2\u64c5\u9577\u7ba1\u7406\u751f\u7269\u91ab\u85e5\u516c\u53f8\uff0c\u4e5f\u6df1\u8af3\u653e\u5c04\u6027\u540c\u4f4d\u7d20\u7684\u7814\u7a76\u548c\u81e8\u5e8a\u958b\u767c\u65b9\u6cd5\u3002<\/p>\n<p><b>\u95dc\u65bc\u7dad\u7738\u751f\u7269<\/b><\/p>\n<p>\u7dad\u7738\u751f\u7269\u662f\u4e00\u5bb6\u5c08\u6ce8\u65bc\u773c\u79d1\u5275\u65b0\u85e5\u7814\u767c\u9818\u57df\u7684\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u64c1\u6709\u570b\u969b\u4e00\u6d41\u7684\u773c\u79d1\u5275\u65b0\u85e5\u7814\u767c\u5718\u968a\u548c\u6280\u8853\u5e73\u53f0\uff0c\u4f9d\u8a17\u81ea\u4e3b\u7814\u767c\u5df2\u7d93\u5efa\u7acb\u8d77\u5177\u6709\u5168\u7403\u7af6\u722d\u529b\u7684\u7522\u54c1\u7ba1\u7dda\u3002\u9664VVN001\u9805\u76ee\u5916\uff0c\u7dad\u7738\u751f\u7269\u6b63\u5728\u958b\u767cVVN539\u7528\u65bc\u6cbb\u7642\u9752\u5149\u773c\u6216\u9ad8\u773c\u58d3\u75c7\uff0cVVN461\u7528\u65bc\u6cbb\u7642\u975e\u611f\u67d3\u6027\u524d\u8461\u8404\u819c\u708e\u548c\u8853\u5f8c\u708e\u75c7\u3002\u7dad\u7738\u751f\u7269\u9084\u81f4\u529b\u65bc\u767c\u73fe\u548c\u958b\u767c\u7528\u65bc\u6cbb\u7642\u5176\u4ed6\u524d\u3001\u5f8c\u773c\u75be\u75c5\u7684\u65b0\u7642\u6cd5\u3002<\/p>\n<p><b>\u95dc\u65bc<\/b><b>Absci<\/b><\/p>\n<p>Absci\u662f\u4e00\u5bb6\u751f\u6210\u578b\u4eba\u5de5\u667a\u80fd\u85e5\u7269\u958b\u767c\u516c\u53f8\uff0c\u5c07\u4eba\u5de5\u667a\u80fd\u8207\u53ef\u64f4\u5c55\u7684\u6fd5\u5be6\u9a57\u5ba4\u6280\u8853\u76f8\u7d50\u5408\uff0c\u66f4\u5feb\u5730\u70ba\u60a3\u8005\u5275\u9020\u66f4\u597d\u7684\u751f\u7269\u88fd\u54c1\u3002\u5176Integrated Drug Creation\u2122\u5e73\u53f0\u901a\u904e\u540c\u6642\u512a\u5316\u517c\u5177\u958b\u767c\u548c\u6cbb\u7642\u6548\u679c\u7684\u591a\u7a2e\u85e5\u7269\u7279\u6027\uff0c\u91cb\u653e\u4e86\u52a0\u5feb\u85e5\u7269\u4e0a\u5e02\u6642\u9593\u548c\u63d0\u9ad8\u6210\u529f\u6982\u7387\u7684\u6f5b\u529b\u3002\u901a\u904e\u6578\u64da\u5b78\u7fd2\u3001\u4eba\u5de5\u667a\u80fd\u5275\u9020\u548c\u6fd5\u6cd5\u5be6\u9a57\u5ba4\u9a57\u8b49\uff0cAbsci \u6bcf\u9031\u53ef\u7be9\u9078\u6578\u5341\u5104\u500b\u7d30\u80de\uff0c\u4f7f\u5176\u80fd\u5920\u5728\u77ed\u77ed\u516d\u9031\u5167\u5b8c\u6210\u5f9e\u4eba\u5de5\u667a\u80fd\u8a2d\u8a08\u6297\u9ad4\u5230\u6fd5\u6cd5\u5be6\u9a57\u5ba4\u9a57\u8b49\u5019\u9078\u85e5\u7269\u7684\u904e\u7a0b\u3002Absci\u7684\u9858\u666f\u662f\u70ba\u6bcf\u500b\u4eba\u4e00\u9375\u63d0\u4f9b\u7a81\u7834\u6027\u7684\u6cbb\u7642\u65b9\u6cd5\u3002\u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8acb\u8a2a\u554f<a href=\"https:\/\/www.absci.com\/\" target=\"_blank\" rel=\"nofollow noopener\">www.absci.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u9999\u6e2f2024\u5e743\u67086\u65e5 \/\u7f8e\u901a&#8230;<\/p>\n","protected":false},"author":16,"featured_media":199219,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"fifu_image_url":"","fifu_image_alt":"","footnotes":""},"categories":[40567],"tags":[],"class_list":["post-222124","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-40567"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>\u7dad\u4e9e\u751f\u7269\u6295\u8cc7\u5b75\u5316\u516c\u53f8\u8fd1\u671f\u767c\u5c55\u52d5\u614b\u4e00\u89bd - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831<\/title>\n<meta name=\"description\" content=\"\u9999\u6e2f2024\u5e743\u67086\u65e5 \/\u7f8e\u901a\u793e\/ -- \u9762\u5c0d\u4e0d\u65b7\u8b8a\u5316\u7684\u5c40\u52e2\uff0c\u6280\u8853\u5275\u65b0\u4f9d\u820a\u662f\u751f\u7269\u91ab\u85e5\u4f01\u696d\u9577\u9060\u767c\u5c55\u6c38\u6046\u7684\u4e3b\u65cb\u5f8b\uff0c\u70ba\u4f01\u696d\u6e90\u6e90\u4e0d\u65b7\u5730\u6ce8\u5165\u751f\u547d\u529b\uff0c\u6301\u7e8c\u63a8\u52d5\u7814\u767c\u300c\u5f9e0\u52301\u300d\u8f49\u5316\u4ee5\u53ca\u5546\u696d\u5316\u6210\u529f\u3002\u8fd1\u671f\uff0c\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u4f01\u696d\u53c8\u6709\u65b0\u7684\u52d5\u614b\uff1aAceLink\u3001\u7279\u79d1\u7f85\u7814\u767c\u9032\u5c55\u9806\u5229\uff1b\u535a\u81f4\u751f\u7269\u3001Basking\u3001\u7279\u79d1\u7f85\u3001\u8f3b\u806f\u79d1\u6280\u6210\u529f\u5b8c\u6210\u878d\u8cc7\uff1b\u7dad\u7738\u751f\u7269\u65ac\u7372\u6b8a\u69ae\uff1bAbsci\u9054\u6210\u91cd\u8981\u5408\u4f5c\u3002 \u535a\u81f4\u751f\u7269\u5b8c\u62101800\u842c\u7f8e\u5143A\u8f2a\u878d\u8cc7 \u8fd1\u65e5\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u535a\u81f4\u751f\u7269\uff08Proviva Therapeutics\uff09\u6b23\u7136\u5ba3\u4f48\u5b8c\u62101800\u842c\u7f8e\u5143\u7684A\u8f2a\u878d\u8cc7\uff0c\u4ee5\u63a8\u9032\u5176\u6838\u5fc3\u7522\u54c1PTX-912\u7684\u81e8\u5e8a\u958b\u767c\u3002\u9f8d\u78d0\u6295\u8cc7\uff0c\u6069\u7136\u5275\u6295\u548c\u4ed9\u77b3\u8cc7\u672c\u806f\u5408\u53c3\u52a0\u672c\u8f2a\u878d\u8cc7\u3002 \u535a\u81f4\u751f\u7269\u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\u7684\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u81f4\u529b\u65bc\u958b\u767c\u65b0\u4e00\u4ee3\u7d30\u80de\u56e0\u5b50\u6297\u816b\u7624\u514d\u75ab\u7642\u6cd5\u3002\u91dd\u5c0d\u7d30\u80de\u56e0\u5b50\u5916\u5468\u6bd2\u6027\u7684\u50b3\u7d71\u96e3\u984c\uff0c\u516c\u53f8\u81ea\u4e3b\u958b\u767c\u4e86\u300cCrossover\u300d\u7d30\u80de\u56e0\u5b50\u524d\u85e5\u6280\u8853\u5e73\u53f0\uff0c\u5be6\u73fe\u5728\u816b\u7624\u5fae\u74b0\u5883\u4e2d\u7279\u7570\u6027\u7684\u85e5\u7269\u6d3b\u6027\u91cb\u653e\u3002\u4f9d\u8a17\u300cCrossover\u300d\u6280\u8853\u5e73\u53f0\uff0c\u535a\u81f4\u6210\u529f\u7814\u767c\u51faPTX-912\u2014\u2014\u65b0\u4e00\u4ee3\u514d\u75ab\u7d30\u80de\u9776\u5411\u7684\u767d\u7d30\u80de\u4ecb\u7d20-2\uff08IL-2\uff09\u524d\u85e5\u878d\u5408\u86cb\u767d\u3002 AceLink Therapeutics\u767c\u4f48\u5065\u5eb7\u5fd7\u9858\u8005\u53c3\u8207\u8a55\u4f30AL01211\u7684I\u671f\u81e8\u5e8a\u8a66\u9a57\u6578\u64da \u7d10\u74e6\u514b\uff0c\u52a0\u5229\u798f\u5c3c\u4e9e\u5dde\u2014\u20142024\u5e742\u670826\u65e5\uff0cAceLink Therapeutics\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u3001\u4e00\u5bb6\u958b\u767c\u4e0b\u4e00\u4ee3\u53e3\u670d\u5e95\u7269\u6e1b\u5c11\u7642\u6cd5\uff08SRTs\uff09\u7684\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u88fd\u85e5\u516c\u53f8\u5ba3\u4f48\uff0c\u5176\u5728\u5065\u5eb7\u5fd7\u9858\u8005\u4e2d\u9032\u884c\u7684AL01211\u7684I\u671f\u7814\u7a76\u7684\u7d50\u679c\u5df2\u7d93\u767c\u8868\u5728\u540c\u884c\u8a55\u5be9\u7684\u7f8e\u570b\u81e8\u5e8a\u85e5\u5b78\u9662\u671f\u520a\u300aClinical Pharmacology in Drug Development\u300b\u4e0a\u3002AL01211\u662f\u4e00\u7a2e\u5f37\u5927\u7684\u53e3\u670d\u8461\u7cd6\u795e\u7d93\u91af\u80fa\u5408\u6210\u9176\uff08GCS\uff09\u6291\u5236\u5291\uff0c\u6b63\u5728\u958b\u767c\u7528\u65bc\u6cbb\u7642\u6cd5\u5e03\u745e\u6c0f\u75c7\u548cI\u578b\u9ad8\u96ea\u6c0f\u75c7\u3002 \u5728\u5df2\u767c\u8868\u7684I\u671f\u7814\u7a76\u4e2d\uff0c\u5c0dAL01211\u9032\u884c\u4e86\u55ae\u5291\u91cf\u905e\u589e\u548c\u591a\u5291\u91cf\u905e\u589e\u7684\u7814\u7a76\uff0c\u4ee5\u78ba\u5b9a\u5176\u5728\u5065\u5eb7\u5fd7\u9858\u8005\u4e2d\u7684\u5b89\u5168\u6027\u3001\u85e5\u4ee3\u52d5\u529b\u5b78\uff08PK\uff09\u548c\u85e5\u6548\u5b78\uff08PD\uff09\u6548\u61c9\u3002\u7e3d\u9ad4\u800c\u8a00\uff0cAL01211\u5177\u6709\u826f\u597d\u7684\u5b89\u5168\u6027\u548c\u8010\u53d7\u6027\uff0c\u7121\u56b4\u91cd\u4e0d\u826f\u4e8b\u4ef6\u3002\u572830mg\u5291\u91cf\u6c34\u5e73\u4e0b\uff0c\u8840\u6f3f\u8461\u7cd6\u57fa\u795e\u7d93\u91af\u80fa\u548c\u7403\u86cb\u767d\u4e09\u7cd6\u795e\u7d93\u91af\u80fa\u5206\u5225\u5f9e\u57fa\u7dda\u6c34\u6e96\u964d\u4f4e\u4e8678%\u548c52%\uff0c\u5f9e\u800c\u652f\u6301AL01211\u7684\u9032\u4e00\u6b65\u81e8\u5e8a\u7814\u7a76\u3002 Basking\u5ba3\u4f48\u5b8c\u6210\u7531ARCH\u9818\u6295\u76845500\u842c\u7f8e\u5143\u878d\u8cc7\uff0c\u52a0\u901f\u53ef\u9006\u6eb6\u6813\u5291\u7684\u81e8\u5e8a\u958b\u767c \u4fc4\u4ea5\u4fc4\u5dde\u54e5\u502b\u5e03\u2014\u20142024\u5e741\u670830\u65e5\uff0cBasking Biosciences\uff08\u4ee5\u4e0b\u7c21\u7a31\u300cBasking\u300d\uff09\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\uff0c\u4e00\u5bb6\u958b\u767c\u65b0\u578b\u6025\u6027\u6eb6\u6813\u7642\u6cd5\u6cbb\u7642\u5352\u4e2d\u7684\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u88fd\u85e5\u516c\u53f8\uff0c\u5ba3\u4f48\u5b8c\u62105500\u842c\u7f8e\u5143\u7684\u878d\u8cc7\u3002\u65b0\u6295\u8cc7\u8005ARCH Venture Partners\u9818\u6295\uff0c\u5176\u4ed6\u65b0\u6295\u8cc7\u8005Insight Partners\u3001Platanus\u3001Solas BioVentures\u548cRTW Investments\uff0c\u4ee5\u53ca\u73fe\u6709\u6295\u8cc7\u8005\u8ddf\u6295\u3002ARCH Venture Partners\u8463\u4e8b\u7e3d\u7d93\u7406Steven Gillis\u535a\u58eb\u5c07\u64d4\u4efbBasking\u8463\u4e8b\u6703\u4e3b\u5e2d\u3002\u6b64\u524d\u516c\u53f8\u66fe\u5b8c\u6210540\u842c\u7f8e\u5143\u7a2e\u5b50\u8f2a\u878d\u8cc7\uff0c\u6295\u8cc7\u8005\u5305\u62ecRev1 Ventures\u3001Broadview Ventures\u548c\u7dad\u4e9e\u751f\u7269\u3002 Basking\u5c07\u5229\u7528\u878d\u8cc7\u52a0\u901fBB-031\u7684\u81e8\u5e8a\u958b\u767c\u3002\u9019\u662f\u4e00\u7a2e\u9776\u5411von Willebrand\u56e0\u5b50\uff08vWF\uff09\u7684\u540c\u985e\u9996\u5275\u53ef\u9006RNA aptamers\uff0c\u5c08\u70ba\u5feb\u901f\u8d77\u6548\u548c\u77ed\u6301\u7e8c\u6642\u9593\u7684\u7642\u6548\u800c\u8a2d\u8a08\u3002 \u7279\u79d1\u7f85\u7372\u842c\u7269\u5275\u6295\u6578\u767e\u842c\u7f8e\u5143Pre-B\u8f2a\u878d\u8cc7\uff0c\u4e14\u5176\u6cbb\u7642\u96c4\u6fc0\u7d20\u6027\u812b\u9aee\u5168\u7403\u9996\u5275\u65b0\u85e5TDM-105795\u81e8\u5e8a\u4e8c\u671fa\u8a66\u9a57\u9806\u5229\u5b8c\u6210\u53ca\u5b8c\u6210\u91dd\u5c0d\u6fd5\u75b9\/\u76ae\u708e\u9069\u61c9\u75c7\u7684TDM-180935\u5291\u91cf\u905e\u589e\u7684\u4e00\u671f\u81e8\u5e8a\u8a66\u9a57 \u64da\u52d5\u8108\u7db21\u670815\u65e5\u6d88\u606f\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u3001\u4e00\u5bb6\u5c08\u6ce8\u76ae\u819a\u75be\u75c5\u65b0\u85e5\u7814\u767c\u7684\u81e8\u5e8a\u968e\u6bb5\u516c\u53f8\u7279\u79d1\u7f85\u751f\u7269\u79d1\u6280\uff08\u6210\u90fd\uff09\u6709\u9650\u516c\u53f8\uff08\u4ee5\u4e0b\u7c21\u7a31\u300c\u7279\u79d1\u7f85\u300d\uff09\uff0c\u5ba3\u4f48\u5df2\u65bc\u8fd1\u671f\u5b8c\u6210\u6578\u5343\u842c\u4eba\u6c11\u5e63\u7684Pre-B\u8f2a\u878d\u8cc7\uff0c\u672c\u8f2a\u878d\u8cc7\u6295\u8cc7\u65b9\u70ba\u842c\u7269\u5275\u6295\uff0c\u6240\u878d\u8cc7\u91d1\u5c07\u7528\u65bc\u6bdb\u9aee\u9805\u76ee\u7684\u5f8c\u7e8c\u81e8\u5e8a\u958b\u767c\u548c\u6fd5\u75b9\u76ae\u708e\u9805\u76ee\u4e2d\u7f8e\u96d9\u5831\u7684\u4e8c\u671f\u81e8\u5e8a\u8a66\u9a57\uff08\u4e2d\u7f8eIIa\u81e8\u5e8a\uff09\u3002\u96a8\u5f8c2\u67085\u65e5\uff0c\u7279\u79d1\u7f85\u5f88\u9ad8\u8208\u5730\u5ba3\u4f48\uff1a\u5916\u7528\u5857\u62b9\u88fd\u5291TDM-105795\u7528\u65bc\u6cbb\u7642\u96c4\u6fc0\u7d20\u6027\u812b\u9aee\uff08AGA\uff09\u7684\u9996\u500b\u81e8\u5e8a\u4e8c\u671f\u8a66\u9a57\uff08NCT05802173\uff09\u9806\u5229\u5b8c\u6210\u3002 \u6b64\u5916\uff0c2023\u5e7412\u67084\u65e5\uff0c\u7279\u79d1\u7f85\u5ba3\u4f48\u5df2\u7d93\u5b8c\u6210\u91dd\u5c0d\u7279\u61c9\u6027\u76ae\u708e\/\u6fd5\u75b9\u7684TDM-180935\u5916\u7528\u8edf\u818f\u7684\u4e00\u671f\u81e8\u5e8a\u8a66\u9a57\uff08NCT05525468\uff09\uff0c\u8a66\u9a57\u7d50\u679c\u5747\u9054\u5230\u9810\u671f\u3002 \u8f3b\u806f\u79d1\u6280\u5ba3\u4f48\u5b8c\u6210B\u8f2a\u7f8e\u5143\u878d\u8cc7\uff0c\u4e14\u5176\u6bd4\u5229\u6642GMP\u751f\u7522\u8a2d\u65bd\u5960\u57fa 2024\u5e741\u67084\u65e5\uff0c\u4e0a\u6d77\/\u8b93\u5e03\u76e7\/\u6d77\u5fb7\u5821\u2014\u2014\u7dad\u4e9e\u751f\u7269\u88ab\u6295\u4f01\u696d\u3001\u5168\u9762\u6574\u5408\u7684\u570b\u969b\u5316\u653e\u5c04\u6027\u85e5\u7269\u6cbb\u7642\u516c\u53f8\u8f3b\u806f\u79d1\u6280\u6709\u9650\u516c\u53f8\uff08\u4ee5\u4e0b\u7c21\u7a31\u300c\u8f3b\u806f\u79d1\u6280\u300d\uff09\uff0c\u5ba3\u4f48\u5b8c\u62106330\u842c\u7f8e\u5143\u878d\u8cc7\uff0c\u5176\u4e2d\u5305\u62ec4730\u842c\u7f8e\u5143\u7684B\u8f2a\u80a1\u6b0a\u878d\u8cc7\u548c1600\u842c\u7f8e\u5143\u7684\u6388\u4fe1\u984d\u5ea6\u3002\u672c\u6b21\u878d\u8cc7\u5c07\u5e6b\u52a9\u516c\u53f8\u5feb\u901f\u63a8\u9032\u5176\u653e\u5c04\u6027\u85e5\u7269\u7ba1\u7dda\u7684\u958b\u767c\u548c\u85e5\u7269\u751f\u7522\u80fd\u529b\u7684\u5efa\u8a2d\uff0c\u4e26\u512a\u5316\u5176\u5c08\u6709\u767c\u73fe\u5e73\u53f0UniRDC\u2122\u3002\u00a0\u96a8\u8457\u672c\u6b21\u878d\u8cc7\u7684\u5b8c\u6210\uff0c\u8f3b\u806f\u79d1\u6280\u81ea2021\u5e748\u6708\u6210\u7acb\u4ee5\u4f86\u5df2\u7d2f\u8a08\u878d\u8cc7\u8d85\u904e1.1\u5104\u7f8e\u5143\uff0c\u5305\u62ec\u80a1\u6b0a\u878d\u8cc7\u3001\u50b5\u6b0a\u878d\u8cc7\u548c\u653f\u5e9c\u88dc\u8cbc\u3002 \u6b64\u524d12\u67088\u65e5\uff0c\u8f3b\u806f\u79d1\u6280\u9084\u5ba3\u4f48\u4e86\u5728\u6bd4\u5229\u6642\u8b93\u5e03\u76e7\u5e02\u958b\u5de5\u5efa\u8a2d\u5176\u7b26\u5408\u751f\u7522\u8cea\u91cf\u7ba1\u7406\u898f\u7bc4\uff08\u300cGMP\u300d\uff09\u7684\u653e\u5c04\u6027\u85e5\u7269\u751f\u7522\u8a2d\u65bd\uff0c\u4ee5\u9032\u4e00\u6b65\u63a8\u9032\u653e\u5c04\u6027\u85e5\u7269\u7684\u5168\u7522\u696d\u93c8\u89e3\u6c7a\u65b9\u6848\u3002 \u7dad\u7738\u751f\u7269\u7372\u9999\u6e2f\u5275\u65b0\u79d1\u6280\u7f72\u300c\u4f01\u696d\u652f\u63f4\u8a08\u5283\u300d\u8cc7\u52a9\uff0c\u4e14\u69ae\u767b\u300a2023\u80e1\u6f64\u5168\u7403\u7375\u8c79\u4f01\u696d\u699c\u300b \u8fd1\u671f\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u7dad\u7738\u751f\u7269\u7684\u9999\u6e2f\u5b50\u516c\u53f8\uff0c\u4e00\u5bb6\u805a\u7126\u5dee\u7570\u5316\u548c\u5168\u7403\u65b0\u958b\u767c\u7684\u773c\u79d1\u5275\u65b0\u85e5\u516c\u53f8\uff0c\u5ba3\u4f48\u5176\u5275\u65b0\u773c\u5e95\u85e5\u7269VVN481\u6210\u529f\u7372\u5f97\u9999\u6e2f\u5275\u65b0\u79d1\u6280\u7f72\u300c\u4f01\u696d\u652f\u63f4\u8a08\u5283Enterprise Support Scheme\u300d\uff08ESS\u2014Hong Kong-Israel R&amp;D Cooperation Programme\uff09\u00a0\u8cc7\u52a9\u3002\u6b64\u6b21\u8cc7\u52a9\u5c07\u7528\u65bc\u63a8\u9032\u8a72\u7ba1\u7dda\u7684\u81e8\u5e8a\u524d\u7814\u767c\u5de5\u4f5c\uff0c\u4ee5\u671f\u66f4\u5feb\u63a8\u9032\u5230\u81e8\u5e8a\u968e\u6bb5\u3002\u6b64\u5916\uff0c\u8fd1\u65e5\u7dad\u7738\u751f\u7269\u9084\u69ae\u767b\u300a2023\u80e1\u6f64\u5168\u7403\u7375\u8c79\u4f01\u696d\u699c\u300b\u3002 \u7dad\u4e9e\u751f\u7269\u88ab\u6295\u4f01\u696dAbsci\u5ba3\u4f48\u8207\u963f\u65af\u5229\u5eb7\u5408\u4f5c\u958b\u767c\u4eba\u5de5\u667a\u80fd\u9a45\u52d5\u7684\u816b\u7624\u5019\u9078\u85e5\u7269 \u83ef\u76db\u9813\u5dde\u6eab\u54e5\u83ef\uff0c2023\u5e7412\u67084\u65e5\u2014\u2014\u7dad\u4e9e\u751f\u7269\u88ab\u6295\u4f01\u696d\u3001\u751f\u6210\u5f0f\u4eba\u5de5\u667a\u80fd\u6297\u9ad4\u767c\u73fe\u9818\u57df\u7684\u9818\u5c0e\u8005Absci\u516c\u53f8\uff08NASDAQ:ABSI\uff09\uff0c\u5ba3\u4f48\u8207\u5168\u7403\u751f\u7269\u88fd\u85e5\u516c\u53f8\u963f\u65af\u5229\u5eb7\uff08AstraZeneca\uff09\u5408\u4f5c\uff0c\u91dd\u5c0d\u816b\u7624\u9776\u9ede\u63d0\u4f9b\u4eba\u5de5\u667a\u80fd\u8a2d\u8a08\u7684\u6297\u9ad4\u3002\u6b64\u6b21\u5408\u4f5c\u5c07Absci\u7684Integrated Drug Creation\u2122\u5e73\u53f0\u8207\u963f\u65af\u5229\u5eb7\u5728\u816b\u7624\u5b78\u9818\u57df\u7684\u5c08\u696d\u77e5\u8b58\u76f8\u7d50\u5408\uff0c\u65e8\u5728\u52a0\u901f\u767c\u73fe\u6f5b\u5728\u7684\u65b0\u578b\u764c\u75c7\u6cbb\u7642\u5019\u9078\u85e5\u7269\u3002\u64da\u6089\uff0c\u8a72\u5354\u8b70\u5305\u62ec\u9810\u4ed8\u6b3e\u3001\u7814\u767c\u7d93\u8cbb\u548c\u91cc\u7a0b\u7891\u6b3e\u9805\u7b49\uff0c\u7e3d\u91d1\u984d\u9ad8\u90542.47\u5104\u7f8e\u5143\u3002 \u95dc\u65bc\u535a\u81f4\u751f\u7269 \u535a\u81f4\u751f\u7269\u5275\u7acb\u65bc2019\u5e74\uff0c\u7531\u86cb\u767d\u8cea\u5de5\u7a0b\u548c\u816b\u7624\u514d\u75ab\u9818\u57df\u7684\u9802\u5c16\u5c08\u5bb6\u5718\u968a\u7d44\u5efa\uff0c\u81f4\u529b\u65bc\u958b\u767c\u65b0\u4e00\u4ee3\u7d30\u80de\u56e0\u5b50\u6297\u816b\u7624\u514d\u75ab\u7642\u6cd5\u3002\u516c\u53f8\u81ea\u4e3b\u7814\u767c\u4e86\u300cCrossover\u300d\u524d\u85e5\u6280\u8853\u5e73\u53f0\uff0c\u80fd\u5be6\u73fe\u7d30\u80de\u56e0\u5b50\u5728\u816b\u7624\u5fae\u74b0\u5883\u4e2d\u7279\u7570\u6027\u91cb\u653e\uff0c\u6709\u6548\u89e3\u6c7a\u4e86\u7d30\u80de\u56e0\u5b50\u7684\u5916\u5468\u6bd2\u6027\u554f\u984c\u3002\u4f9d\u8a17\u8a72\u5e73\u53f0\u6280\u8853\uff0c\u516c\u53f8\u6210\u529f\u958b\u767c\u4e86\u81e8\u5e8a\u5019\u9078\u85e5\u7269PTX-912\uff0c\u5df2\u7d93\u555f\u52d5\u7f8e\u570b1\u671f\u81e8\u5e8a\u8a66\u9a57\u3002 \u95dc\u65bcAceLink Therapeutics AceLink Therapeutics\u6210\u7acb\u65bc2018\u5e74\uff0c\u662f\u4e00\u5bb6\u5275\u65b0\u578b\u751f\u7269\u88fd\u85e5\u521d\u5275\u516c\u53f8\uff0c\u5c08\u6ce8\u65bc\u958b\u767c\u5b89\u5168\u6709\u6548\u7684\u85e5\u7269\uff0c\u4ee5\u6eff\u8db3\u5b58\u5728\u9ad8\u5ea6\u672a\u6eff\u8db3\u7684\u81e8\u5e8a\u9700\u6c42\u7684\u907a\u50b3\u6027\u75be\u75c5\u3002\u516c\u53f8\u6700\u521d\u7684\u91cd\u9ede\u662f\u958b\u767c\u6cd5\u5e03\u745e\u6c0f\u75c7\u7684\u65b0\u578b\u6cbb\u7642\u65b9\u6cd5\u3002\u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8acb\u8a2a\u554f www.acelinktherapeutics.com \u95dc\u65bcBasking Biosciences Basking Biosciences\u662f\u4e00\u5bb6\u8655\u65bc\u81e8\u5e8a\u968e\u6bb5\u7684\u516c\u53f8\uff0c\u65e8\u5728\u89e3\u6c7a\u7f3a\u8840\u6027\u8166\u5352\u4e2d\u6cbb\u7642\u7684\u6700\u5927\u9700\u6c42\u2014\u2014\u4e00\u7a2e\u5feb\u901f\u8d77\u6548\u7684\u77ed\u6548\u6eb6\u6813\u85e5\u7269\uff0c\u80fd\u5920\u63d0\u4f9b\u6bd4\u73fe\u6709\u7642\u6cd5\u5927\u5927\u5ef6\u9577\u7684\u6cbb\u7642\u7a97\u53e3\uff0c\u4e26\u91cd\u65b0\u758f\u901a\u963b\u585e\u7684\u52d5\u8108\uff0c\u4e26\u4e14\u5728\u51fa\u8840\u6642\u53ef\u4ee5\u8fc5\u901f\u88ab\u9006\u8f49\u6d3b\u6027\u3002\u516c\u53f8\u6b63\u5728\u958b\u767c\u7684\u85e5\u7269BB-031\uff0c\u5373\u662f\u9019\u7a2efirst -in-class RNA\u9069\u914d\u9ad4\uff0c\u9776\u5411\u8840\u6813\u7684\u91cd\u8981\u7d50\u69cb\u6210\u5206\u548c\u51dd\u8840\u904e\u7a0b\u7684\u9a45\u52d5\u56e0\u7d20\u8840\u7ba1\u6027\u8840\u53cb\u75c5\u56e0\u5b50\uff08von Willebrand Factor\uff0cvWF\uff09\u3002 \u95dc\u65bc\u7279\u79d1\u7f85\u751f\u7269\u79d1\u6280\uff08\u6210\u90fd\uff09\u6709\u9650\u516c\u53f8\u00a0 \u7279\u79d1\u7f85\u751f\u7269\u79d1\u6280\uff08\u6210\u90fd\uff09\u6709\u9650\u516c\u53f8\u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\u7684\u751f\u7269\u91ab\u85e5\u516c\u53f8\u3002\u516c\u53f8\u524d\u8eab\u70ba\u5609\u8208\u7279\u79d1\u7f85\u751f\u7269\u79d1\u6280\u6709\u9650\u516c\u53f8\uff0c\u65b0\u8fd1\u65bc2023\u5e743\u6708\u642c\u9077\u81f3\u56db\u5ddd\u7701\u6210\u90fd\u5929\u5e9c\u570b\u969b\u751f\u7269\u57ce\u3002 \u516c\u53f8\u76ee\u524d\u7684\u6838\u5fc3\u7814\u767c\u9805\u76ee\u5305\u62ec\u91dd\u5c0d\u6cbb\u7642\u96c4\u6fc0\u7d20\u6027\u812b\u9aee\u3001\u7279\u61c9\u6027\u76ae\u708e\/\u6fd5\u75b9\u3001\u9280\u5c51\u75c5\u548c\u7d05\u6591\u72fc\u7621\u7b49\u75be\u75c5\u7684\u5275\u65b0\u85e5\u7269\u3002\u516c\u53f8\u5168\u7403\u9818\u5148\u7684\u6cbb\u7642\u96c4\u6fc0\u7d20\u6027\u812b\u9aee\u7684\u5c0f\u5206\u5b50\u5019\u9078\u85e5\u7269TDM-105795\u5373\u5c07\u5b8c\u6210\u4e8c\u671fa\u968e\u6bb5\u81e8\u5e8a\u8a66\u9a57\uff0c\u91dd\u5c0d\u7279\u61c9\u6027\u76ae\u708e\/\u6fd5\u75b9\u7684\u5275\u65b0\u578bJAK1\/TYK2\u6291\u5236\u5291\u4e5f\u5df2\u7d93\u5b8c\u6210\u4e00\u671f\u81e8\u5e8a\u8a66\u9a57\uff0c\u5373\u5c07\u958b\u5c55\u81e8\u5e8a\u4e8c\u671fPOC\u8a66\u9a57\u3002\u516c\u53f8\u5177\u6709\u591a\u500b\u81e8\u5e8a\u524d\u6216\u81e8\u5e8a\u968e\u6bb5\u7684\u5019\u9078\u85e5\u7269\uff0c\u5728\u7814\u7ba1\u7dda\u7522\u54c1\u90fd\u662f\u91dd\u5c0d\u6cbb\u7642\u5404\u7a2e\u76ae\u819a\u9069\u61c9\u75c7\u3002 \u95dc\u65bc\u8f3b\u806f\u79d1\u6280 \u8f3b\u806f\u79d1\u6280\u6709\u9650\u516c\u53f8\uff08\u300c\u8f3b\u806f\u79d1\u6280\u300d\uff09\u662f\u4e00\u5bb6\u5168\u9762\u6574\u5408\u7684\u570b\u969b\u5316\u653e\u5c04\u6027\u85e5\u7269\u6cbb\u7642\u516c\u53f8\uff0c\u5728\u6bd4\u5229\u6642\u3001\u5fb7\u570b\u548c\u4e2d\u570b\u5747\u8a2d\u6709\u8fa6\u4e8b\u8655\u3002\u6211\u5011\u81f4\u529b\u65bc\u6253\u9020\u64c1\u6709\u653e\u5c04\u6027\u85e5\u7269\u7814\u767c\u3001\u751f\u7522\u548c\u5546\u696d\u5316\u7684\u5168\u7522\u696d\u93c8\u7684\u6838\u85e5\u516c\u53f8\u4ee5\u9020\u798f\u5168\u7403\u60a3\u8005\u3002\u6211\u5011\u8a08\u5283\u901a\u904e\u91dd\u5c0d\u672a\u4f86\u6cbb\u7642\u65b9\u6cd5\u7684\u5275\u65b0\u7814\u7a76\u4f86\u89e3\u6c7a\u76ee\u524d\u5f71\u97ff\u653e\u5c04\u6027\u85e5\u7269\u7814\u767c\u7684\u6838\u5fc3\u554f\u984c\u3002\u6211\u5011\u5718\u968a\u4e2d\u4e0d\u4e4f\u7d93\u9a57\u8c50\u5bcc\u7684\u4f01\u696d\u5bb6\u548c\u79d1\u5b78\u5bb6\uff0c\u4ed6\u5011\u65e2\u64c5\u9577\u7ba1\u7406\u751f\u7269\u91ab\u85e5\u516c\u53f8\uff0c\u4e5f\u6df1\u8af3\u653e\u5c04\u6027\u540c\u4f4d\u7d20\u7684\u7814\u7a76\u548c\u81e8\u5e8a\u958b\u767c\u65b9\u6cd5\u3002 \u95dc\u65bc\u7dad\u7738\u751f\u7269 \u7dad\u7738\u751f\u7269\u662f\u4e00\u5bb6\u5c08\u6ce8\u65bc\u773c\u79d1\u5275\u65b0\u85e5\u7814\u767c\u9818\u57df\u7684\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u64c1\u6709\u570b\u969b\u4e00\u6d41\u7684\u773c\u79d1\u5275\u65b0\u85e5\u7814\u767c\u5718\u968a\u548c\u6280\u8853\u5e73\u53f0\uff0c\u4f9d\u8a17\u81ea\u4e3b\u7814\u767c\u5df2\u7d93\u5efa\u7acb\u8d77\u5177\u6709\u5168\u7403\u7af6\u722d\u529b\u7684\u7522\u54c1\u7ba1\u7dda\u3002\u9664VVN001\u9805\u76ee\u5916\uff0c\u7dad\u7738\u751f\u7269\u6b63\u5728\u958b\u767cVVN539\u7528\u65bc\u6cbb\u7642\u9752\u5149\u773c\u6216\u9ad8\u773c\u58d3\u75c7\uff0cVVN461\u7528\u65bc\u6cbb\u7642\u975e\u611f\u67d3\u6027\u524d\u8461\u8404\u819c\u708e\u548c\u8853\u5f8c\u708e\u75c7\u3002\u7dad\u7738\u751f\u7269\u9084\u81f4\u529b\u65bc\u767c\u73fe\u548c\u958b\u767c\u7528\u65bc\u6cbb\u7642\u5176\u4ed6\u524d\u3001\u5f8c\u773c\u75be\u75c5\u7684\u65b0\u7642\u6cd5\u3002 \u95dc\u65bcAbsci Absci\u662f\u4e00\u5bb6\u751f\u6210\u578b\u4eba\u5de5\u667a\u80fd\u85e5\u7269\u958b\u767c\u516c\u53f8\uff0c\u5c07\u4eba\u5de5\u667a\u80fd\u8207\u53ef\u64f4\u5c55\u7684\u6fd5\u5be6\u9a57\u5ba4\u6280\u8853\u76f8\u7d50\u5408\uff0c\u66f4\u5feb\u5730\u70ba\u60a3\u8005\u5275\u9020\u66f4\u597d\u7684\u751f\u7269\u88fd\u54c1\u3002\u5176Integrated Drug Creation\u2122\u5e73\u53f0\u901a\u904e\u540c\u6642\u512a\u5316\u517c\u5177\u958b\u767c\u548c\u6cbb\u7642\u6548\u679c\u7684\u591a\u7a2e\u85e5\u7269\u7279\u6027\uff0c\u91cb\u653e\u4e86\u52a0\u5feb\u85e5\u7269\u4e0a\u5e02\u6642\u9593\u548c\u63d0\u9ad8\u6210\u529f\u6982\u7387\u7684\u6f5b\u529b\u3002\u901a\u904e\u6578\u64da\u5b78\u7fd2\u3001\u4eba\u5de5\u667a\u80fd\u5275\u9020\u548c\u6fd5\u6cd5\u5be6\u9a57\u5ba4\u9a57\u8b49\uff0cAbsci \u6bcf\u9031\u53ef\u7be9\u9078\u6578\u5341\u5104\u500b\u7d30\u80de\uff0c\u4f7f\u5176\u80fd\u5920\u5728\u77ed\u77ed\u516d\u9031\u5167\u5b8c\u6210\u5f9e\u4eba\u5de5\u667a\u80fd\u8a2d\u8a08\u6297\u9ad4\u5230\u6fd5\u6cd5\u5be6\u9a57\u5ba4\u9a57\u8b49\u5019\u9078\u85e5\u7269\u7684\u904e\u7a0b\u3002Absci\u7684\u9858\u666f\u662f\u70ba\u6bcf\u500b\u4eba\u4e00\u9375\u63d0\u4f9b\u7a81\u7834\u6027\u7684\u6cbb\u7642\u65b9\u6cd5\u3002\u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8acb\u8a2a\u554fwww.absci.com\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pingtungtimes.com.tw\/?p=222124\" \/>\n<meta property=\"og:locale\" content=\"zh_TW\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u7dad\u4e9e\u751f\u7269\u6295\u8cc7\u5b75\u5316\u516c\u53f8\u8fd1\u671f\u767c\u5c55\u52d5\u614b\u4e00\u89bd - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\" \/>\n<meta property=\"og:description\" content=\"\u9999\u6e2f2024\u5e743\u67086\u65e5 \/\u7f8e\u901a\u793e\/ -- \u9762\u5c0d\u4e0d\u65b7\u8b8a\u5316\u7684\u5c40\u52e2\uff0c\u6280\u8853\u5275\u65b0\u4f9d\u820a\u662f\u751f\u7269\u91ab\u85e5\u4f01\u696d\u9577\u9060\u767c\u5c55\u6c38\u6046\u7684\u4e3b\u65cb\u5f8b\uff0c\u70ba\u4f01\u696d\u6e90\u6e90\u4e0d\u65b7\u5730\u6ce8\u5165\u751f\u547d\u529b\uff0c\u6301\u7e8c\u63a8\u52d5\u7814\u767c\u300c\u5f9e0\u52301\u300d\u8f49\u5316\u4ee5\u53ca\u5546\u696d\u5316\u6210\u529f\u3002\u8fd1\u671f\uff0c\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u4f01\u696d\u53c8\u6709\u65b0\u7684\u52d5\u614b\uff1aAceLink\u3001\u7279\u79d1\u7f85\u7814\u767c\u9032\u5c55\u9806\u5229\uff1b\u535a\u81f4\u751f\u7269\u3001Basking\u3001\u7279\u79d1\u7f85\u3001\u8f3b\u806f\u79d1\u6280\u6210\u529f\u5b8c\u6210\u878d\u8cc7\uff1b\u7dad\u7738\u751f\u7269\u65ac\u7372\u6b8a\u69ae\uff1bAbsci\u9054\u6210\u91cd\u8981\u5408\u4f5c\u3002 \u535a\u81f4\u751f\u7269\u5b8c\u62101800\u842c\u7f8e\u5143A\u8f2a\u878d\u8cc7 \u8fd1\u65e5\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u535a\u81f4\u751f\u7269\uff08Proviva Therapeutics\uff09\u6b23\u7136\u5ba3\u4f48\u5b8c\u62101800\u842c\u7f8e\u5143\u7684A\u8f2a\u878d\u8cc7\uff0c\u4ee5\u63a8\u9032\u5176\u6838\u5fc3\u7522\u54c1PTX-912\u7684\u81e8\u5e8a\u958b\u767c\u3002\u9f8d\u78d0\u6295\u8cc7\uff0c\u6069\u7136\u5275\u6295\u548c\u4ed9\u77b3\u8cc7\u672c\u806f\u5408\u53c3\u52a0\u672c\u8f2a\u878d\u8cc7\u3002 \u535a\u81f4\u751f\u7269\u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\u7684\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u81f4\u529b\u65bc\u958b\u767c\u65b0\u4e00\u4ee3\u7d30\u80de\u56e0\u5b50\u6297\u816b\u7624\u514d\u75ab\u7642\u6cd5\u3002\u91dd\u5c0d\u7d30\u80de\u56e0\u5b50\u5916\u5468\u6bd2\u6027\u7684\u50b3\u7d71\u96e3\u984c\uff0c\u516c\u53f8\u81ea\u4e3b\u958b\u767c\u4e86\u300cCrossover\u300d\u7d30\u80de\u56e0\u5b50\u524d\u85e5\u6280\u8853\u5e73\u53f0\uff0c\u5be6\u73fe\u5728\u816b\u7624\u5fae\u74b0\u5883\u4e2d\u7279\u7570\u6027\u7684\u85e5\u7269\u6d3b\u6027\u91cb\u653e\u3002\u4f9d\u8a17\u300cCrossover\u300d\u6280\u8853\u5e73\u53f0\uff0c\u535a\u81f4\u6210\u529f\u7814\u767c\u51faPTX-912\u2014\u2014\u65b0\u4e00\u4ee3\u514d\u75ab\u7d30\u80de\u9776\u5411\u7684\u767d\u7d30\u80de\u4ecb\u7d20-2\uff08IL-2\uff09\u524d\u85e5\u878d\u5408\u86cb\u767d\u3002 AceLink Therapeutics\u767c\u4f48\u5065\u5eb7\u5fd7\u9858\u8005\u53c3\u8207\u8a55\u4f30AL01211\u7684I\u671f\u81e8\u5e8a\u8a66\u9a57\u6578\u64da \u7d10\u74e6\u514b\uff0c\u52a0\u5229\u798f\u5c3c\u4e9e\u5dde\u2014\u20142024\u5e742\u670826\u65e5\uff0cAceLink Therapeutics\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u3001\u4e00\u5bb6\u958b\u767c\u4e0b\u4e00\u4ee3\u53e3\u670d\u5e95\u7269\u6e1b\u5c11\u7642\u6cd5\uff08SRTs\uff09\u7684\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u88fd\u85e5\u516c\u53f8\u5ba3\u4f48\uff0c\u5176\u5728\u5065\u5eb7\u5fd7\u9858\u8005\u4e2d\u9032\u884c\u7684AL01211\u7684I\u671f\u7814\u7a76\u7684\u7d50\u679c\u5df2\u7d93\u767c\u8868\u5728\u540c\u884c\u8a55\u5be9\u7684\u7f8e\u570b\u81e8\u5e8a\u85e5\u5b78\u9662\u671f\u520a\u300aClinical Pharmacology in Drug Development\u300b\u4e0a\u3002AL01211\u662f\u4e00\u7a2e\u5f37\u5927\u7684\u53e3\u670d\u8461\u7cd6\u795e\u7d93\u91af\u80fa\u5408\u6210\u9176\uff08GCS\uff09\u6291\u5236\u5291\uff0c\u6b63\u5728\u958b\u767c\u7528\u65bc\u6cbb\u7642\u6cd5\u5e03\u745e\u6c0f\u75c7\u548cI\u578b\u9ad8\u96ea\u6c0f\u75c7\u3002 \u5728\u5df2\u767c\u8868\u7684I\u671f\u7814\u7a76\u4e2d\uff0c\u5c0dAL01211\u9032\u884c\u4e86\u55ae\u5291\u91cf\u905e\u589e\u548c\u591a\u5291\u91cf\u905e\u589e\u7684\u7814\u7a76\uff0c\u4ee5\u78ba\u5b9a\u5176\u5728\u5065\u5eb7\u5fd7\u9858\u8005\u4e2d\u7684\u5b89\u5168\u6027\u3001\u85e5\u4ee3\u52d5\u529b\u5b78\uff08PK\uff09\u548c\u85e5\u6548\u5b78\uff08PD\uff09\u6548\u61c9\u3002\u7e3d\u9ad4\u800c\u8a00\uff0cAL01211\u5177\u6709\u826f\u597d\u7684\u5b89\u5168\u6027\u548c\u8010\u53d7\u6027\uff0c\u7121\u56b4\u91cd\u4e0d\u826f\u4e8b\u4ef6\u3002\u572830mg\u5291\u91cf\u6c34\u5e73\u4e0b\uff0c\u8840\u6f3f\u8461\u7cd6\u57fa\u795e\u7d93\u91af\u80fa\u548c\u7403\u86cb\u767d\u4e09\u7cd6\u795e\u7d93\u91af\u80fa\u5206\u5225\u5f9e\u57fa\u7dda\u6c34\u6e96\u964d\u4f4e\u4e8678%\u548c52%\uff0c\u5f9e\u800c\u652f\u6301AL01211\u7684\u9032\u4e00\u6b65\u81e8\u5e8a\u7814\u7a76\u3002 Basking\u5ba3\u4f48\u5b8c\u6210\u7531ARCH\u9818\u6295\u76845500\u842c\u7f8e\u5143\u878d\u8cc7\uff0c\u52a0\u901f\u53ef\u9006\u6eb6\u6813\u5291\u7684\u81e8\u5e8a\u958b\u767c \u4fc4\u4ea5\u4fc4\u5dde\u54e5\u502b\u5e03\u2014\u20142024\u5e741\u670830\u65e5\uff0cBasking Biosciences\uff08\u4ee5\u4e0b\u7c21\u7a31\u300cBasking\u300d\uff09\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\uff0c\u4e00\u5bb6\u958b\u767c\u65b0\u578b\u6025\u6027\u6eb6\u6813\u7642\u6cd5\u6cbb\u7642\u5352\u4e2d\u7684\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u88fd\u85e5\u516c\u53f8\uff0c\u5ba3\u4f48\u5b8c\u62105500\u842c\u7f8e\u5143\u7684\u878d\u8cc7\u3002\u65b0\u6295\u8cc7\u8005ARCH Venture Partners\u9818\u6295\uff0c\u5176\u4ed6\u65b0\u6295\u8cc7\u8005Insight Partners\u3001Platanus\u3001Solas BioVentures\u548cRTW Investments\uff0c\u4ee5\u53ca\u73fe\u6709\u6295\u8cc7\u8005\u8ddf\u6295\u3002ARCH Venture Partners\u8463\u4e8b\u7e3d\u7d93\u7406Steven Gillis\u535a\u58eb\u5c07\u64d4\u4efbBasking\u8463\u4e8b\u6703\u4e3b\u5e2d\u3002\u6b64\u524d\u516c\u53f8\u66fe\u5b8c\u6210540\u842c\u7f8e\u5143\u7a2e\u5b50\u8f2a\u878d\u8cc7\uff0c\u6295\u8cc7\u8005\u5305\u62ecRev1 Ventures\u3001Broadview Ventures\u548c\u7dad\u4e9e\u751f\u7269\u3002 Basking\u5c07\u5229\u7528\u878d\u8cc7\u52a0\u901fBB-031\u7684\u81e8\u5e8a\u958b\u767c\u3002\u9019\u662f\u4e00\u7a2e\u9776\u5411von Willebrand\u56e0\u5b50\uff08vWF\uff09\u7684\u540c\u985e\u9996\u5275\u53ef\u9006RNA aptamers\uff0c\u5c08\u70ba\u5feb\u901f\u8d77\u6548\u548c\u77ed\u6301\u7e8c\u6642\u9593\u7684\u7642\u6548\u800c\u8a2d\u8a08\u3002 \u7279\u79d1\u7f85\u7372\u842c\u7269\u5275\u6295\u6578\u767e\u842c\u7f8e\u5143Pre-B\u8f2a\u878d\u8cc7\uff0c\u4e14\u5176\u6cbb\u7642\u96c4\u6fc0\u7d20\u6027\u812b\u9aee\u5168\u7403\u9996\u5275\u65b0\u85e5TDM-105795\u81e8\u5e8a\u4e8c\u671fa\u8a66\u9a57\u9806\u5229\u5b8c\u6210\u53ca\u5b8c\u6210\u91dd\u5c0d\u6fd5\u75b9\/\u76ae\u708e\u9069\u61c9\u75c7\u7684TDM-180935\u5291\u91cf\u905e\u589e\u7684\u4e00\u671f\u81e8\u5e8a\u8a66\u9a57 \u64da\u52d5\u8108\u7db21\u670815\u65e5\u6d88\u606f\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u3001\u4e00\u5bb6\u5c08\u6ce8\u76ae\u819a\u75be\u75c5\u65b0\u85e5\u7814\u767c\u7684\u81e8\u5e8a\u968e\u6bb5\u516c\u53f8\u7279\u79d1\u7f85\u751f\u7269\u79d1\u6280\uff08\u6210\u90fd\uff09\u6709\u9650\u516c\u53f8\uff08\u4ee5\u4e0b\u7c21\u7a31\u300c\u7279\u79d1\u7f85\u300d\uff09\uff0c\u5ba3\u4f48\u5df2\u65bc\u8fd1\u671f\u5b8c\u6210\u6578\u5343\u842c\u4eba\u6c11\u5e63\u7684Pre-B\u8f2a\u878d\u8cc7\uff0c\u672c\u8f2a\u878d\u8cc7\u6295\u8cc7\u65b9\u70ba\u842c\u7269\u5275\u6295\uff0c\u6240\u878d\u8cc7\u91d1\u5c07\u7528\u65bc\u6bdb\u9aee\u9805\u76ee\u7684\u5f8c\u7e8c\u81e8\u5e8a\u958b\u767c\u548c\u6fd5\u75b9\u76ae\u708e\u9805\u76ee\u4e2d\u7f8e\u96d9\u5831\u7684\u4e8c\u671f\u81e8\u5e8a\u8a66\u9a57\uff08\u4e2d\u7f8eIIa\u81e8\u5e8a\uff09\u3002\u96a8\u5f8c2\u67085\u65e5\uff0c\u7279\u79d1\u7f85\u5f88\u9ad8\u8208\u5730\u5ba3\u4f48\uff1a\u5916\u7528\u5857\u62b9\u88fd\u5291TDM-105795\u7528\u65bc\u6cbb\u7642\u96c4\u6fc0\u7d20\u6027\u812b\u9aee\uff08AGA\uff09\u7684\u9996\u500b\u81e8\u5e8a\u4e8c\u671f\u8a66\u9a57\uff08NCT05802173\uff09\u9806\u5229\u5b8c\u6210\u3002 \u6b64\u5916\uff0c2023\u5e7412\u67084\u65e5\uff0c\u7279\u79d1\u7f85\u5ba3\u4f48\u5df2\u7d93\u5b8c\u6210\u91dd\u5c0d\u7279\u61c9\u6027\u76ae\u708e\/\u6fd5\u75b9\u7684TDM-180935\u5916\u7528\u8edf\u818f\u7684\u4e00\u671f\u81e8\u5e8a\u8a66\u9a57\uff08NCT05525468\uff09\uff0c\u8a66\u9a57\u7d50\u679c\u5747\u9054\u5230\u9810\u671f\u3002 \u8f3b\u806f\u79d1\u6280\u5ba3\u4f48\u5b8c\u6210B\u8f2a\u7f8e\u5143\u878d\u8cc7\uff0c\u4e14\u5176\u6bd4\u5229\u6642GMP\u751f\u7522\u8a2d\u65bd\u5960\u57fa 2024\u5e741\u67084\u65e5\uff0c\u4e0a\u6d77\/\u8b93\u5e03\u76e7\/\u6d77\u5fb7\u5821\u2014\u2014\u7dad\u4e9e\u751f\u7269\u88ab\u6295\u4f01\u696d\u3001\u5168\u9762\u6574\u5408\u7684\u570b\u969b\u5316\u653e\u5c04\u6027\u85e5\u7269\u6cbb\u7642\u516c\u53f8\u8f3b\u806f\u79d1\u6280\u6709\u9650\u516c\u53f8\uff08\u4ee5\u4e0b\u7c21\u7a31\u300c\u8f3b\u806f\u79d1\u6280\u300d\uff09\uff0c\u5ba3\u4f48\u5b8c\u62106330\u842c\u7f8e\u5143\u878d\u8cc7\uff0c\u5176\u4e2d\u5305\u62ec4730\u842c\u7f8e\u5143\u7684B\u8f2a\u80a1\u6b0a\u878d\u8cc7\u548c1600\u842c\u7f8e\u5143\u7684\u6388\u4fe1\u984d\u5ea6\u3002\u672c\u6b21\u878d\u8cc7\u5c07\u5e6b\u52a9\u516c\u53f8\u5feb\u901f\u63a8\u9032\u5176\u653e\u5c04\u6027\u85e5\u7269\u7ba1\u7dda\u7684\u958b\u767c\u548c\u85e5\u7269\u751f\u7522\u80fd\u529b\u7684\u5efa\u8a2d\uff0c\u4e26\u512a\u5316\u5176\u5c08\u6709\u767c\u73fe\u5e73\u53f0UniRDC\u2122\u3002\u00a0\u96a8\u8457\u672c\u6b21\u878d\u8cc7\u7684\u5b8c\u6210\uff0c\u8f3b\u806f\u79d1\u6280\u81ea2021\u5e748\u6708\u6210\u7acb\u4ee5\u4f86\u5df2\u7d2f\u8a08\u878d\u8cc7\u8d85\u904e1.1\u5104\u7f8e\u5143\uff0c\u5305\u62ec\u80a1\u6b0a\u878d\u8cc7\u3001\u50b5\u6b0a\u878d\u8cc7\u548c\u653f\u5e9c\u88dc\u8cbc\u3002 \u6b64\u524d12\u67088\u65e5\uff0c\u8f3b\u806f\u79d1\u6280\u9084\u5ba3\u4f48\u4e86\u5728\u6bd4\u5229\u6642\u8b93\u5e03\u76e7\u5e02\u958b\u5de5\u5efa\u8a2d\u5176\u7b26\u5408\u751f\u7522\u8cea\u91cf\u7ba1\u7406\u898f\u7bc4\uff08\u300cGMP\u300d\uff09\u7684\u653e\u5c04\u6027\u85e5\u7269\u751f\u7522\u8a2d\u65bd\uff0c\u4ee5\u9032\u4e00\u6b65\u63a8\u9032\u653e\u5c04\u6027\u85e5\u7269\u7684\u5168\u7522\u696d\u93c8\u89e3\u6c7a\u65b9\u6848\u3002 \u7dad\u7738\u751f\u7269\u7372\u9999\u6e2f\u5275\u65b0\u79d1\u6280\u7f72\u300c\u4f01\u696d\u652f\u63f4\u8a08\u5283\u300d\u8cc7\u52a9\uff0c\u4e14\u69ae\u767b\u300a2023\u80e1\u6f64\u5168\u7403\u7375\u8c79\u4f01\u696d\u699c\u300b \u8fd1\u671f\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u7dad\u7738\u751f\u7269\u7684\u9999\u6e2f\u5b50\u516c\u53f8\uff0c\u4e00\u5bb6\u805a\u7126\u5dee\u7570\u5316\u548c\u5168\u7403\u65b0\u958b\u767c\u7684\u773c\u79d1\u5275\u65b0\u85e5\u516c\u53f8\uff0c\u5ba3\u4f48\u5176\u5275\u65b0\u773c\u5e95\u85e5\u7269VVN481\u6210\u529f\u7372\u5f97\u9999\u6e2f\u5275\u65b0\u79d1\u6280\u7f72\u300c\u4f01\u696d\u652f\u63f4\u8a08\u5283Enterprise Support Scheme\u300d\uff08ESS\u2014Hong Kong-Israel R&amp;D Cooperation Programme\uff09\u00a0\u8cc7\u52a9\u3002\u6b64\u6b21\u8cc7\u52a9\u5c07\u7528\u65bc\u63a8\u9032\u8a72\u7ba1\u7dda\u7684\u81e8\u5e8a\u524d\u7814\u767c\u5de5\u4f5c\uff0c\u4ee5\u671f\u66f4\u5feb\u63a8\u9032\u5230\u81e8\u5e8a\u968e\u6bb5\u3002\u6b64\u5916\uff0c\u8fd1\u65e5\u7dad\u7738\u751f\u7269\u9084\u69ae\u767b\u300a2023\u80e1\u6f64\u5168\u7403\u7375\u8c79\u4f01\u696d\u699c\u300b\u3002 \u7dad\u4e9e\u751f\u7269\u88ab\u6295\u4f01\u696dAbsci\u5ba3\u4f48\u8207\u963f\u65af\u5229\u5eb7\u5408\u4f5c\u958b\u767c\u4eba\u5de5\u667a\u80fd\u9a45\u52d5\u7684\u816b\u7624\u5019\u9078\u85e5\u7269 \u83ef\u76db\u9813\u5dde\u6eab\u54e5\u83ef\uff0c2023\u5e7412\u67084\u65e5\u2014\u2014\u7dad\u4e9e\u751f\u7269\u88ab\u6295\u4f01\u696d\u3001\u751f\u6210\u5f0f\u4eba\u5de5\u667a\u80fd\u6297\u9ad4\u767c\u73fe\u9818\u57df\u7684\u9818\u5c0e\u8005Absci\u516c\u53f8\uff08NASDAQ:ABSI\uff09\uff0c\u5ba3\u4f48\u8207\u5168\u7403\u751f\u7269\u88fd\u85e5\u516c\u53f8\u963f\u65af\u5229\u5eb7\uff08AstraZeneca\uff09\u5408\u4f5c\uff0c\u91dd\u5c0d\u816b\u7624\u9776\u9ede\u63d0\u4f9b\u4eba\u5de5\u667a\u80fd\u8a2d\u8a08\u7684\u6297\u9ad4\u3002\u6b64\u6b21\u5408\u4f5c\u5c07Absci\u7684Integrated Drug Creation\u2122\u5e73\u53f0\u8207\u963f\u65af\u5229\u5eb7\u5728\u816b\u7624\u5b78\u9818\u57df\u7684\u5c08\u696d\u77e5\u8b58\u76f8\u7d50\u5408\uff0c\u65e8\u5728\u52a0\u901f\u767c\u73fe\u6f5b\u5728\u7684\u65b0\u578b\u764c\u75c7\u6cbb\u7642\u5019\u9078\u85e5\u7269\u3002\u64da\u6089\uff0c\u8a72\u5354\u8b70\u5305\u62ec\u9810\u4ed8\u6b3e\u3001\u7814\u767c\u7d93\u8cbb\u548c\u91cc\u7a0b\u7891\u6b3e\u9805\u7b49\uff0c\u7e3d\u91d1\u984d\u9ad8\u90542.47\u5104\u7f8e\u5143\u3002 \u95dc\u65bc\u535a\u81f4\u751f\u7269 \u535a\u81f4\u751f\u7269\u5275\u7acb\u65bc2019\u5e74\uff0c\u7531\u86cb\u767d\u8cea\u5de5\u7a0b\u548c\u816b\u7624\u514d\u75ab\u9818\u57df\u7684\u9802\u5c16\u5c08\u5bb6\u5718\u968a\u7d44\u5efa\uff0c\u81f4\u529b\u65bc\u958b\u767c\u65b0\u4e00\u4ee3\u7d30\u80de\u56e0\u5b50\u6297\u816b\u7624\u514d\u75ab\u7642\u6cd5\u3002\u516c\u53f8\u81ea\u4e3b\u7814\u767c\u4e86\u300cCrossover\u300d\u524d\u85e5\u6280\u8853\u5e73\u53f0\uff0c\u80fd\u5be6\u73fe\u7d30\u80de\u56e0\u5b50\u5728\u816b\u7624\u5fae\u74b0\u5883\u4e2d\u7279\u7570\u6027\u91cb\u653e\uff0c\u6709\u6548\u89e3\u6c7a\u4e86\u7d30\u80de\u56e0\u5b50\u7684\u5916\u5468\u6bd2\u6027\u554f\u984c\u3002\u4f9d\u8a17\u8a72\u5e73\u53f0\u6280\u8853\uff0c\u516c\u53f8\u6210\u529f\u958b\u767c\u4e86\u81e8\u5e8a\u5019\u9078\u85e5\u7269PTX-912\uff0c\u5df2\u7d93\u555f\u52d5\u7f8e\u570b1\u671f\u81e8\u5e8a\u8a66\u9a57\u3002 \u95dc\u65bcAceLink Therapeutics AceLink Therapeutics\u6210\u7acb\u65bc2018\u5e74\uff0c\u662f\u4e00\u5bb6\u5275\u65b0\u578b\u751f\u7269\u88fd\u85e5\u521d\u5275\u516c\u53f8\uff0c\u5c08\u6ce8\u65bc\u958b\u767c\u5b89\u5168\u6709\u6548\u7684\u85e5\u7269\uff0c\u4ee5\u6eff\u8db3\u5b58\u5728\u9ad8\u5ea6\u672a\u6eff\u8db3\u7684\u81e8\u5e8a\u9700\u6c42\u7684\u907a\u50b3\u6027\u75be\u75c5\u3002\u516c\u53f8\u6700\u521d\u7684\u91cd\u9ede\u662f\u958b\u767c\u6cd5\u5e03\u745e\u6c0f\u75c7\u7684\u65b0\u578b\u6cbb\u7642\u65b9\u6cd5\u3002\u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8acb\u8a2a\u554f www.acelinktherapeutics.com \u95dc\u65bcBasking Biosciences Basking Biosciences\u662f\u4e00\u5bb6\u8655\u65bc\u81e8\u5e8a\u968e\u6bb5\u7684\u516c\u53f8\uff0c\u65e8\u5728\u89e3\u6c7a\u7f3a\u8840\u6027\u8166\u5352\u4e2d\u6cbb\u7642\u7684\u6700\u5927\u9700\u6c42\u2014\u2014\u4e00\u7a2e\u5feb\u901f\u8d77\u6548\u7684\u77ed\u6548\u6eb6\u6813\u85e5\u7269\uff0c\u80fd\u5920\u63d0\u4f9b\u6bd4\u73fe\u6709\u7642\u6cd5\u5927\u5927\u5ef6\u9577\u7684\u6cbb\u7642\u7a97\u53e3\uff0c\u4e26\u91cd\u65b0\u758f\u901a\u963b\u585e\u7684\u52d5\u8108\uff0c\u4e26\u4e14\u5728\u51fa\u8840\u6642\u53ef\u4ee5\u8fc5\u901f\u88ab\u9006\u8f49\u6d3b\u6027\u3002\u516c\u53f8\u6b63\u5728\u958b\u767c\u7684\u85e5\u7269BB-031\uff0c\u5373\u662f\u9019\u7a2efirst -in-class RNA\u9069\u914d\u9ad4\uff0c\u9776\u5411\u8840\u6813\u7684\u91cd\u8981\u7d50\u69cb\u6210\u5206\u548c\u51dd\u8840\u904e\u7a0b\u7684\u9a45\u52d5\u56e0\u7d20\u8840\u7ba1\u6027\u8840\u53cb\u75c5\u56e0\u5b50\uff08von Willebrand Factor\uff0cvWF\uff09\u3002 \u95dc\u65bc\u7279\u79d1\u7f85\u751f\u7269\u79d1\u6280\uff08\u6210\u90fd\uff09\u6709\u9650\u516c\u53f8\u00a0 \u7279\u79d1\u7f85\u751f\u7269\u79d1\u6280\uff08\u6210\u90fd\uff09\u6709\u9650\u516c\u53f8\u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\u7684\u751f\u7269\u91ab\u85e5\u516c\u53f8\u3002\u516c\u53f8\u524d\u8eab\u70ba\u5609\u8208\u7279\u79d1\u7f85\u751f\u7269\u79d1\u6280\u6709\u9650\u516c\u53f8\uff0c\u65b0\u8fd1\u65bc2023\u5e743\u6708\u642c\u9077\u81f3\u56db\u5ddd\u7701\u6210\u90fd\u5929\u5e9c\u570b\u969b\u751f\u7269\u57ce\u3002 \u516c\u53f8\u76ee\u524d\u7684\u6838\u5fc3\u7814\u767c\u9805\u76ee\u5305\u62ec\u91dd\u5c0d\u6cbb\u7642\u96c4\u6fc0\u7d20\u6027\u812b\u9aee\u3001\u7279\u61c9\u6027\u76ae\u708e\/\u6fd5\u75b9\u3001\u9280\u5c51\u75c5\u548c\u7d05\u6591\u72fc\u7621\u7b49\u75be\u75c5\u7684\u5275\u65b0\u85e5\u7269\u3002\u516c\u53f8\u5168\u7403\u9818\u5148\u7684\u6cbb\u7642\u96c4\u6fc0\u7d20\u6027\u812b\u9aee\u7684\u5c0f\u5206\u5b50\u5019\u9078\u85e5\u7269TDM-105795\u5373\u5c07\u5b8c\u6210\u4e8c\u671fa\u968e\u6bb5\u81e8\u5e8a\u8a66\u9a57\uff0c\u91dd\u5c0d\u7279\u61c9\u6027\u76ae\u708e\/\u6fd5\u75b9\u7684\u5275\u65b0\u578bJAK1\/TYK2\u6291\u5236\u5291\u4e5f\u5df2\u7d93\u5b8c\u6210\u4e00\u671f\u81e8\u5e8a\u8a66\u9a57\uff0c\u5373\u5c07\u958b\u5c55\u81e8\u5e8a\u4e8c\u671fPOC\u8a66\u9a57\u3002\u516c\u53f8\u5177\u6709\u591a\u500b\u81e8\u5e8a\u524d\u6216\u81e8\u5e8a\u968e\u6bb5\u7684\u5019\u9078\u85e5\u7269\uff0c\u5728\u7814\u7ba1\u7dda\u7522\u54c1\u90fd\u662f\u91dd\u5c0d\u6cbb\u7642\u5404\u7a2e\u76ae\u819a\u9069\u61c9\u75c7\u3002 \u95dc\u65bc\u8f3b\u806f\u79d1\u6280 \u8f3b\u806f\u79d1\u6280\u6709\u9650\u516c\u53f8\uff08\u300c\u8f3b\u806f\u79d1\u6280\u300d\uff09\u662f\u4e00\u5bb6\u5168\u9762\u6574\u5408\u7684\u570b\u969b\u5316\u653e\u5c04\u6027\u85e5\u7269\u6cbb\u7642\u516c\u53f8\uff0c\u5728\u6bd4\u5229\u6642\u3001\u5fb7\u570b\u548c\u4e2d\u570b\u5747\u8a2d\u6709\u8fa6\u4e8b\u8655\u3002\u6211\u5011\u81f4\u529b\u65bc\u6253\u9020\u64c1\u6709\u653e\u5c04\u6027\u85e5\u7269\u7814\u767c\u3001\u751f\u7522\u548c\u5546\u696d\u5316\u7684\u5168\u7522\u696d\u93c8\u7684\u6838\u85e5\u516c\u53f8\u4ee5\u9020\u798f\u5168\u7403\u60a3\u8005\u3002\u6211\u5011\u8a08\u5283\u901a\u904e\u91dd\u5c0d\u672a\u4f86\u6cbb\u7642\u65b9\u6cd5\u7684\u5275\u65b0\u7814\u7a76\u4f86\u89e3\u6c7a\u76ee\u524d\u5f71\u97ff\u653e\u5c04\u6027\u85e5\u7269\u7814\u767c\u7684\u6838\u5fc3\u554f\u984c\u3002\u6211\u5011\u5718\u968a\u4e2d\u4e0d\u4e4f\u7d93\u9a57\u8c50\u5bcc\u7684\u4f01\u696d\u5bb6\u548c\u79d1\u5b78\u5bb6\uff0c\u4ed6\u5011\u65e2\u64c5\u9577\u7ba1\u7406\u751f\u7269\u91ab\u85e5\u516c\u53f8\uff0c\u4e5f\u6df1\u8af3\u653e\u5c04\u6027\u540c\u4f4d\u7d20\u7684\u7814\u7a76\u548c\u81e8\u5e8a\u958b\u767c\u65b9\u6cd5\u3002 \u95dc\u65bc\u7dad\u7738\u751f\u7269 \u7dad\u7738\u751f\u7269\u662f\u4e00\u5bb6\u5c08\u6ce8\u65bc\u773c\u79d1\u5275\u65b0\u85e5\u7814\u767c\u9818\u57df\u7684\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u64c1\u6709\u570b\u969b\u4e00\u6d41\u7684\u773c\u79d1\u5275\u65b0\u85e5\u7814\u767c\u5718\u968a\u548c\u6280\u8853\u5e73\u53f0\uff0c\u4f9d\u8a17\u81ea\u4e3b\u7814\u767c\u5df2\u7d93\u5efa\u7acb\u8d77\u5177\u6709\u5168\u7403\u7af6\u722d\u529b\u7684\u7522\u54c1\u7ba1\u7dda\u3002\u9664VVN001\u9805\u76ee\u5916\uff0c\u7dad\u7738\u751f\u7269\u6b63\u5728\u958b\u767cVVN539\u7528\u65bc\u6cbb\u7642\u9752\u5149\u773c\u6216\u9ad8\u773c\u58d3\u75c7\uff0cVVN461\u7528\u65bc\u6cbb\u7642\u975e\u611f\u67d3\u6027\u524d\u8461\u8404\u819c\u708e\u548c\u8853\u5f8c\u708e\u75c7\u3002\u7dad\u7738\u751f\u7269\u9084\u81f4\u529b\u65bc\u767c\u73fe\u548c\u958b\u767c\u7528\u65bc\u6cbb\u7642\u5176\u4ed6\u524d\u3001\u5f8c\u773c\u75be\u75c5\u7684\u65b0\u7642\u6cd5\u3002 \u95dc\u65bcAbsci Absci\u662f\u4e00\u5bb6\u751f\u6210\u578b\u4eba\u5de5\u667a\u80fd\u85e5\u7269\u958b\u767c\u516c\u53f8\uff0c\u5c07\u4eba\u5de5\u667a\u80fd\u8207\u53ef\u64f4\u5c55\u7684\u6fd5\u5be6\u9a57\u5ba4\u6280\u8853\u76f8\u7d50\u5408\uff0c\u66f4\u5feb\u5730\u70ba\u60a3\u8005\u5275\u9020\u66f4\u597d\u7684\u751f\u7269\u88fd\u54c1\u3002\u5176Integrated Drug Creation\u2122\u5e73\u53f0\u901a\u904e\u540c\u6642\u512a\u5316\u517c\u5177\u958b\u767c\u548c\u6cbb\u7642\u6548\u679c\u7684\u591a\u7a2e\u85e5\u7269\u7279\u6027\uff0c\u91cb\u653e\u4e86\u52a0\u5feb\u85e5\u7269\u4e0a\u5e02\u6642\u9593\u548c\u63d0\u9ad8\u6210\u529f\u6982\u7387\u7684\u6f5b\u529b\u3002\u901a\u904e\u6578\u64da\u5b78\u7fd2\u3001\u4eba\u5de5\u667a\u80fd\u5275\u9020\u548c\u6fd5\u6cd5\u5be6\u9a57\u5ba4\u9a57\u8b49\uff0cAbsci \u6bcf\u9031\u53ef\u7be9\u9078\u6578\u5341\u5104\u500b\u7d30\u80de\uff0c\u4f7f\u5176\u80fd\u5920\u5728\u77ed\u77ed\u516d\u9031\u5167\u5b8c\u6210\u5f9e\u4eba\u5de5\u667a\u80fd\u8a2d\u8a08\u6297\u9ad4\u5230\u6fd5\u6cd5\u5be6\u9a57\u5ba4\u9a57\u8b49\u5019\u9078\u85e5\u7269\u7684\u904e\u7a0b\u3002Absci\u7684\u9858\u666f\u662f\u70ba\u6bcf\u500b\u4eba\u4e00\u9375\u63d0\u4f9b\u7a81\u7834\u6027\u7684\u6cbb\u7642\u65b9\u6cd5\u3002\u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8acb\u8a2a\u554fwww.absci.com\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pingtungtimes.com.tw\/?p=222124\" \/>\n<meta property=\"og:site_name\" content=\"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/pingtungnews\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-06T10:46:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png\" \/>\n<meta name=\"author\" content=\"\u7f8e\u901a\u793e\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005:\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u7f8e\u901a\u793e\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9810\u4f30\u95b1\u8b80\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 \u5206\u9418\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=222124#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=222124\"},\"author\":{\"name\":\"\u7f8e\u901a\u793e\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#\\\/schema\\\/person\\\/683b937f29ec1537972f6c41e22a2cf3\"},\"headline\":\"\u7dad\u4e9e\u751f\u7269\u6295\u8cc7\u5b75\u5316\u516c\u53f8\u8fd1\u671f\u767c\u5c55\u52d5\u614b\u4e00\u89bd\",\"datePublished\":\"2024-03-06T10:46:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=222124\"},\"wordCount\":146,\"publisher\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=222124#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo-150.png\",\"articleSection\":[\"\u7f8e\u901a\u793e\"],\"inLanguage\":\"zh-TW\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=222124\",\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=222124\",\"name\":\"\u7dad\u4e9e\u751f\u7269\u6295\u8cc7\u5b75\u5316\u516c\u53f8\u8fd1\u671f\u767c\u5c55\u52d5\u614b\u4e00\u89bd - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=222124#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=222124#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo-150.png\",\"datePublished\":\"2024-03-06T10:46:00+00:00\",\"description\":\"\u9999\u6e2f2024\u5e743\u67086\u65e5 \\\/\u7f8e\u901a\u793e\\\/ -- \u9762\u5c0d\u4e0d\u65b7\u8b8a\u5316\u7684\u5c40\u52e2\uff0c\u6280\u8853\u5275\u65b0\u4f9d\u820a\u662f\u751f\u7269\u91ab\u85e5\u4f01\u696d\u9577\u9060\u767c\u5c55\u6c38\u6046\u7684\u4e3b\u65cb\u5f8b\uff0c\u70ba\u4f01\u696d\u6e90\u6e90\u4e0d\u65b7\u5730\u6ce8\u5165\u751f\u547d\u529b\uff0c\u6301\u7e8c\u63a8\u52d5\u7814\u767c\u300c\u5f9e0\u52301\u300d\u8f49\u5316\u4ee5\u53ca\u5546\u696d\u5316\u6210\u529f\u3002\u8fd1\u671f\uff0c\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u4f01\u696d\u53c8\u6709\u65b0\u7684\u52d5\u614b\uff1aAceLink\u3001\u7279\u79d1\u7f85\u7814\u767c\u9032\u5c55\u9806\u5229\uff1b\u535a\u81f4\u751f\u7269\u3001Basking\u3001\u7279\u79d1\u7f85\u3001\u8f3b\u806f\u79d1\u6280\u6210\u529f\u5b8c\u6210\u878d\u8cc7\uff1b\u7dad\u7738\u751f\u7269\u65ac\u7372\u6b8a\u69ae\uff1bAbsci\u9054\u6210\u91cd\u8981\u5408\u4f5c\u3002 \u535a\u81f4\u751f\u7269\u5b8c\u62101800\u842c\u7f8e\u5143A\u8f2a\u878d\u8cc7 \u8fd1\u65e5\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u535a\u81f4\u751f\u7269\uff08Proviva Therapeutics\uff09\u6b23\u7136\u5ba3\u4f48\u5b8c\u62101800\u842c\u7f8e\u5143\u7684A\u8f2a\u878d\u8cc7\uff0c\u4ee5\u63a8\u9032\u5176\u6838\u5fc3\u7522\u54c1PTX-912\u7684\u81e8\u5e8a\u958b\u767c\u3002\u9f8d\u78d0\u6295\u8cc7\uff0c\u6069\u7136\u5275\u6295\u548c\u4ed9\u77b3\u8cc7\u672c\u806f\u5408\u53c3\u52a0\u672c\u8f2a\u878d\u8cc7\u3002 \u535a\u81f4\u751f\u7269\u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\u7684\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u81f4\u529b\u65bc\u958b\u767c\u65b0\u4e00\u4ee3\u7d30\u80de\u56e0\u5b50\u6297\u816b\u7624\u514d\u75ab\u7642\u6cd5\u3002\u91dd\u5c0d\u7d30\u80de\u56e0\u5b50\u5916\u5468\u6bd2\u6027\u7684\u50b3\u7d71\u96e3\u984c\uff0c\u516c\u53f8\u81ea\u4e3b\u958b\u767c\u4e86\u300cCrossover\u300d\u7d30\u80de\u56e0\u5b50\u524d\u85e5\u6280\u8853\u5e73\u53f0\uff0c\u5be6\u73fe\u5728\u816b\u7624\u5fae\u74b0\u5883\u4e2d\u7279\u7570\u6027\u7684\u85e5\u7269\u6d3b\u6027\u91cb\u653e\u3002\u4f9d\u8a17\u300cCrossover\u300d\u6280\u8853\u5e73\u53f0\uff0c\u535a\u81f4\u6210\u529f\u7814\u767c\u51faPTX-912\u2014\u2014\u65b0\u4e00\u4ee3\u514d\u75ab\u7d30\u80de\u9776\u5411\u7684\u767d\u7d30\u80de\u4ecb\u7d20-2\uff08IL-2\uff09\u524d\u85e5\u878d\u5408\u86cb\u767d\u3002 AceLink Therapeutics\u767c\u4f48\u5065\u5eb7\u5fd7\u9858\u8005\u53c3\u8207\u8a55\u4f30AL01211\u7684I\u671f\u81e8\u5e8a\u8a66\u9a57\u6578\u64da \u7d10\u74e6\u514b\uff0c\u52a0\u5229\u798f\u5c3c\u4e9e\u5dde\u2014\u20142024\u5e742\u670826\u65e5\uff0cAceLink Therapeutics\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u3001\u4e00\u5bb6\u958b\u767c\u4e0b\u4e00\u4ee3\u53e3\u670d\u5e95\u7269\u6e1b\u5c11\u7642\u6cd5\uff08SRTs\uff09\u7684\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u88fd\u85e5\u516c\u53f8\u5ba3\u4f48\uff0c\u5176\u5728\u5065\u5eb7\u5fd7\u9858\u8005\u4e2d\u9032\u884c\u7684AL01211\u7684I\u671f\u7814\u7a76\u7684\u7d50\u679c\u5df2\u7d93\u767c\u8868\u5728\u540c\u884c\u8a55\u5be9\u7684\u7f8e\u570b\u81e8\u5e8a\u85e5\u5b78\u9662\u671f\u520a\u300aClinical Pharmacology in Drug Development\u300b\u4e0a\u3002AL01211\u662f\u4e00\u7a2e\u5f37\u5927\u7684\u53e3\u670d\u8461\u7cd6\u795e\u7d93\u91af\u80fa\u5408\u6210\u9176\uff08GCS\uff09\u6291\u5236\u5291\uff0c\u6b63\u5728\u958b\u767c\u7528\u65bc\u6cbb\u7642\u6cd5\u5e03\u745e\u6c0f\u75c7\u548cI\u578b\u9ad8\u96ea\u6c0f\u75c7\u3002 \u5728\u5df2\u767c\u8868\u7684I\u671f\u7814\u7a76\u4e2d\uff0c\u5c0dAL01211\u9032\u884c\u4e86\u55ae\u5291\u91cf\u905e\u589e\u548c\u591a\u5291\u91cf\u905e\u589e\u7684\u7814\u7a76\uff0c\u4ee5\u78ba\u5b9a\u5176\u5728\u5065\u5eb7\u5fd7\u9858\u8005\u4e2d\u7684\u5b89\u5168\u6027\u3001\u85e5\u4ee3\u52d5\u529b\u5b78\uff08PK\uff09\u548c\u85e5\u6548\u5b78\uff08PD\uff09\u6548\u61c9\u3002\u7e3d\u9ad4\u800c\u8a00\uff0cAL01211\u5177\u6709\u826f\u597d\u7684\u5b89\u5168\u6027\u548c\u8010\u53d7\u6027\uff0c\u7121\u56b4\u91cd\u4e0d\u826f\u4e8b\u4ef6\u3002\u572830mg\u5291\u91cf\u6c34\u5e73\u4e0b\uff0c\u8840\u6f3f\u8461\u7cd6\u57fa\u795e\u7d93\u91af\u80fa\u548c\u7403\u86cb\u767d\u4e09\u7cd6\u795e\u7d93\u91af\u80fa\u5206\u5225\u5f9e\u57fa\u7dda\u6c34\u6e96\u964d\u4f4e\u4e8678%\u548c52%\uff0c\u5f9e\u800c\u652f\u6301AL01211\u7684\u9032\u4e00\u6b65\u81e8\u5e8a\u7814\u7a76\u3002 Basking\u5ba3\u4f48\u5b8c\u6210\u7531ARCH\u9818\u6295\u76845500\u842c\u7f8e\u5143\u878d\u8cc7\uff0c\u52a0\u901f\u53ef\u9006\u6eb6\u6813\u5291\u7684\u81e8\u5e8a\u958b\u767c \u4fc4\u4ea5\u4fc4\u5dde\u54e5\u502b\u5e03\u2014\u20142024\u5e741\u670830\u65e5\uff0cBasking Biosciences\uff08\u4ee5\u4e0b\u7c21\u7a31\u300cBasking\u300d\uff09\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\uff0c\u4e00\u5bb6\u958b\u767c\u65b0\u578b\u6025\u6027\u6eb6\u6813\u7642\u6cd5\u6cbb\u7642\u5352\u4e2d\u7684\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u88fd\u85e5\u516c\u53f8\uff0c\u5ba3\u4f48\u5b8c\u62105500\u842c\u7f8e\u5143\u7684\u878d\u8cc7\u3002\u65b0\u6295\u8cc7\u8005ARCH Venture Partners\u9818\u6295\uff0c\u5176\u4ed6\u65b0\u6295\u8cc7\u8005Insight Partners\u3001Platanus\u3001Solas BioVentures\u548cRTW Investments\uff0c\u4ee5\u53ca\u73fe\u6709\u6295\u8cc7\u8005\u8ddf\u6295\u3002ARCH Venture Partners\u8463\u4e8b\u7e3d\u7d93\u7406Steven Gillis\u535a\u58eb\u5c07\u64d4\u4efbBasking\u8463\u4e8b\u6703\u4e3b\u5e2d\u3002\u6b64\u524d\u516c\u53f8\u66fe\u5b8c\u6210540\u842c\u7f8e\u5143\u7a2e\u5b50\u8f2a\u878d\u8cc7\uff0c\u6295\u8cc7\u8005\u5305\u62ecRev1 Ventures\u3001Broadview Ventures\u548c\u7dad\u4e9e\u751f\u7269\u3002 Basking\u5c07\u5229\u7528\u878d\u8cc7\u52a0\u901fBB-031\u7684\u81e8\u5e8a\u958b\u767c\u3002\u9019\u662f\u4e00\u7a2e\u9776\u5411von Willebrand\u56e0\u5b50\uff08vWF\uff09\u7684\u540c\u985e\u9996\u5275\u53ef\u9006RNA aptamers\uff0c\u5c08\u70ba\u5feb\u901f\u8d77\u6548\u548c\u77ed\u6301\u7e8c\u6642\u9593\u7684\u7642\u6548\u800c\u8a2d\u8a08\u3002 \u7279\u79d1\u7f85\u7372\u842c\u7269\u5275\u6295\u6578\u767e\u842c\u7f8e\u5143Pre-B\u8f2a\u878d\u8cc7\uff0c\u4e14\u5176\u6cbb\u7642\u96c4\u6fc0\u7d20\u6027\u812b\u9aee\u5168\u7403\u9996\u5275\u65b0\u85e5TDM-105795\u81e8\u5e8a\u4e8c\u671fa\u8a66\u9a57\u9806\u5229\u5b8c\u6210\u53ca\u5b8c\u6210\u91dd\u5c0d\u6fd5\u75b9\\\/\u76ae\u708e\u9069\u61c9\u75c7\u7684TDM-180935\u5291\u91cf\u905e\u589e\u7684\u4e00\u671f\u81e8\u5e8a\u8a66\u9a57 \u64da\u52d5\u8108\u7db21\u670815\u65e5\u6d88\u606f\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u3001\u4e00\u5bb6\u5c08\u6ce8\u76ae\u819a\u75be\u75c5\u65b0\u85e5\u7814\u767c\u7684\u81e8\u5e8a\u968e\u6bb5\u516c\u53f8\u7279\u79d1\u7f85\u751f\u7269\u79d1\u6280\uff08\u6210\u90fd\uff09\u6709\u9650\u516c\u53f8\uff08\u4ee5\u4e0b\u7c21\u7a31\u300c\u7279\u79d1\u7f85\u300d\uff09\uff0c\u5ba3\u4f48\u5df2\u65bc\u8fd1\u671f\u5b8c\u6210\u6578\u5343\u842c\u4eba\u6c11\u5e63\u7684Pre-B\u8f2a\u878d\u8cc7\uff0c\u672c\u8f2a\u878d\u8cc7\u6295\u8cc7\u65b9\u70ba\u842c\u7269\u5275\u6295\uff0c\u6240\u878d\u8cc7\u91d1\u5c07\u7528\u65bc\u6bdb\u9aee\u9805\u76ee\u7684\u5f8c\u7e8c\u81e8\u5e8a\u958b\u767c\u548c\u6fd5\u75b9\u76ae\u708e\u9805\u76ee\u4e2d\u7f8e\u96d9\u5831\u7684\u4e8c\u671f\u81e8\u5e8a\u8a66\u9a57\uff08\u4e2d\u7f8eIIa\u81e8\u5e8a\uff09\u3002\u96a8\u5f8c2\u67085\u65e5\uff0c\u7279\u79d1\u7f85\u5f88\u9ad8\u8208\u5730\u5ba3\u4f48\uff1a\u5916\u7528\u5857\u62b9\u88fd\u5291TDM-105795\u7528\u65bc\u6cbb\u7642\u96c4\u6fc0\u7d20\u6027\u812b\u9aee\uff08AGA\uff09\u7684\u9996\u500b\u81e8\u5e8a\u4e8c\u671f\u8a66\u9a57\uff08NCT05802173\uff09\u9806\u5229\u5b8c\u6210\u3002 \u6b64\u5916\uff0c2023\u5e7412\u67084\u65e5\uff0c\u7279\u79d1\u7f85\u5ba3\u4f48\u5df2\u7d93\u5b8c\u6210\u91dd\u5c0d\u7279\u61c9\u6027\u76ae\u708e\\\/\u6fd5\u75b9\u7684TDM-180935\u5916\u7528\u8edf\u818f\u7684\u4e00\u671f\u81e8\u5e8a\u8a66\u9a57\uff08NCT05525468\uff09\uff0c\u8a66\u9a57\u7d50\u679c\u5747\u9054\u5230\u9810\u671f\u3002 \u8f3b\u806f\u79d1\u6280\u5ba3\u4f48\u5b8c\u6210B\u8f2a\u7f8e\u5143\u878d\u8cc7\uff0c\u4e14\u5176\u6bd4\u5229\u6642GMP\u751f\u7522\u8a2d\u65bd\u5960\u57fa 2024\u5e741\u67084\u65e5\uff0c\u4e0a\u6d77\\\/\u8b93\u5e03\u76e7\\\/\u6d77\u5fb7\u5821\u2014\u2014\u7dad\u4e9e\u751f\u7269\u88ab\u6295\u4f01\u696d\u3001\u5168\u9762\u6574\u5408\u7684\u570b\u969b\u5316\u653e\u5c04\u6027\u85e5\u7269\u6cbb\u7642\u516c\u53f8\u8f3b\u806f\u79d1\u6280\u6709\u9650\u516c\u53f8\uff08\u4ee5\u4e0b\u7c21\u7a31\u300c\u8f3b\u806f\u79d1\u6280\u300d\uff09\uff0c\u5ba3\u4f48\u5b8c\u62106330\u842c\u7f8e\u5143\u878d\u8cc7\uff0c\u5176\u4e2d\u5305\u62ec4730\u842c\u7f8e\u5143\u7684B\u8f2a\u80a1\u6b0a\u878d\u8cc7\u548c1600\u842c\u7f8e\u5143\u7684\u6388\u4fe1\u984d\u5ea6\u3002\u672c\u6b21\u878d\u8cc7\u5c07\u5e6b\u52a9\u516c\u53f8\u5feb\u901f\u63a8\u9032\u5176\u653e\u5c04\u6027\u85e5\u7269\u7ba1\u7dda\u7684\u958b\u767c\u548c\u85e5\u7269\u751f\u7522\u80fd\u529b\u7684\u5efa\u8a2d\uff0c\u4e26\u512a\u5316\u5176\u5c08\u6709\u767c\u73fe\u5e73\u53f0UniRDC\u2122\u3002\u00a0\u96a8\u8457\u672c\u6b21\u878d\u8cc7\u7684\u5b8c\u6210\uff0c\u8f3b\u806f\u79d1\u6280\u81ea2021\u5e748\u6708\u6210\u7acb\u4ee5\u4f86\u5df2\u7d2f\u8a08\u878d\u8cc7\u8d85\u904e1.1\u5104\u7f8e\u5143\uff0c\u5305\u62ec\u80a1\u6b0a\u878d\u8cc7\u3001\u50b5\u6b0a\u878d\u8cc7\u548c\u653f\u5e9c\u88dc\u8cbc\u3002 \u6b64\u524d12\u67088\u65e5\uff0c\u8f3b\u806f\u79d1\u6280\u9084\u5ba3\u4f48\u4e86\u5728\u6bd4\u5229\u6642\u8b93\u5e03\u76e7\u5e02\u958b\u5de5\u5efa\u8a2d\u5176\u7b26\u5408\u751f\u7522\u8cea\u91cf\u7ba1\u7406\u898f\u7bc4\uff08\u300cGMP\u300d\uff09\u7684\u653e\u5c04\u6027\u85e5\u7269\u751f\u7522\u8a2d\u65bd\uff0c\u4ee5\u9032\u4e00\u6b65\u63a8\u9032\u653e\u5c04\u6027\u85e5\u7269\u7684\u5168\u7522\u696d\u93c8\u89e3\u6c7a\u65b9\u6848\u3002 \u7dad\u7738\u751f\u7269\u7372\u9999\u6e2f\u5275\u65b0\u79d1\u6280\u7f72\u300c\u4f01\u696d\u652f\u63f4\u8a08\u5283\u300d\u8cc7\u52a9\uff0c\u4e14\u69ae\u767b\u300a2023\u80e1\u6f64\u5168\u7403\u7375\u8c79\u4f01\u696d\u699c\u300b \u8fd1\u671f\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u7dad\u7738\u751f\u7269\u7684\u9999\u6e2f\u5b50\u516c\u53f8\uff0c\u4e00\u5bb6\u805a\u7126\u5dee\u7570\u5316\u548c\u5168\u7403\u65b0\u958b\u767c\u7684\u773c\u79d1\u5275\u65b0\u85e5\u516c\u53f8\uff0c\u5ba3\u4f48\u5176\u5275\u65b0\u773c\u5e95\u85e5\u7269VVN481\u6210\u529f\u7372\u5f97\u9999\u6e2f\u5275\u65b0\u79d1\u6280\u7f72\u300c\u4f01\u696d\u652f\u63f4\u8a08\u5283Enterprise Support Scheme\u300d\uff08ESS\u2014Hong Kong-Israel R&amp;D Cooperation Programme\uff09\u00a0\u8cc7\u52a9\u3002\u6b64\u6b21\u8cc7\u52a9\u5c07\u7528\u65bc\u63a8\u9032\u8a72\u7ba1\u7dda\u7684\u81e8\u5e8a\u524d\u7814\u767c\u5de5\u4f5c\uff0c\u4ee5\u671f\u66f4\u5feb\u63a8\u9032\u5230\u81e8\u5e8a\u968e\u6bb5\u3002\u6b64\u5916\uff0c\u8fd1\u65e5\u7dad\u7738\u751f\u7269\u9084\u69ae\u767b\u300a2023\u80e1\u6f64\u5168\u7403\u7375\u8c79\u4f01\u696d\u699c\u300b\u3002 \u7dad\u4e9e\u751f\u7269\u88ab\u6295\u4f01\u696dAbsci\u5ba3\u4f48\u8207\u963f\u65af\u5229\u5eb7\u5408\u4f5c\u958b\u767c\u4eba\u5de5\u667a\u80fd\u9a45\u52d5\u7684\u816b\u7624\u5019\u9078\u85e5\u7269 \u83ef\u76db\u9813\u5dde\u6eab\u54e5\u83ef\uff0c2023\u5e7412\u67084\u65e5\u2014\u2014\u7dad\u4e9e\u751f\u7269\u88ab\u6295\u4f01\u696d\u3001\u751f\u6210\u5f0f\u4eba\u5de5\u667a\u80fd\u6297\u9ad4\u767c\u73fe\u9818\u57df\u7684\u9818\u5c0e\u8005Absci\u516c\u53f8\uff08NASDAQ:ABSI\uff09\uff0c\u5ba3\u4f48\u8207\u5168\u7403\u751f\u7269\u88fd\u85e5\u516c\u53f8\u963f\u65af\u5229\u5eb7\uff08AstraZeneca\uff09\u5408\u4f5c\uff0c\u91dd\u5c0d\u816b\u7624\u9776\u9ede\u63d0\u4f9b\u4eba\u5de5\u667a\u80fd\u8a2d\u8a08\u7684\u6297\u9ad4\u3002\u6b64\u6b21\u5408\u4f5c\u5c07Absci\u7684Integrated Drug Creation\u2122\u5e73\u53f0\u8207\u963f\u65af\u5229\u5eb7\u5728\u816b\u7624\u5b78\u9818\u57df\u7684\u5c08\u696d\u77e5\u8b58\u76f8\u7d50\u5408\uff0c\u65e8\u5728\u52a0\u901f\u767c\u73fe\u6f5b\u5728\u7684\u65b0\u578b\u764c\u75c7\u6cbb\u7642\u5019\u9078\u85e5\u7269\u3002\u64da\u6089\uff0c\u8a72\u5354\u8b70\u5305\u62ec\u9810\u4ed8\u6b3e\u3001\u7814\u767c\u7d93\u8cbb\u548c\u91cc\u7a0b\u7891\u6b3e\u9805\u7b49\uff0c\u7e3d\u91d1\u984d\u9ad8\u90542.47\u5104\u7f8e\u5143\u3002 \u95dc\u65bc\u535a\u81f4\u751f\u7269 \u535a\u81f4\u751f\u7269\u5275\u7acb\u65bc2019\u5e74\uff0c\u7531\u86cb\u767d\u8cea\u5de5\u7a0b\u548c\u816b\u7624\u514d\u75ab\u9818\u57df\u7684\u9802\u5c16\u5c08\u5bb6\u5718\u968a\u7d44\u5efa\uff0c\u81f4\u529b\u65bc\u958b\u767c\u65b0\u4e00\u4ee3\u7d30\u80de\u56e0\u5b50\u6297\u816b\u7624\u514d\u75ab\u7642\u6cd5\u3002\u516c\u53f8\u81ea\u4e3b\u7814\u767c\u4e86\u300cCrossover\u300d\u524d\u85e5\u6280\u8853\u5e73\u53f0\uff0c\u80fd\u5be6\u73fe\u7d30\u80de\u56e0\u5b50\u5728\u816b\u7624\u5fae\u74b0\u5883\u4e2d\u7279\u7570\u6027\u91cb\u653e\uff0c\u6709\u6548\u89e3\u6c7a\u4e86\u7d30\u80de\u56e0\u5b50\u7684\u5916\u5468\u6bd2\u6027\u554f\u984c\u3002\u4f9d\u8a17\u8a72\u5e73\u53f0\u6280\u8853\uff0c\u516c\u53f8\u6210\u529f\u958b\u767c\u4e86\u81e8\u5e8a\u5019\u9078\u85e5\u7269PTX-912\uff0c\u5df2\u7d93\u555f\u52d5\u7f8e\u570b1\u671f\u81e8\u5e8a\u8a66\u9a57\u3002 \u95dc\u65bcAceLink Therapeutics AceLink Therapeutics\u6210\u7acb\u65bc2018\u5e74\uff0c\u662f\u4e00\u5bb6\u5275\u65b0\u578b\u751f\u7269\u88fd\u85e5\u521d\u5275\u516c\u53f8\uff0c\u5c08\u6ce8\u65bc\u958b\u767c\u5b89\u5168\u6709\u6548\u7684\u85e5\u7269\uff0c\u4ee5\u6eff\u8db3\u5b58\u5728\u9ad8\u5ea6\u672a\u6eff\u8db3\u7684\u81e8\u5e8a\u9700\u6c42\u7684\u907a\u50b3\u6027\u75be\u75c5\u3002\u516c\u53f8\u6700\u521d\u7684\u91cd\u9ede\u662f\u958b\u767c\u6cd5\u5e03\u745e\u6c0f\u75c7\u7684\u65b0\u578b\u6cbb\u7642\u65b9\u6cd5\u3002\u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8acb\u8a2a\u554f www.acelinktherapeutics.com \u95dc\u65bcBasking Biosciences Basking Biosciences\u662f\u4e00\u5bb6\u8655\u65bc\u81e8\u5e8a\u968e\u6bb5\u7684\u516c\u53f8\uff0c\u65e8\u5728\u89e3\u6c7a\u7f3a\u8840\u6027\u8166\u5352\u4e2d\u6cbb\u7642\u7684\u6700\u5927\u9700\u6c42\u2014\u2014\u4e00\u7a2e\u5feb\u901f\u8d77\u6548\u7684\u77ed\u6548\u6eb6\u6813\u85e5\u7269\uff0c\u80fd\u5920\u63d0\u4f9b\u6bd4\u73fe\u6709\u7642\u6cd5\u5927\u5927\u5ef6\u9577\u7684\u6cbb\u7642\u7a97\u53e3\uff0c\u4e26\u91cd\u65b0\u758f\u901a\u963b\u585e\u7684\u52d5\u8108\uff0c\u4e26\u4e14\u5728\u51fa\u8840\u6642\u53ef\u4ee5\u8fc5\u901f\u88ab\u9006\u8f49\u6d3b\u6027\u3002\u516c\u53f8\u6b63\u5728\u958b\u767c\u7684\u85e5\u7269BB-031\uff0c\u5373\u662f\u9019\u7a2efirst -in-class RNA\u9069\u914d\u9ad4\uff0c\u9776\u5411\u8840\u6813\u7684\u91cd\u8981\u7d50\u69cb\u6210\u5206\u548c\u51dd\u8840\u904e\u7a0b\u7684\u9a45\u52d5\u56e0\u7d20\u8840\u7ba1\u6027\u8840\u53cb\u75c5\u56e0\u5b50\uff08von Willebrand Factor\uff0cvWF\uff09\u3002 \u95dc\u65bc\u7279\u79d1\u7f85\u751f\u7269\u79d1\u6280\uff08\u6210\u90fd\uff09\u6709\u9650\u516c\u53f8\u00a0 \u7279\u79d1\u7f85\u751f\u7269\u79d1\u6280\uff08\u6210\u90fd\uff09\u6709\u9650\u516c\u53f8\u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\u7684\u751f\u7269\u91ab\u85e5\u516c\u53f8\u3002\u516c\u53f8\u524d\u8eab\u70ba\u5609\u8208\u7279\u79d1\u7f85\u751f\u7269\u79d1\u6280\u6709\u9650\u516c\u53f8\uff0c\u65b0\u8fd1\u65bc2023\u5e743\u6708\u642c\u9077\u81f3\u56db\u5ddd\u7701\u6210\u90fd\u5929\u5e9c\u570b\u969b\u751f\u7269\u57ce\u3002 \u516c\u53f8\u76ee\u524d\u7684\u6838\u5fc3\u7814\u767c\u9805\u76ee\u5305\u62ec\u91dd\u5c0d\u6cbb\u7642\u96c4\u6fc0\u7d20\u6027\u812b\u9aee\u3001\u7279\u61c9\u6027\u76ae\u708e\\\/\u6fd5\u75b9\u3001\u9280\u5c51\u75c5\u548c\u7d05\u6591\u72fc\u7621\u7b49\u75be\u75c5\u7684\u5275\u65b0\u85e5\u7269\u3002\u516c\u53f8\u5168\u7403\u9818\u5148\u7684\u6cbb\u7642\u96c4\u6fc0\u7d20\u6027\u812b\u9aee\u7684\u5c0f\u5206\u5b50\u5019\u9078\u85e5\u7269TDM-105795\u5373\u5c07\u5b8c\u6210\u4e8c\u671fa\u968e\u6bb5\u81e8\u5e8a\u8a66\u9a57\uff0c\u91dd\u5c0d\u7279\u61c9\u6027\u76ae\u708e\\\/\u6fd5\u75b9\u7684\u5275\u65b0\u578bJAK1\\\/TYK2\u6291\u5236\u5291\u4e5f\u5df2\u7d93\u5b8c\u6210\u4e00\u671f\u81e8\u5e8a\u8a66\u9a57\uff0c\u5373\u5c07\u958b\u5c55\u81e8\u5e8a\u4e8c\u671fPOC\u8a66\u9a57\u3002\u516c\u53f8\u5177\u6709\u591a\u500b\u81e8\u5e8a\u524d\u6216\u81e8\u5e8a\u968e\u6bb5\u7684\u5019\u9078\u85e5\u7269\uff0c\u5728\u7814\u7ba1\u7dda\u7522\u54c1\u90fd\u662f\u91dd\u5c0d\u6cbb\u7642\u5404\u7a2e\u76ae\u819a\u9069\u61c9\u75c7\u3002 \u95dc\u65bc\u8f3b\u806f\u79d1\u6280 \u8f3b\u806f\u79d1\u6280\u6709\u9650\u516c\u53f8\uff08\u300c\u8f3b\u806f\u79d1\u6280\u300d\uff09\u662f\u4e00\u5bb6\u5168\u9762\u6574\u5408\u7684\u570b\u969b\u5316\u653e\u5c04\u6027\u85e5\u7269\u6cbb\u7642\u516c\u53f8\uff0c\u5728\u6bd4\u5229\u6642\u3001\u5fb7\u570b\u548c\u4e2d\u570b\u5747\u8a2d\u6709\u8fa6\u4e8b\u8655\u3002\u6211\u5011\u81f4\u529b\u65bc\u6253\u9020\u64c1\u6709\u653e\u5c04\u6027\u85e5\u7269\u7814\u767c\u3001\u751f\u7522\u548c\u5546\u696d\u5316\u7684\u5168\u7522\u696d\u93c8\u7684\u6838\u85e5\u516c\u53f8\u4ee5\u9020\u798f\u5168\u7403\u60a3\u8005\u3002\u6211\u5011\u8a08\u5283\u901a\u904e\u91dd\u5c0d\u672a\u4f86\u6cbb\u7642\u65b9\u6cd5\u7684\u5275\u65b0\u7814\u7a76\u4f86\u89e3\u6c7a\u76ee\u524d\u5f71\u97ff\u653e\u5c04\u6027\u85e5\u7269\u7814\u767c\u7684\u6838\u5fc3\u554f\u984c\u3002\u6211\u5011\u5718\u968a\u4e2d\u4e0d\u4e4f\u7d93\u9a57\u8c50\u5bcc\u7684\u4f01\u696d\u5bb6\u548c\u79d1\u5b78\u5bb6\uff0c\u4ed6\u5011\u65e2\u64c5\u9577\u7ba1\u7406\u751f\u7269\u91ab\u85e5\u516c\u53f8\uff0c\u4e5f\u6df1\u8af3\u653e\u5c04\u6027\u540c\u4f4d\u7d20\u7684\u7814\u7a76\u548c\u81e8\u5e8a\u958b\u767c\u65b9\u6cd5\u3002 \u95dc\u65bc\u7dad\u7738\u751f\u7269 \u7dad\u7738\u751f\u7269\u662f\u4e00\u5bb6\u5c08\u6ce8\u65bc\u773c\u79d1\u5275\u65b0\u85e5\u7814\u767c\u9818\u57df\u7684\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u64c1\u6709\u570b\u969b\u4e00\u6d41\u7684\u773c\u79d1\u5275\u65b0\u85e5\u7814\u767c\u5718\u968a\u548c\u6280\u8853\u5e73\u53f0\uff0c\u4f9d\u8a17\u81ea\u4e3b\u7814\u767c\u5df2\u7d93\u5efa\u7acb\u8d77\u5177\u6709\u5168\u7403\u7af6\u722d\u529b\u7684\u7522\u54c1\u7ba1\u7dda\u3002\u9664VVN001\u9805\u76ee\u5916\uff0c\u7dad\u7738\u751f\u7269\u6b63\u5728\u958b\u767cVVN539\u7528\u65bc\u6cbb\u7642\u9752\u5149\u773c\u6216\u9ad8\u773c\u58d3\u75c7\uff0cVVN461\u7528\u65bc\u6cbb\u7642\u975e\u611f\u67d3\u6027\u524d\u8461\u8404\u819c\u708e\u548c\u8853\u5f8c\u708e\u75c7\u3002\u7dad\u7738\u751f\u7269\u9084\u81f4\u529b\u65bc\u767c\u73fe\u548c\u958b\u767c\u7528\u65bc\u6cbb\u7642\u5176\u4ed6\u524d\u3001\u5f8c\u773c\u75be\u75c5\u7684\u65b0\u7642\u6cd5\u3002 \u95dc\u65bcAbsci Absci\u662f\u4e00\u5bb6\u751f\u6210\u578b\u4eba\u5de5\u667a\u80fd\u85e5\u7269\u958b\u767c\u516c\u53f8\uff0c\u5c07\u4eba\u5de5\u667a\u80fd\u8207\u53ef\u64f4\u5c55\u7684\u6fd5\u5be6\u9a57\u5ba4\u6280\u8853\u76f8\u7d50\u5408\uff0c\u66f4\u5feb\u5730\u70ba\u60a3\u8005\u5275\u9020\u66f4\u597d\u7684\u751f\u7269\u88fd\u54c1\u3002\u5176Integrated Drug Creation\u2122\u5e73\u53f0\u901a\u904e\u540c\u6642\u512a\u5316\u517c\u5177\u958b\u767c\u548c\u6cbb\u7642\u6548\u679c\u7684\u591a\u7a2e\u85e5\u7269\u7279\u6027\uff0c\u91cb\u653e\u4e86\u52a0\u5feb\u85e5\u7269\u4e0a\u5e02\u6642\u9593\u548c\u63d0\u9ad8\u6210\u529f\u6982\u7387\u7684\u6f5b\u529b\u3002\u901a\u904e\u6578\u64da\u5b78\u7fd2\u3001\u4eba\u5de5\u667a\u80fd\u5275\u9020\u548c\u6fd5\u6cd5\u5be6\u9a57\u5ba4\u9a57\u8b49\uff0cAbsci \u6bcf\u9031\u53ef\u7be9\u9078\u6578\u5341\u5104\u500b\u7d30\u80de\uff0c\u4f7f\u5176\u80fd\u5920\u5728\u77ed\u77ed\u516d\u9031\u5167\u5b8c\u6210\u5f9e\u4eba\u5de5\u667a\u80fd\u8a2d\u8a08\u6297\u9ad4\u5230\u6fd5\u6cd5\u5be6\u9a57\u5ba4\u9a57\u8b49\u5019\u9078\u85e5\u7269\u7684\u904e\u7a0b\u3002Absci\u7684\u9858\u666f\u662f\u70ba\u6bcf\u500b\u4eba\u4e00\u9375\u63d0\u4f9b\u7a81\u7834\u6027\u7684\u6cbb\u7642\u65b9\u6cd5\u3002\u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8acb\u8a2a\u554fwww.absci.com\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=222124#breadcrumb\"},\"inLanguage\":\"zh-TW\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=222124\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-TW\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=222124#primaryimage\",\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo-150.png\",\"contentUrl\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo-150.png\",\"width\":\"3000\",\"height\":\"1990\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=222124#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u9996\u9801\",\"item\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u7dad\u4e9e\u751f\u7269\u6295\u8cc7\u5b75\u5316\u516c\u53f8\u8fd1\u671f\u767c\u5c55\u52d5\u614b\u4e00\u89bd\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#website\",\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/\",\"name\":\"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\",\"description\":\"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831PingtungTimes\uff0c\u6700\u95dc\u5fc3\u5728\u5730\u7684\u5a92\u9ad4\",\"publisher\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-TW\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#organization\",\"name\":\"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\",\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-TW\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo-150.png\",\"contentUrl\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo-150.png\",\"width\":150,\"height\":150,\"caption\":\"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\"},\"image\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/pingtungnews\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#\\\/schema\\\/person\\\/683b937f29ec1537972f6c41e22a2cf3\",\"name\":\"\u7f8e\u901a\u793e\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-TW\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g\",\"caption\":\"\u7f8e\u901a\u793e\"},\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?author=16\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u7dad\u4e9e\u751f\u7269\u6295\u8cc7\u5b75\u5316\u516c\u53f8\u8fd1\u671f\u767c\u5c55\u52d5\u614b\u4e00\u89bd - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","description":"\u9999\u6e2f2024\u5e743\u67086\u65e5 \/\u7f8e\u901a\u793e\/ -- \u9762\u5c0d\u4e0d\u65b7\u8b8a\u5316\u7684\u5c40\u52e2\uff0c\u6280\u8853\u5275\u65b0\u4f9d\u820a\u662f\u751f\u7269\u91ab\u85e5\u4f01\u696d\u9577\u9060\u767c\u5c55\u6c38\u6046\u7684\u4e3b\u65cb\u5f8b\uff0c\u70ba\u4f01\u696d\u6e90\u6e90\u4e0d\u65b7\u5730\u6ce8\u5165\u751f\u547d\u529b\uff0c\u6301\u7e8c\u63a8\u52d5\u7814\u767c\u300c\u5f9e0\u52301\u300d\u8f49\u5316\u4ee5\u53ca\u5546\u696d\u5316\u6210\u529f\u3002\u8fd1\u671f\uff0c\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u4f01\u696d\u53c8\u6709\u65b0\u7684\u52d5\u614b\uff1aAceLink\u3001\u7279\u79d1\u7f85\u7814\u767c\u9032\u5c55\u9806\u5229\uff1b\u535a\u81f4\u751f\u7269\u3001Basking\u3001\u7279\u79d1\u7f85\u3001\u8f3b\u806f\u79d1\u6280\u6210\u529f\u5b8c\u6210\u878d\u8cc7\uff1b\u7dad\u7738\u751f\u7269\u65ac\u7372\u6b8a\u69ae\uff1bAbsci\u9054\u6210\u91cd\u8981\u5408\u4f5c\u3002 \u535a\u81f4\u751f\u7269\u5b8c\u62101800\u842c\u7f8e\u5143A\u8f2a\u878d\u8cc7 \u8fd1\u65e5\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u535a\u81f4\u751f\u7269\uff08Proviva Therapeutics\uff09\u6b23\u7136\u5ba3\u4f48\u5b8c\u62101800\u842c\u7f8e\u5143\u7684A\u8f2a\u878d\u8cc7\uff0c\u4ee5\u63a8\u9032\u5176\u6838\u5fc3\u7522\u54c1PTX-912\u7684\u81e8\u5e8a\u958b\u767c\u3002\u9f8d\u78d0\u6295\u8cc7\uff0c\u6069\u7136\u5275\u6295\u548c\u4ed9\u77b3\u8cc7\u672c\u806f\u5408\u53c3\u52a0\u672c\u8f2a\u878d\u8cc7\u3002 \u535a\u81f4\u751f\u7269\u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\u7684\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u81f4\u529b\u65bc\u958b\u767c\u65b0\u4e00\u4ee3\u7d30\u80de\u56e0\u5b50\u6297\u816b\u7624\u514d\u75ab\u7642\u6cd5\u3002\u91dd\u5c0d\u7d30\u80de\u56e0\u5b50\u5916\u5468\u6bd2\u6027\u7684\u50b3\u7d71\u96e3\u984c\uff0c\u516c\u53f8\u81ea\u4e3b\u958b\u767c\u4e86\u300cCrossover\u300d\u7d30\u80de\u56e0\u5b50\u524d\u85e5\u6280\u8853\u5e73\u53f0\uff0c\u5be6\u73fe\u5728\u816b\u7624\u5fae\u74b0\u5883\u4e2d\u7279\u7570\u6027\u7684\u85e5\u7269\u6d3b\u6027\u91cb\u653e\u3002\u4f9d\u8a17\u300cCrossover\u300d\u6280\u8853\u5e73\u53f0\uff0c\u535a\u81f4\u6210\u529f\u7814\u767c\u51faPTX-912\u2014\u2014\u65b0\u4e00\u4ee3\u514d\u75ab\u7d30\u80de\u9776\u5411\u7684\u767d\u7d30\u80de\u4ecb\u7d20-2\uff08IL-2\uff09\u524d\u85e5\u878d\u5408\u86cb\u767d\u3002 AceLink Therapeutics\u767c\u4f48\u5065\u5eb7\u5fd7\u9858\u8005\u53c3\u8207\u8a55\u4f30AL01211\u7684I\u671f\u81e8\u5e8a\u8a66\u9a57\u6578\u64da \u7d10\u74e6\u514b\uff0c\u52a0\u5229\u798f\u5c3c\u4e9e\u5dde\u2014\u20142024\u5e742\u670826\u65e5\uff0cAceLink Therapeutics\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u3001\u4e00\u5bb6\u958b\u767c\u4e0b\u4e00\u4ee3\u53e3\u670d\u5e95\u7269\u6e1b\u5c11\u7642\u6cd5\uff08SRTs\uff09\u7684\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u88fd\u85e5\u516c\u53f8\u5ba3\u4f48\uff0c\u5176\u5728\u5065\u5eb7\u5fd7\u9858\u8005\u4e2d\u9032\u884c\u7684AL01211\u7684I\u671f\u7814\u7a76\u7684\u7d50\u679c\u5df2\u7d93\u767c\u8868\u5728\u540c\u884c\u8a55\u5be9\u7684\u7f8e\u570b\u81e8\u5e8a\u85e5\u5b78\u9662\u671f\u520a\u300aClinical Pharmacology in Drug Development\u300b\u4e0a\u3002AL01211\u662f\u4e00\u7a2e\u5f37\u5927\u7684\u53e3\u670d\u8461\u7cd6\u795e\u7d93\u91af\u80fa\u5408\u6210\u9176\uff08GCS\uff09\u6291\u5236\u5291\uff0c\u6b63\u5728\u958b\u767c\u7528\u65bc\u6cbb\u7642\u6cd5\u5e03\u745e\u6c0f\u75c7\u548cI\u578b\u9ad8\u96ea\u6c0f\u75c7\u3002 \u5728\u5df2\u767c\u8868\u7684I\u671f\u7814\u7a76\u4e2d\uff0c\u5c0dAL01211\u9032\u884c\u4e86\u55ae\u5291\u91cf\u905e\u589e\u548c\u591a\u5291\u91cf\u905e\u589e\u7684\u7814\u7a76\uff0c\u4ee5\u78ba\u5b9a\u5176\u5728\u5065\u5eb7\u5fd7\u9858\u8005\u4e2d\u7684\u5b89\u5168\u6027\u3001\u85e5\u4ee3\u52d5\u529b\u5b78\uff08PK\uff09\u548c\u85e5\u6548\u5b78\uff08PD\uff09\u6548\u61c9\u3002\u7e3d\u9ad4\u800c\u8a00\uff0cAL01211\u5177\u6709\u826f\u597d\u7684\u5b89\u5168\u6027\u548c\u8010\u53d7\u6027\uff0c\u7121\u56b4\u91cd\u4e0d\u826f\u4e8b\u4ef6\u3002\u572830mg\u5291\u91cf\u6c34\u5e73\u4e0b\uff0c\u8840\u6f3f\u8461\u7cd6\u57fa\u795e\u7d93\u91af\u80fa\u548c\u7403\u86cb\u767d\u4e09\u7cd6\u795e\u7d93\u91af\u80fa\u5206\u5225\u5f9e\u57fa\u7dda\u6c34\u6e96\u964d\u4f4e\u4e8678%\u548c52%\uff0c\u5f9e\u800c\u652f\u6301AL01211\u7684\u9032\u4e00\u6b65\u81e8\u5e8a\u7814\u7a76\u3002 Basking\u5ba3\u4f48\u5b8c\u6210\u7531ARCH\u9818\u6295\u76845500\u842c\u7f8e\u5143\u878d\u8cc7\uff0c\u52a0\u901f\u53ef\u9006\u6eb6\u6813\u5291\u7684\u81e8\u5e8a\u958b\u767c \u4fc4\u4ea5\u4fc4\u5dde\u54e5\u502b\u5e03\u2014\u20142024\u5e741\u670830\u65e5\uff0cBasking Biosciences\uff08\u4ee5\u4e0b\u7c21\u7a31\u300cBasking\u300d\uff09\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\uff0c\u4e00\u5bb6\u958b\u767c\u65b0\u578b\u6025\u6027\u6eb6\u6813\u7642\u6cd5\u6cbb\u7642\u5352\u4e2d\u7684\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u88fd\u85e5\u516c\u53f8\uff0c\u5ba3\u4f48\u5b8c\u62105500\u842c\u7f8e\u5143\u7684\u878d\u8cc7\u3002\u65b0\u6295\u8cc7\u8005ARCH Venture Partners\u9818\u6295\uff0c\u5176\u4ed6\u65b0\u6295\u8cc7\u8005Insight Partners\u3001Platanus\u3001Solas BioVentures\u548cRTW Investments\uff0c\u4ee5\u53ca\u73fe\u6709\u6295\u8cc7\u8005\u8ddf\u6295\u3002ARCH Venture Partners\u8463\u4e8b\u7e3d\u7d93\u7406Steven Gillis\u535a\u58eb\u5c07\u64d4\u4efbBasking\u8463\u4e8b\u6703\u4e3b\u5e2d\u3002\u6b64\u524d\u516c\u53f8\u66fe\u5b8c\u6210540\u842c\u7f8e\u5143\u7a2e\u5b50\u8f2a\u878d\u8cc7\uff0c\u6295\u8cc7\u8005\u5305\u62ecRev1 Ventures\u3001Broadview Ventures\u548c\u7dad\u4e9e\u751f\u7269\u3002 Basking\u5c07\u5229\u7528\u878d\u8cc7\u52a0\u901fBB-031\u7684\u81e8\u5e8a\u958b\u767c\u3002\u9019\u662f\u4e00\u7a2e\u9776\u5411von Willebrand\u56e0\u5b50\uff08vWF\uff09\u7684\u540c\u985e\u9996\u5275\u53ef\u9006RNA aptamers\uff0c\u5c08\u70ba\u5feb\u901f\u8d77\u6548\u548c\u77ed\u6301\u7e8c\u6642\u9593\u7684\u7642\u6548\u800c\u8a2d\u8a08\u3002 \u7279\u79d1\u7f85\u7372\u842c\u7269\u5275\u6295\u6578\u767e\u842c\u7f8e\u5143Pre-B\u8f2a\u878d\u8cc7\uff0c\u4e14\u5176\u6cbb\u7642\u96c4\u6fc0\u7d20\u6027\u812b\u9aee\u5168\u7403\u9996\u5275\u65b0\u85e5TDM-105795\u81e8\u5e8a\u4e8c\u671fa\u8a66\u9a57\u9806\u5229\u5b8c\u6210\u53ca\u5b8c\u6210\u91dd\u5c0d\u6fd5\u75b9\/\u76ae\u708e\u9069\u61c9\u75c7\u7684TDM-180935\u5291\u91cf\u905e\u589e\u7684\u4e00\u671f\u81e8\u5e8a\u8a66\u9a57 \u64da\u52d5\u8108\u7db21\u670815\u65e5\u6d88\u606f\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u3001\u4e00\u5bb6\u5c08\u6ce8\u76ae\u819a\u75be\u75c5\u65b0\u85e5\u7814\u767c\u7684\u81e8\u5e8a\u968e\u6bb5\u516c\u53f8\u7279\u79d1\u7f85\u751f\u7269\u79d1\u6280\uff08\u6210\u90fd\uff09\u6709\u9650\u516c\u53f8\uff08\u4ee5\u4e0b\u7c21\u7a31\u300c\u7279\u79d1\u7f85\u300d\uff09\uff0c\u5ba3\u4f48\u5df2\u65bc\u8fd1\u671f\u5b8c\u6210\u6578\u5343\u842c\u4eba\u6c11\u5e63\u7684Pre-B\u8f2a\u878d\u8cc7\uff0c\u672c\u8f2a\u878d\u8cc7\u6295\u8cc7\u65b9\u70ba\u842c\u7269\u5275\u6295\uff0c\u6240\u878d\u8cc7\u91d1\u5c07\u7528\u65bc\u6bdb\u9aee\u9805\u76ee\u7684\u5f8c\u7e8c\u81e8\u5e8a\u958b\u767c\u548c\u6fd5\u75b9\u76ae\u708e\u9805\u76ee\u4e2d\u7f8e\u96d9\u5831\u7684\u4e8c\u671f\u81e8\u5e8a\u8a66\u9a57\uff08\u4e2d\u7f8eIIa\u81e8\u5e8a\uff09\u3002\u96a8\u5f8c2\u67085\u65e5\uff0c\u7279\u79d1\u7f85\u5f88\u9ad8\u8208\u5730\u5ba3\u4f48\uff1a\u5916\u7528\u5857\u62b9\u88fd\u5291TDM-105795\u7528\u65bc\u6cbb\u7642\u96c4\u6fc0\u7d20\u6027\u812b\u9aee\uff08AGA\uff09\u7684\u9996\u500b\u81e8\u5e8a\u4e8c\u671f\u8a66\u9a57\uff08NCT05802173\uff09\u9806\u5229\u5b8c\u6210\u3002 \u6b64\u5916\uff0c2023\u5e7412\u67084\u65e5\uff0c\u7279\u79d1\u7f85\u5ba3\u4f48\u5df2\u7d93\u5b8c\u6210\u91dd\u5c0d\u7279\u61c9\u6027\u76ae\u708e\/\u6fd5\u75b9\u7684TDM-180935\u5916\u7528\u8edf\u818f\u7684\u4e00\u671f\u81e8\u5e8a\u8a66\u9a57\uff08NCT05525468\uff09\uff0c\u8a66\u9a57\u7d50\u679c\u5747\u9054\u5230\u9810\u671f\u3002 \u8f3b\u806f\u79d1\u6280\u5ba3\u4f48\u5b8c\u6210B\u8f2a\u7f8e\u5143\u878d\u8cc7\uff0c\u4e14\u5176\u6bd4\u5229\u6642GMP\u751f\u7522\u8a2d\u65bd\u5960\u57fa 2024\u5e741\u67084\u65e5\uff0c\u4e0a\u6d77\/\u8b93\u5e03\u76e7\/\u6d77\u5fb7\u5821\u2014\u2014\u7dad\u4e9e\u751f\u7269\u88ab\u6295\u4f01\u696d\u3001\u5168\u9762\u6574\u5408\u7684\u570b\u969b\u5316\u653e\u5c04\u6027\u85e5\u7269\u6cbb\u7642\u516c\u53f8\u8f3b\u806f\u79d1\u6280\u6709\u9650\u516c\u53f8\uff08\u4ee5\u4e0b\u7c21\u7a31\u300c\u8f3b\u806f\u79d1\u6280\u300d\uff09\uff0c\u5ba3\u4f48\u5b8c\u62106330\u842c\u7f8e\u5143\u878d\u8cc7\uff0c\u5176\u4e2d\u5305\u62ec4730\u842c\u7f8e\u5143\u7684B\u8f2a\u80a1\u6b0a\u878d\u8cc7\u548c1600\u842c\u7f8e\u5143\u7684\u6388\u4fe1\u984d\u5ea6\u3002\u672c\u6b21\u878d\u8cc7\u5c07\u5e6b\u52a9\u516c\u53f8\u5feb\u901f\u63a8\u9032\u5176\u653e\u5c04\u6027\u85e5\u7269\u7ba1\u7dda\u7684\u958b\u767c\u548c\u85e5\u7269\u751f\u7522\u80fd\u529b\u7684\u5efa\u8a2d\uff0c\u4e26\u512a\u5316\u5176\u5c08\u6709\u767c\u73fe\u5e73\u53f0UniRDC\u2122\u3002\u00a0\u96a8\u8457\u672c\u6b21\u878d\u8cc7\u7684\u5b8c\u6210\uff0c\u8f3b\u806f\u79d1\u6280\u81ea2021\u5e748\u6708\u6210\u7acb\u4ee5\u4f86\u5df2\u7d2f\u8a08\u878d\u8cc7\u8d85\u904e1.1\u5104\u7f8e\u5143\uff0c\u5305\u62ec\u80a1\u6b0a\u878d\u8cc7\u3001\u50b5\u6b0a\u878d\u8cc7\u548c\u653f\u5e9c\u88dc\u8cbc\u3002 \u6b64\u524d12\u67088\u65e5\uff0c\u8f3b\u806f\u79d1\u6280\u9084\u5ba3\u4f48\u4e86\u5728\u6bd4\u5229\u6642\u8b93\u5e03\u76e7\u5e02\u958b\u5de5\u5efa\u8a2d\u5176\u7b26\u5408\u751f\u7522\u8cea\u91cf\u7ba1\u7406\u898f\u7bc4\uff08\u300cGMP\u300d\uff09\u7684\u653e\u5c04\u6027\u85e5\u7269\u751f\u7522\u8a2d\u65bd\uff0c\u4ee5\u9032\u4e00\u6b65\u63a8\u9032\u653e\u5c04\u6027\u85e5\u7269\u7684\u5168\u7522\u696d\u93c8\u89e3\u6c7a\u65b9\u6848\u3002 \u7dad\u7738\u751f\u7269\u7372\u9999\u6e2f\u5275\u65b0\u79d1\u6280\u7f72\u300c\u4f01\u696d\u652f\u63f4\u8a08\u5283\u300d\u8cc7\u52a9\uff0c\u4e14\u69ae\u767b\u300a2023\u80e1\u6f64\u5168\u7403\u7375\u8c79\u4f01\u696d\u699c\u300b \u8fd1\u671f\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u7dad\u7738\u751f\u7269\u7684\u9999\u6e2f\u5b50\u516c\u53f8\uff0c\u4e00\u5bb6\u805a\u7126\u5dee\u7570\u5316\u548c\u5168\u7403\u65b0\u958b\u767c\u7684\u773c\u79d1\u5275\u65b0\u85e5\u516c\u53f8\uff0c\u5ba3\u4f48\u5176\u5275\u65b0\u773c\u5e95\u85e5\u7269VVN481\u6210\u529f\u7372\u5f97\u9999\u6e2f\u5275\u65b0\u79d1\u6280\u7f72\u300c\u4f01\u696d\u652f\u63f4\u8a08\u5283Enterprise Support Scheme\u300d\uff08ESS\u2014Hong Kong-Israel R&amp;D Cooperation Programme\uff09\u00a0\u8cc7\u52a9\u3002\u6b64\u6b21\u8cc7\u52a9\u5c07\u7528\u65bc\u63a8\u9032\u8a72\u7ba1\u7dda\u7684\u81e8\u5e8a\u524d\u7814\u767c\u5de5\u4f5c\uff0c\u4ee5\u671f\u66f4\u5feb\u63a8\u9032\u5230\u81e8\u5e8a\u968e\u6bb5\u3002\u6b64\u5916\uff0c\u8fd1\u65e5\u7dad\u7738\u751f\u7269\u9084\u69ae\u767b\u300a2023\u80e1\u6f64\u5168\u7403\u7375\u8c79\u4f01\u696d\u699c\u300b\u3002 \u7dad\u4e9e\u751f\u7269\u88ab\u6295\u4f01\u696dAbsci\u5ba3\u4f48\u8207\u963f\u65af\u5229\u5eb7\u5408\u4f5c\u958b\u767c\u4eba\u5de5\u667a\u80fd\u9a45\u52d5\u7684\u816b\u7624\u5019\u9078\u85e5\u7269 \u83ef\u76db\u9813\u5dde\u6eab\u54e5\u83ef\uff0c2023\u5e7412\u67084\u65e5\u2014\u2014\u7dad\u4e9e\u751f\u7269\u88ab\u6295\u4f01\u696d\u3001\u751f\u6210\u5f0f\u4eba\u5de5\u667a\u80fd\u6297\u9ad4\u767c\u73fe\u9818\u57df\u7684\u9818\u5c0e\u8005Absci\u516c\u53f8\uff08NASDAQ:ABSI\uff09\uff0c\u5ba3\u4f48\u8207\u5168\u7403\u751f\u7269\u88fd\u85e5\u516c\u53f8\u963f\u65af\u5229\u5eb7\uff08AstraZeneca\uff09\u5408\u4f5c\uff0c\u91dd\u5c0d\u816b\u7624\u9776\u9ede\u63d0\u4f9b\u4eba\u5de5\u667a\u80fd\u8a2d\u8a08\u7684\u6297\u9ad4\u3002\u6b64\u6b21\u5408\u4f5c\u5c07Absci\u7684Integrated Drug Creation\u2122\u5e73\u53f0\u8207\u963f\u65af\u5229\u5eb7\u5728\u816b\u7624\u5b78\u9818\u57df\u7684\u5c08\u696d\u77e5\u8b58\u76f8\u7d50\u5408\uff0c\u65e8\u5728\u52a0\u901f\u767c\u73fe\u6f5b\u5728\u7684\u65b0\u578b\u764c\u75c7\u6cbb\u7642\u5019\u9078\u85e5\u7269\u3002\u64da\u6089\uff0c\u8a72\u5354\u8b70\u5305\u62ec\u9810\u4ed8\u6b3e\u3001\u7814\u767c\u7d93\u8cbb\u548c\u91cc\u7a0b\u7891\u6b3e\u9805\u7b49\uff0c\u7e3d\u91d1\u984d\u9ad8\u90542.47\u5104\u7f8e\u5143\u3002 \u95dc\u65bc\u535a\u81f4\u751f\u7269 \u535a\u81f4\u751f\u7269\u5275\u7acb\u65bc2019\u5e74\uff0c\u7531\u86cb\u767d\u8cea\u5de5\u7a0b\u548c\u816b\u7624\u514d\u75ab\u9818\u57df\u7684\u9802\u5c16\u5c08\u5bb6\u5718\u968a\u7d44\u5efa\uff0c\u81f4\u529b\u65bc\u958b\u767c\u65b0\u4e00\u4ee3\u7d30\u80de\u56e0\u5b50\u6297\u816b\u7624\u514d\u75ab\u7642\u6cd5\u3002\u516c\u53f8\u81ea\u4e3b\u7814\u767c\u4e86\u300cCrossover\u300d\u524d\u85e5\u6280\u8853\u5e73\u53f0\uff0c\u80fd\u5be6\u73fe\u7d30\u80de\u56e0\u5b50\u5728\u816b\u7624\u5fae\u74b0\u5883\u4e2d\u7279\u7570\u6027\u91cb\u653e\uff0c\u6709\u6548\u89e3\u6c7a\u4e86\u7d30\u80de\u56e0\u5b50\u7684\u5916\u5468\u6bd2\u6027\u554f\u984c\u3002\u4f9d\u8a17\u8a72\u5e73\u53f0\u6280\u8853\uff0c\u516c\u53f8\u6210\u529f\u958b\u767c\u4e86\u81e8\u5e8a\u5019\u9078\u85e5\u7269PTX-912\uff0c\u5df2\u7d93\u555f\u52d5\u7f8e\u570b1\u671f\u81e8\u5e8a\u8a66\u9a57\u3002 \u95dc\u65bcAceLink Therapeutics AceLink Therapeutics\u6210\u7acb\u65bc2018\u5e74\uff0c\u662f\u4e00\u5bb6\u5275\u65b0\u578b\u751f\u7269\u88fd\u85e5\u521d\u5275\u516c\u53f8\uff0c\u5c08\u6ce8\u65bc\u958b\u767c\u5b89\u5168\u6709\u6548\u7684\u85e5\u7269\uff0c\u4ee5\u6eff\u8db3\u5b58\u5728\u9ad8\u5ea6\u672a\u6eff\u8db3\u7684\u81e8\u5e8a\u9700\u6c42\u7684\u907a\u50b3\u6027\u75be\u75c5\u3002\u516c\u53f8\u6700\u521d\u7684\u91cd\u9ede\u662f\u958b\u767c\u6cd5\u5e03\u745e\u6c0f\u75c7\u7684\u65b0\u578b\u6cbb\u7642\u65b9\u6cd5\u3002\u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8acb\u8a2a\u554f www.acelinktherapeutics.com \u95dc\u65bcBasking Biosciences Basking Biosciences\u662f\u4e00\u5bb6\u8655\u65bc\u81e8\u5e8a\u968e\u6bb5\u7684\u516c\u53f8\uff0c\u65e8\u5728\u89e3\u6c7a\u7f3a\u8840\u6027\u8166\u5352\u4e2d\u6cbb\u7642\u7684\u6700\u5927\u9700\u6c42\u2014\u2014\u4e00\u7a2e\u5feb\u901f\u8d77\u6548\u7684\u77ed\u6548\u6eb6\u6813\u85e5\u7269\uff0c\u80fd\u5920\u63d0\u4f9b\u6bd4\u73fe\u6709\u7642\u6cd5\u5927\u5927\u5ef6\u9577\u7684\u6cbb\u7642\u7a97\u53e3\uff0c\u4e26\u91cd\u65b0\u758f\u901a\u963b\u585e\u7684\u52d5\u8108\uff0c\u4e26\u4e14\u5728\u51fa\u8840\u6642\u53ef\u4ee5\u8fc5\u901f\u88ab\u9006\u8f49\u6d3b\u6027\u3002\u516c\u53f8\u6b63\u5728\u958b\u767c\u7684\u85e5\u7269BB-031\uff0c\u5373\u662f\u9019\u7a2efirst -in-class RNA\u9069\u914d\u9ad4\uff0c\u9776\u5411\u8840\u6813\u7684\u91cd\u8981\u7d50\u69cb\u6210\u5206\u548c\u51dd\u8840\u904e\u7a0b\u7684\u9a45\u52d5\u56e0\u7d20\u8840\u7ba1\u6027\u8840\u53cb\u75c5\u56e0\u5b50\uff08von Willebrand Factor\uff0cvWF\uff09\u3002 \u95dc\u65bc\u7279\u79d1\u7f85\u751f\u7269\u79d1\u6280\uff08\u6210\u90fd\uff09\u6709\u9650\u516c\u53f8\u00a0 \u7279\u79d1\u7f85\u751f\u7269\u79d1\u6280\uff08\u6210\u90fd\uff09\u6709\u9650\u516c\u53f8\u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\u7684\u751f\u7269\u91ab\u85e5\u516c\u53f8\u3002\u516c\u53f8\u524d\u8eab\u70ba\u5609\u8208\u7279\u79d1\u7f85\u751f\u7269\u79d1\u6280\u6709\u9650\u516c\u53f8\uff0c\u65b0\u8fd1\u65bc2023\u5e743\u6708\u642c\u9077\u81f3\u56db\u5ddd\u7701\u6210\u90fd\u5929\u5e9c\u570b\u969b\u751f\u7269\u57ce\u3002 \u516c\u53f8\u76ee\u524d\u7684\u6838\u5fc3\u7814\u767c\u9805\u76ee\u5305\u62ec\u91dd\u5c0d\u6cbb\u7642\u96c4\u6fc0\u7d20\u6027\u812b\u9aee\u3001\u7279\u61c9\u6027\u76ae\u708e\/\u6fd5\u75b9\u3001\u9280\u5c51\u75c5\u548c\u7d05\u6591\u72fc\u7621\u7b49\u75be\u75c5\u7684\u5275\u65b0\u85e5\u7269\u3002\u516c\u53f8\u5168\u7403\u9818\u5148\u7684\u6cbb\u7642\u96c4\u6fc0\u7d20\u6027\u812b\u9aee\u7684\u5c0f\u5206\u5b50\u5019\u9078\u85e5\u7269TDM-105795\u5373\u5c07\u5b8c\u6210\u4e8c\u671fa\u968e\u6bb5\u81e8\u5e8a\u8a66\u9a57\uff0c\u91dd\u5c0d\u7279\u61c9\u6027\u76ae\u708e\/\u6fd5\u75b9\u7684\u5275\u65b0\u578bJAK1\/TYK2\u6291\u5236\u5291\u4e5f\u5df2\u7d93\u5b8c\u6210\u4e00\u671f\u81e8\u5e8a\u8a66\u9a57\uff0c\u5373\u5c07\u958b\u5c55\u81e8\u5e8a\u4e8c\u671fPOC\u8a66\u9a57\u3002\u516c\u53f8\u5177\u6709\u591a\u500b\u81e8\u5e8a\u524d\u6216\u81e8\u5e8a\u968e\u6bb5\u7684\u5019\u9078\u85e5\u7269\uff0c\u5728\u7814\u7ba1\u7dda\u7522\u54c1\u90fd\u662f\u91dd\u5c0d\u6cbb\u7642\u5404\u7a2e\u76ae\u819a\u9069\u61c9\u75c7\u3002 \u95dc\u65bc\u8f3b\u806f\u79d1\u6280 \u8f3b\u806f\u79d1\u6280\u6709\u9650\u516c\u53f8\uff08\u300c\u8f3b\u806f\u79d1\u6280\u300d\uff09\u662f\u4e00\u5bb6\u5168\u9762\u6574\u5408\u7684\u570b\u969b\u5316\u653e\u5c04\u6027\u85e5\u7269\u6cbb\u7642\u516c\u53f8\uff0c\u5728\u6bd4\u5229\u6642\u3001\u5fb7\u570b\u548c\u4e2d\u570b\u5747\u8a2d\u6709\u8fa6\u4e8b\u8655\u3002\u6211\u5011\u81f4\u529b\u65bc\u6253\u9020\u64c1\u6709\u653e\u5c04\u6027\u85e5\u7269\u7814\u767c\u3001\u751f\u7522\u548c\u5546\u696d\u5316\u7684\u5168\u7522\u696d\u93c8\u7684\u6838\u85e5\u516c\u53f8\u4ee5\u9020\u798f\u5168\u7403\u60a3\u8005\u3002\u6211\u5011\u8a08\u5283\u901a\u904e\u91dd\u5c0d\u672a\u4f86\u6cbb\u7642\u65b9\u6cd5\u7684\u5275\u65b0\u7814\u7a76\u4f86\u89e3\u6c7a\u76ee\u524d\u5f71\u97ff\u653e\u5c04\u6027\u85e5\u7269\u7814\u767c\u7684\u6838\u5fc3\u554f\u984c\u3002\u6211\u5011\u5718\u968a\u4e2d\u4e0d\u4e4f\u7d93\u9a57\u8c50\u5bcc\u7684\u4f01\u696d\u5bb6\u548c\u79d1\u5b78\u5bb6\uff0c\u4ed6\u5011\u65e2\u64c5\u9577\u7ba1\u7406\u751f\u7269\u91ab\u85e5\u516c\u53f8\uff0c\u4e5f\u6df1\u8af3\u653e\u5c04\u6027\u540c\u4f4d\u7d20\u7684\u7814\u7a76\u548c\u81e8\u5e8a\u958b\u767c\u65b9\u6cd5\u3002 \u95dc\u65bc\u7dad\u7738\u751f\u7269 \u7dad\u7738\u751f\u7269\u662f\u4e00\u5bb6\u5c08\u6ce8\u65bc\u773c\u79d1\u5275\u65b0\u85e5\u7814\u767c\u9818\u57df\u7684\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u64c1\u6709\u570b\u969b\u4e00\u6d41\u7684\u773c\u79d1\u5275\u65b0\u85e5\u7814\u767c\u5718\u968a\u548c\u6280\u8853\u5e73\u53f0\uff0c\u4f9d\u8a17\u81ea\u4e3b\u7814\u767c\u5df2\u7d93\u5efa\u7acb\u8d77\u5177\u6709\u5168\u7403\u7af6\u722d\u529b\u7684\u7522\u54c1\u7ba1\u7dda\u3002\u9664VVN001\u9805\u76ee\u5916\uff0c\u7dad\u7738\u751f\u7269\u6b63\u5728\u958b\u767cVVN539\u7528\u65bc\u6cbb\u7642\u9752\u5149\u773c\u6216\u9ad8\u773c\u58d3\u75c7\uff0cVVN461\u7528\u65bc\u6cbb\u7642\u975e\u611f\u67d3\u6027\u524d\u8461\u8404\u819c\u708e\u548c\u8853\u5f8c\u708e\u75c7\u3002\u7dad\u7738\u751f\u7269\u9084\u81f4\u529b\u65bc\u767c\u73fe\u548c\u958b\u767c\u7528\u65bc\u6cbb\u7642\u5176\u4ed6\u524d\u3001\u5f8c\u773c\u75be\u75c5\u7684\u65b0\u7642\u6cd5\u3002 \u95dc\u65bcAbsci Absci\u662f\u4e00\u5bb6\u751f\u6210\u578b\u4eba\u5de5\u667a\u80fd\u85e5\u7269\u958b\u767c\u516c\u53f8\uff0c\u5c07\u4eba\u5de5\u667a\u80fd\u8207\u53ef\u64f4\u5c55\u7684\u6fd5\u5be6\u9a57\u5ba4\u6280\u8853\u76f8\u7d50\u5408\uff0c\u66f4\u5feb\u5730\u70ba\u60a3\u8005\u5275\u9020\u66f4\u597d\u7684\u751f\u7269\u88fd\u54c1\u3002\u5176Integrated Drug Creation\u2122\u5e73\u53f0\u901a\u904e\u540c\u6642\u512a\u5316\u517c\u5177\u958b\u767c\u548c\u6cbb\u7642\u6548\u679c\u7684\u591a\u7a2e\u85e5\u7269\u7279\u6027\uff0c\u91cb\u653e\u4e86\u52a0\u5feb\u85e5\u7269\u4e0a\u5e02\u6642\u9593\u548c\u63d0\u9ad8\u6210\u529f\u6982\u7387\u7684\u6f5b\u529b\u3002\u901a\u904e\u6578\u64da\u5b78\u7fd2\u3001\u4eba\u5de5\u667a\u80fd\u5275\u9020\u548c\u6fd5\u6cd5\u5be6\u9a57\u5ba4\u9a57\u8b49\uff0cAbsci \u6bcf\u9031\u53ef\u7be9\u9078\u6578\u5341\u5104\u500b\u7d30\u80de\uff0c\u4f7f\u5176\u80fd\u5920\u5728\u77ed\u77ed\u516d\u9031\u5167\u5b8c\u6210\u5f9e\u4eba\u5de5\u667a\u80fd\u8a2d\u8a08\u6297\u9ad4\u5230\u6fd5\u6cd5\u5be6\u9a57\u5ba4\u9a57\u8b49\u5019\u9078\u85e5\u7269\u7684\u904e\u7a0b\u3002Absci\u7684\u9858\u666f\u662f\u70ba\u6bcf\u500b\u4eba\u4e00\u9375\u63d0\u4f9b\u7a81\u7834\u6027\u7684\u6cbb\u7642\u65b9\u6cd5\u3002\u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8acb\u8a2a\u554fwww.absci.com","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pingtungtimes.com.tw\/?p=222124","og_locale":"zh_TW","og_type":"article","og_title":"\u7dad\u4e9e\u751f\u7269\u6295\u8cc7\u5b75\u5316\u516c\u53f8\u8fd1\u671f\u767c\u5c55\u52d5\u614b\u4e00\u89bd - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","og_description":"\u9999\u6e2f2024\u5e743\u67086\u65e5 \/\u7f8e\u901a\u793e\/ -- \u9762\u5c0d\u4e0d\u65b7\u8b8a\u5316\u7684\u5c40\u52e2\uff0c\u6280\u8853\u5275\u65b0\u4f9d\u820a\u662f\u751f\u7269\u91ab\u85e5\u4f01\u696d\u9577\u9060\u767c\u5c55\u6c38\u6046\u7684\u4e3b\u65cb\u5f8b\uff0c\u70ba\u4f01\u696d\u6e90\u6e90\u4e0d\u65b7\u5730\u6ce8\u5165\u751f\u547d\u529b\uff0c\u6301\u7e8c\u63a8\u52d5\u7814\u767c\u300c\u5f9e0\u52301\u300d\u8f49\u5316\u4ee5\u53ca\u5546\u696d\u5316\u6210\u529f\u3002\u8fd1\u671f\uff0c\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u4f01\u696d\u53c8\u6709\u65b0\u7684\u52d5\u614b\uff1aAceLink\u3001\u7279\u79d1\u7f85\u7814\u767c\u9032\u5c55\u9806\u5229\uff1b\u535a\u81f4\u751f\u7269\u3001Basking\u3001\u7279\u79d1\u7f85\u3001\u8f3b\u806f\u79d1\u6280\u6210\u529f\u5b8c\u6210\u878d\u8cc7\uff1b\u7dad\u7738\u751f\u7269\u65ac\u7372\u6b8a\u69ae\uff1bAbsci\u9054\u6210\u91cd\u8981\u5408\u4f5c\u3002 \u535a\u81f4\u751f\u7269\u5b8c\u62101800\u842c\u7f8e\u5143A\u8f2a\u878d\u8cc7 \u8fd1\u65e5\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u535a\u81f4\u751f\u7269\uff08Proviva Therapeutics\uff09\u6b23\u7136\u5ba3\u4f48\u5b8c\u62101800\u842c\u7f8e\u5143\u7684A\u8f2a\u878d\u8cc7\uff0c\u4ee5\u63a8\u9032\u5176\u6838\u5fc3\u7522\u54c1PTX-912\u7684\u81e8\u5e8a\u958b\u767c\u3002\u9f8d\u78d0\u6295\u8cc7\uff0c\u6069\u7136\u5275\u6295\u548c\u4ed9\u77b3\u8cc7\u672c\u806f\u5408\u53c3\u52a0\u672c\u8f2a\u878d\u8cc7\u3002 \u535a\u81f4\u751f\u7269\u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\u7684\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u81f4\u529b\u65bc\u958b\u767c\u65b0\u4e00\u4ee3\u7d30\u80de\u56e0\u5b50\u6297\u816b\u7624\u514d\u75ab\u7642\u6cd5\u3002\u91dd\u5c0d\u7d30\u80de\u56e0\u5b50\u5916\u5468\u6bd2\u6027\u7684\u50b3\u7d71\u96e3\u984c\uff0c\u516c\u53f8\u81ea\u4e3b\u958b\u767c\u4e86\u300cCrossover\u300d\u7d30\u80de\u56e0\u5b50\u524d\u85e5\u6280\u8853\u5e73\u53f0\uff0c\u5be6\u73fe\u5728\u816b\u7624\u5fae\u74b0\u5883\u4e2d\u7279\u7570\u6027\u7684\u85e5\u7269\u6d3b\u6027\u91cb\u653e\u3002\u4f9d\u8a17\u300cCrossover\u300d\u6280\u8853\u5e73\u53f0\uff0c\u535a\u81f4\u6210\u529f\u7814\u767c\u51faPTX-912\u2014\u2014\u65b0\u4e00\u4ee3\u514d\u75ab\u7d30\u80de\u9776\u5411\u7684\u767d\u7d30\u80de\u4ecb\u7d20-2\uff08IL-2\uff09\u524d\u85e5\u878d\u5408\u86cb\u767d\u3002 AceLink Therapeutics\u767c\u4f48\u5065\u5eb7\u5fd7\u9858\u8005\u53c3\u8207\u8a55\u4f30AL01211\u7684I\u671f\u81e8\u5e8a\u8a66\u9a57\u6578\u64da \u7d10\u74e6\u514b\uff0c\u52a0\u5229\u798f\u5c3c\u4e9e\u5dde\u2014\u20142024\u5e742\u670826\u65e5\uff0cAceLink Therapeutics\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u3001\u4e00\u5bb6\u958b\u767c\u4e0b\u4e00\u4ee3\u53e3\u670d\u5e95\u7269\u6e1b\u5c11\u7642\u6cd5\uff08SRTs\uff09\u7684\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u88fd\u85e5\u516c\u53f8\u5ba3\u4f48\uff0c\u5176\u5728\u5065\u5eb7\u5fd7\u9858\u8005\u4e2d\u9032\u884c\u7684AL01211\u7684I\u671f\u7814\u7a76\u7684\u7d50\u679c\u5df2\u7d93\u767c\u8868\u5728\u540c\u884c\u8a55\u5be9\u7684\u7f8e\u570b\u81e8\u5e8a\u85e5\u5b78\u9662\u671f\u520a\u300aClinical Pharmacology in Drug Development\u300b\u4e0a\u3002AL01211\u662f\u4e00\u7a2e\u5f37\u5927\u7684\u53e3\u670d\u8461\u7cd6\u795e\u7d93\u91af\u80fa\u5408\u6210\u9176\uff08GCS\uff09\u6291\u5236\u5291\uff0c\u6b63\u5728\u958b\u767c\u7528\u65bc\u6cbb\u7642\u6cd5\u5e03\u745e\u6c0f\u75c7\u548cI\u578b\u9ad8\u96ea\u6c0f\u75c7\u3002 \u5728\u5df2\u767c\u8868\u7684I\u671f\u7814\u7a76\u4e2d\uff0c\u5c0dAL01211\u9032\u884c\u4e86\u55ae\u5291\u91cf\u905e\u589e\u548c\u591a\u5291\u91cf\u905e\u589e\u7684\u7814\u7a76\uff0c\u4ee5\u78ba\u5b9a\u5176\u5728\u5065\u5eb7\u5fd7\u9858\u8005\u4e2d\u7684\u5b89\u5168\u6027\u3001\u85e5\u4ee3\u52d5\u529b\u5b78\uff08PK\uff09\u548c\u85e5\u6548\u5b78\uff08PD\uff09\u6548\u61c9\u3002\u7e3d\u9ad4\u800c\u8a00\uff0cAL01211\u5177\u6709\u826f\u597d\u7684\u5b89\u5168\u6027\u548c\u8010\u53d7\u6027\uff0c\u7121\u56b4\u91cd\u4e0d\u826f\u4e8b\u4ef6\u3002\u572830mg\u5291\u91cf\u6c34\u5e73\u4e0b\uff0c\u8840\u6f3f\u8461\u7cd6\u57fa\u795e\u7d93\u91af\u80fa\u548c\u7403\u86cb\u767d\u4e09\u7cd6\u795e\u7d93\u91af\u80fa\u5206\u5225\u5f9e\u57fa\u7dda\u6c34\u6e96\u964d\u4f4e\u4e8678%\u548c52%\uff0c\u5f9e\u800c\u652f\u6301AL01211\u7684\u9032\u4e00\u6b65\u81e8\u5e8a\u7814\u7a76\u3002 Basking\u5ba3\u4f48\u5b8c\u6210\u7531ARCH\u9818\u6295\u76845500\u842c\u7f8e\u5143\u878d\u8cc7\uff0c\u52a0\u901f\u53ef\u9006\u6eb6\u6813\u5291\u7684\u81e8\u5e8a\u958b\u767c \u4fc4\u4ea5\u4fc4\u5dde\u54e5\u502b\u5e03\u2014\u20142024\u5e741\u670830\u65e5\uff0cBasking Biosciences\uff08\u4ee5\u4e0b\u7c21\u7a31\u300cBasking\u300d\uff09\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\uff0c\u4e00\u5bb6\u958b\u767c\u65b0\u578b\u6025\u6027\u6eb6\u6813\u7642\u6cd5\u6cbb\u7642\u5352\u4e2d\u7684\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u88fd\u85e5\u516c\u53f8\uff0c\u5ba3\u4f48\u5b8c\u62105500\u842c\u7f8e\u5143\u7684\u878d\u8cc7\u3002\u65b0\u6295\u8cc7\u8005ARCH Venture Partners\u9818\u6295\uff0c\u5176\u4ed6\u65b0\u6295\u8cc7\u8005Insight Partners\u3001Platanus\u3001Solas BioVentures\u548cRTW Investments\uff0c\u4ee5\u53ca\u73fe\u6709\u6295\u8cc7\u8005\u8ddf\u6295\u3002ARCH Venture Partners\u8463\u4e8b\u7e3d\u7d93\u7406Steven Gillis\u535a\u58eb\u5c07\u64d4\u4efbBasking\u8463\u4e8b\u6703\u4e3b\u5e2d\u3002\u6b64\u524d\u516c\u53f8\u66fe\u5b8c\u6210540\u842c\u7f8e\u5143\u7a2e\u5b50\u8f2a\u878d\u8cc7\uff0c\u6295\u8cc7\u8005\u5305\u62ecRev1 Ventures\u3001Broadview Ventures\u548c\u7dad\u4e9e\u751f\u7269\u3002 Basking\u5c07\u5229\u7528\u878d\u8cc7\u52a0\u901fBB-031\u7684\u81e8\u5e8a\u958b\u767c\u3002\u9019\u662f\u4e00\u7a2e\u9776\u5411von Willebrand\u56e0\u5b50\uff08vWF\uff09\u7684\u540c\u985e\u9996\u5275\u53ef\u9006RNA aptamers\uff0c\u5c08\u70ba\u5feb\u901f\u8d77\u6548\u548c\u77ed\u6301\u7e8c\u6642\u9593\u7684\u7642\u6548\u800c\u8a2d\u8a08\u3002 \u7279\u79d1\u7f85\u7372\u842c\u7269\u5275\u6295\u6578\u767e\u842c\u7f8e\u5143Pre-B\u8f2a\u878d\u8cc7\uff0c\u4e14\u5176\u6cbb\u7642\u96c4\u6fc0\u7d20\u6027\u812b\u9aee\u5168\u7403\u9996\u5275\u65b0\u85e5TDM-105795\u81e8\u5e8a\u4e8c\u671fa\u8a66\u9a57\u9806\u5229\u5b8c\u6210\u53ca\u5b8c\u6210\u91dd\u5c0d\u6fd5\u75b9\/\u76ae\u708e\u9069\u61c9\u75c7\u7684TDM-180935\u5291\u91cf\u905e\u589e\u7684\u4e00\u671f\u81e8\u5e8a\u8a66\u9a57 \u64da\u52d5\u8108\u7db21\u670815\u65e5\u6d88\u606f\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u3001\u4e00\u5bb6\u5c08\u6ce8\u76ae\u819a\u75be\u75c5\u65b0\u85e5\u7814\u767c\u7684\u81e8\u5e8a\u968e\u6bb5\u516c\u53f8\u7279\u79d1\u7f85\u751f\u7269\u79d1\u6280\uff08\u6210\u90fd\uff09\u6709\u9650\u516c\u53f8\uff08\u4ee5\u4e0b\u7c21\u7a31\u300c\u7279\u79d1\u7f85\u300d\uff09\uff0c\u5ba3\u4f48\u5df2\u65bc\u8fd1\u671f\u5b8c\u6210\u6578\u5343\u842c\u4eba\u6c11\u5e63\u7684Pre-B\u8f2a\u878d\u8cc7\uff0c\u672c\u8f2a\u878d\u8cc7\u6295\u8cc7\u65b9\u70ba\u842c\u7269\u5275\u6295\uff0c\u6240\u878d\u8cc7\u91d1\u5c07\u7528\u65bc\u6bdb\u9aee\u9805\u76ee\u7684\u5f8c\u7e8c\u81e8\u5e8a\u958b\u767c\u548c\u6fd5\u75b9\u76ae\u708e\u9805\u76ee\u4e2d\u7f8e\u96d9\u5831\u7684\u4e8c\u671f\u81e8\u5e8a\u8a66\u9a57\uff08\u4e2d\u7f8eIIa\u81e8\u5e8a\uff09\u3002\u96a8\u5f8c2\u67085\u65e5\uff0c\u7279\u79d1\u7f85\u5f88\u9ad8\u8208\u5730\u5ba3\u4f48\uff1a\u5916\u7528\u5857\u62b9\u88fd\u5291TDM-105795\u7528\u65bc\u6cbb\u7642\u96c4\u6fc0\u7d20\u6027\u812b\u9aee\uff08AGA\uff09\u7684\u9996\u500b\u81e8\u5e8a\u4e8c\u671f\u8a66\u9a57\uff08NCT05802173\uff09\u9806\u5229\u5b8c\u6210\u3002 \u6b64\u5916\uff0c2023\u5e7412\u67084\u65e5\uff0c\u7279\u79d1\u7f85\u5ba3\u4f48\u5df2\u7d93\u5b8c\u6210\u91dd\u5c0d\u7279\u61c9\u6027\u76ae\u708e\/\u6fd5\u75b9\u7684TDM-180935\u5916\u7528\u8edf\u818f\u7684\u4e00\u671f\u81e8\u5e8a\u8a66\u9a57\uff08NCT05525468\uff09\uff0c\u8a66\u9a57\u7d50\u679c\u5747\u9054\u5230\u9810\u671f\u3002 \u8f3b\u806f\u79d1\u6280\u5ba3\u4f48\u5b8c\u6210B\u8f2a\u7f8e\u5143\u878d\u8cc7\uff0c\u4e14\u5176\u6bd4\u5229\u6642GMP\u751f\u7522\u8a2d\u65bd\u5960\u57fa 2024\u5e741\u67084\u65e5\uff0c\u4e0a\u6d77\/\u8b93\u5e03\u76e7\/\u6d77\u5fb7\u5821\u2014\u2014\u7dad\u4e9e\u751f\u7269\u88ab\u6295\u4f01\u696d\u3001\u5168\u9762\u6574\u5408\u7684\u570b\u969b\u5316\u653e\u5c04\u6027\u85e5\u7269\u6cbb\u7642\u516c\u53f8\u8f3b\u806f\u79d1\u6280\u6709\u9650\u516c\u53f8\uff08\u4ee5\u4e0b\u7c21\u7a31\u300c\u8f3b\u806f\u79d1\u6280\u300d\uff09\uff0c\u5ba3\u4f48\u5b8c\u62106330\u842c\u7f8e\u5143\u878d\u8cc7\uff0c\u5176\u4e2d\u5305\u62ec4730\u842c\u7f8e\u5143\u7684B\u8f2a\u80a1\u6b0a\u878d\u8cc7\u548c1600\u842c\u7f8e\u5143\u7684\u6388\u4fe1\u984d\u5ea6\u3002\u672c\u6b21\u878d\u8cc7\u5c07\u5e6b\u52a9\u516c\u53f8\u5feb\u901f\u63a8\u9032\u5176\u653e\u5c04\u6027\u85e5\u7269\u7ba1\u7dda\u7684\u958b\u767c\u548c\u85e5\u7269\u751f\u7522\u80fd\u529b\u7684\u5efa\u8a2d\uff0c\u4e26\u512a\u5316\u5176\u5c08\u6709\u767c\u73fe\u5e73\u53f0UniRDC\u2122\u3002\u00a0\u96a8\u8457\u672c\u6b21\u878d\u8cc7\u7684\u5b8c\u6210\uff0c\u8f3b\u806f\u79d1\u6280\u81ea2021\u5e748\u6708\u6210\u7acb\u4ee5\u4f86\u5df2\u7d2f\u8a08\u878d\u8cc7\u8d85\u904e1.1\u5104\u7f8e\u5143\uff0c\u5305\u62ec\u80a1\u6b0a\u878d\u8cc7\u3001\u50b5\u6b0a\u878d\u8cc7\u548c\u653f\u5e9c\u88dc\u8cbc\u3002 \u6b64\u524d12\u67088\u65e5\uff0c\u8f3b\u806f\u79d1\u6280\u9084\u5ba3\u4f48\u4e86\u5728\u6bd4\u5229\u6642\u8b93\u5e03\u76e7\u5e02\u958b\u5de5\u5efa\u8a2d\u5176\u7b26\u5408\u751f\u7522\u8cea\u91cf\u7ba1\u7406\u898f\u7bc4\uff08\u300cGMP\u300d\uff09\u7684\u653e\u5c04\u6027\u85e5\u7269\u751f\u7522\u8a2d\u65bd\uff0c\u4ee5\u9032\u4e00\u6b65\u63a8\u9032\u653e\u5c04\u6027\u85e5\u7269\u7684\u5168\u7522\u696d\u93c8\u89e3\u6c7a\u65b9\u6848\u3002 \u7dad\u7738\u751f\u7269\u7372\u9999\u6e2f\u5275\u65b0\u79d1\u6280\u7f72\u300c\u4f01\u696d\u652f\u63f4\u8a08\u5283\u300d\u8cc7\u52a9\uff0c\u4e14\u69ae\u767b\u300a2023\u80e1\u6f64\u5168\u7403\u7375\u8c79\u4f01\u696d\u699c\u300b \u8fd1\u671f\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u7dad\u7738\u751f\u7269\u7684\u9999\u6e2f\u5b50\u516c\u53f8\uff0c\u4e00\u5bb6\u805a\u7126\u5dee\u7570\u5316\u548c\u5168\u7403\u65b0\u958b\u767c\u7684\u773c\u79d1\u5275\u65b0\u85e5\u516c\u53f8\uff0c\u5ba3\u4f48\u5176\u5275\u65b0\u773c\u5e95\u85e5\u7269VVN481\u6210\u529f\u7372\u5f97\u9999\u6e2f\u5275\u65b0\u79d1\u6280\u7f72\u300c\u4f01\u696d\u652f\u63f4\u8a08\u5283Enterprise Support Scheme\u300d\uff08ESS\u2014Hong Kong-Israel R&amp;D Cooperation Programme\uff09\u00a0\u8cc7\u52a9\u3002\u6b64\u6b21\u8cc7\u52a9\u5c07\u7528\u65bc\u63a8\u9032\u8a72\u7ba1\u7dda\u7684\u81e8\u5e8a\u524d\u7814\u767c\u5de5\u4f5c\uff0c\u4ee5\u671f\u66f4\u5feb\u63a8\u9032\u5230\u81e8\u5e8a\u968e\u6bb5\u3002\u6b64\u5916\uff0c\u8fd1\u65e5\u7dad\u7738\u751f\u7269\u9084\u69ae\u767b\u300a2023\u80e1\u6f64\u5168\u7403\u7375\u8c79\u4f01\u696d\u699c\u300b\u3002 \u7dad\u4e9e\u751f\u7269\u88ab\u6295\u4f01\u696dAbsci\u5ba3\u4f48\u8207\u963f\u65af\u5229\u5eb7\u5408\u4f5c\u958b\u767c\u4eba\u5de5\u667a\u80fd\u9a45\u52d5\u7684\u816b\u7624\u5019\u9078\u85e5\u7269 \u83ef\u76db\u9813\u5dde\u6eab\u54e5\u83ef\uff0c2023\u5e7412\u67084\u65e5\u2014\u2014\u7dad\u4e9e\u751f\u7269\u88ab\u6295\u4f01\u696d\u3001\u751f\u6210\u5f0f\u4eba\u5de5\u667a\u80fd\u6297\u9ad4\u767c\u73fe\u9818\u57df\u7684\u9818\u5c0e\u8005Absci\u516c\u53f8\uff08NASDAQ:ABSI\uff09\uff0c\u5ba3\u4f48\u8207\u5168\u7403\u751f\u7269\u88fd\u85e5\u516c\u53f8\u963f\u65af\u5229\u5eb7\uff08AstraZeneca\uff09\u5408\u4f5c\uff0c\u91dd\u5c0d\u816b\u7624\u9776\u9ede\u63d0\u4f9b\u4eba\u5de5\u667a\u80fd\u8a2d\u8a08\u7684\u6297\u9ad4\u3002\u6b64\u6b21\u5408\u4f5c\u5c07Absci\u7684Integrated Drug Creation\u2122\u5e73\u53f0\u8207\u963f\u65af\u5229\u5eb7\u5728\u816b\u7624\u5b78\u9818\u57df\u7684\u5c08\u696d\u77e5\u8b58\u76f8\u7d50\u5408\uff0c\u65e8\u5728\u52a0\u901f\u767c\u73fe\u6f5b\u5728\u7684\u65b0\u578b\u764c\u75c7\u6cbb\u7642\u5019\u9078\u85e5\u7269\u3002\u64da\u6089\uff0c\u8a72\u5354\u8b70\u5305\u62ec\u9810\u4ed8\u6b3e\u3001\u7814\u767c\u7d93\u8cbb\u548c\u91cc\u7a0b\u7891\u6b3e\u9805\u7b49\uff0c\u7e3d\u91d1\u984d\u9ad8\u90542.47\u5104\u7f8e\u5143\u3002 \u95dc\u65bc\u535a\u81f4\u751f\u7269 \u535a\u81f4\u751f\u7269\u5275\u7acb\u65bc2019\u5e74\uff0c\u7531\u86cb\u767d\u8cea\u5de5\u7a0b\u548c\u816b\u7624\u514d\u75ab\u9818\u57df\u7684\u9802\u5c16\u5c08\u5bb6\u5718\u968a\u7d44\u5efa\uff0c\u81f4\u529b\u65bc\u958b\u767c\u65b0\u4e00\u4ee3\u7d30\u80de\u56e0\u5b50\u6297\u816b\u7624\u514d\u75ab\u7642\u6cd5\u3002\u516c\u53f8\u81ea\u4e3b\u7814\u767c\u4e86\u300cCrossover\u300d\u524d\u85e5\u6280\u8853\u5e73\u53f0\uff0c\u80fd\u5be6\u73fe\u7d30\u80de\u56e0\u5b50\u5728\u816b\u7624\u5fae\u74b0\u5883\u4e2d\u7279\u7570\u6027\u91cb\u653e\uff0c\u6709\u6548\u89e3\u6c7a\u4e86\u7d30\u80de\u56e0\u5b50\u7684\u5916\u5468\u6bd2\u6027\u554f\u984c\u3002\u4f9d\u8a17\u8a72\u5e73\u53f0\u6280\u8853\uff0c\u516c\u53f8\u6210\u529f\u958b\u767c\u4e86\u81e8\u5e8a\u5019\u9078\u85e5\u7269PTX-912\uff0c\u5df2\u7d93\u555f\u52d5\u7f8e\u570b1\u671f\u81e8\u5e8a\u8a66\u9a57\u3002 \u95dc\u65bcAceLink Therapeutics AceLink Therapeutics\u6210\u7acb\u65bc2018\u5e74\uff0c\u662f\u4e00\u5bb6\u5275\u65b0\u578b\u751f\u7269\u88fd\u85e5\u521d\u5275\u516c\u53f8\uff0c\u5c08\u6ce8\u65bc\u958b\u767c\u5b89\u5168\u6709\u6548\u7684\u85e5\u7269\uff0c\u4ee5\u6eff\u8db3\u5b58\u5728\u9ad8\u5ea6\u672a\u6eff\u8db3\u7684\u81e8\u5e8a\u9700\u6c42\u7684\u907a\u50b3\u6027\u75be\u75c5\u3002\u516c\u53f8\u6700\u521d\u7684\u91cd\u9ede\u662f\u958b\u767c\u6cd5\u5e03\u745e\u6c0f\u75c7\u7684\u65b0\u578b\u6cbb\u7642\u65b9\u6cd5\u3002\u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8acb\u8a2a\u554f www.acelinktherapeutics.com \u95dc\u65bcBasking Biosciences Basking Biosciences\u662f\u4e00\u5bb6\u8655\u65bc\u81e8\u5e8a\u968e\u6bb5\u7684\u516c\u53f8\uff0c\u65e8\u5728\u89e3\u6c7a\u7f3a\u8840\u6027\u8166\u5352\u4e2d\u6cbb\u7642\u7684\u6700\u5927\u9700\u6c42\u2014\u2014\u4e00\u7a2e\u5feb\u901f\u8d77\u6548\u7684\u77ed\u6548\u6eb6\u6813\u85e5\u7269\uff0c\u80fd\u5920\u63d0\u4f9b\u6bd4\u73fe\u6709\u7642\u6cd5\u5927\u5927\u5ef6\u9577\u7684\u6cbb\u7642\u7a97\u53e3\uff0c\u4e26\u91cd\u65b0\u758f\u901a\u963b\u585e\u7684\u52d5\u8108\uff0c\u4e26\u4e14\u5728\u51fa\u8840\u6642\u53ef\u4ee5\u8fc5\u901f\u88ab\u9006\u8f49\u6d3b\u6027\u3002\u516c\u53f8\u6b63\u5728\u958b\u767c\u7684\u85e5\u7269BB-031\uff0c\u5373\u662f\u9019\u7a2efirst -in-class RNA\u9069\u914d\u9ad4\uff0c\u9776\u5411\u8840\u6813\u7684\u91cd\u8981\u7d50\u69cb\u6210\u5206\u548c\u51dd\u8840\u904e\u7a0b\u7684\u9a45\u52d5\u56e0\u7d20\u8840\u7ba1\u6027\u8840\u53cb\u75c5\u56e0\u5b50\uff08von Willebrand Factor\uff0cvWF\uff09\u3002 \u95dc\u65bc\u7279\u79d1\u7f85\u751f\u7269\u79d1\u6280\uff08\u6210\u90fd\uff09\u6709\u9650\u516c\u53f8\u00a0 \u7279\u79d1\u7f85\u751f\u7269\u79d1\u6280\uff08\u6210\u90fd\uff09\u6709\u9650\u516c\u53f8\u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\u7684\u751f\u7269\u91ab\u85e5\u516c\u53f8\u3002\u516c\u53f8\u524d\u8eab\u70ba\u5609\u8208\u7279\u79d1\u7f85\u751f\u7269\u79d1\u6280\u6709\u9650\u516c\u53f8\uff0c\u65b0\u8fd1\u65bc2023\u5e743\u6708\u642c\u9077\u81f3\u56db\u5ddd\u7701\u6210\u90fd\u5929\u5e9c\u570b\u969b\u751f\u7269\u57ce\u3002 \u516c\u53f8\u76ee\u524d\u7684\u6838\u5fc3\u7814\u767c\u9805\u76ee\u5305\u62ec\u91dd\u5c0d\u6cbb\u7642\u96c4\u6fc0\u7d20\u6027\u812b\u9aee\u3001\u7279\u61c9\u6027\u76ae\u708e\/\u6fd5\u75b9\u3001\u9280\u5c51\u75c5\u548c\u7d05\u6591\u72fc\u7621\u7b49\u75be\u75c5\u7684\u5275\u65b0\u85e5\u7269\u3002\u516c\u53f8\u5168\u7403\u9818\u5148\u7684\u6cbb\u7642\u96c4\u6fc0\u7d20\u6027\u812b\u9aee\u7684\u5c0f\u5206\u5b50\u5019\u9078\u85e5\u7269TDM-105795\u5373\u5c07\u5b8c\u6210\u4e8c\u671fa\u968e\u6bb5\u81e8\u5e8a\u8a66\u9a57\uff0c\u91dd\u5c0d\u7279\u61c9\u6027\u76ae\u708e\/\u6fd5\u75b9\u7684\u5275\u65b0\u578bJAK1\/TYK2\u6291\u5236\u5291\u4e5f\u5df2\u7d93\u5b8c\u6210\u4e00\u671f\u81e8\u5e8a\u8a66\u9a57\uff0c\u5373\u5c07\u958b\u5c55\u81e8\u5e8a\u4e8c\u671fPOC\u8a66\u9a57\u3002\u516c\u53f8\u5177\u6709\u591a\u500b\u81e8\u5e8a\u524d\u6216\u81e8\u5e8a\u968e\u6bb5\u7684\u5019\u9078\u85e5\u7269\uff0c\u5728\u7814\u7ba1\u7dda\u7522\u54c1\u90fd\u662f\u91dd\u5c0d\u6cbb\u7642\u5404\u7a2e\u76ae\u819a\u9069\u61c9\u75c7\u3002 \u95dc\u65bc\u8f3b\u806f\u79d1\u6280 \u8f3b\u806f\u79d1\u6280\u6709\u9650\u516c\u53f8\uff08\u300c\u8f3b\u806f\u79d1\u6280\u300d\uff09\u662f\u4e00\u5bb6\u5168\u9762\u6574\u5408\u7684\u570b\u969b\u5316\u653e\u5c04\u6027\u85e5\u7269\u6cbb\u7642\u516c\u53f8\uff0c\u5728\u6bd4\u5229\u6642\u3001\u5fb7\u570b\u548c\u4e2d\u570b\u5747\u8a2d\u6709\u8fa6\u4e8b\u8655\u3002\u6211\u5011\u81f4\u529b\u65bc\u6253\u9020\u64c1\u6709\u653e\u5c04\u6027\u85e5\u7269\u7814\u767c\u3001\u751f\u7522\u548c\u5546\u696d\u5316\u7684\u5168\u7522\u696d\u93c8\u7684\u6838\u85e5\u516c\u53f8\u4ee5\u9020\u798f\u5168\u7403\u60a3\u8005\u3002\u6211\u5011\u8a08\u5283\u901a\u904e\u91dd\u5c0d\u672a\u4f86\u6cbb\u7642\u65b9\u6cd5\u7684\u5275\u65b0\u7814\u7a76\u4f86\u89e3\u6c7a\u76ee\u524d\u5f71\u97ff\u653e\u5c04\u6027\u85e5\u7269\u7814\u767c\u7684\u6838\u5fc3\u554f\u984c\u3002\u6211\u5011\u5718\u968a\u4e2d\u4e0d\u4e4f\u7d93\u9a57\u8c50\u5bcc\u7684\u4f01\u696d\u5bb6\u548c\u79d1\u5b78\u5bb6\uff0c\u4ed6\u5011\u65e2\u64c5\u9577\u7ba1\u7406\u751f\u7269\u91ab\u85e5\u516c\u53f8\uff0c\u4e5f\u6df1\u8af3\u653e\u5c04\u6027\u540c\u4f4d\u7d20\u7684\u7814\u7a76\u548c\u81e8\u5e8a\u958b\u767c\u65b9\u6cd5\u3002 \u95dc\u65bc\u7dad\u7738\u751f\u7269 \u7dad\u7738\u751f\u7269\u662f\u4e00\u5bb6\u5c08\u6ce8\u65bc\u773c\u79d1\u5275\u65b0\u85e5\u7814\u767c\u9818\u57df\u7684\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u64c1\u6709\u570b\u969b\u4e00\u6d41\u7684\u773c\u79d1\u5275\u65b0\u85e5\u7814\u767c\u5718\u968a\u548c\u6280\u8853\u5e73\u53f0\uff0c\u4f9d\u8a17\u81ea\u4e3b\u7814\u767c\u5df2\u7d93\u5efa\u7acb\u8d77\u5177\u6709\u5168\u7403\u7af6\u722d\u529b\u7684\u7522\u54c1\u7ba1\u7dda\u3002\u9664VVN001\u9805\u76ee\u5916\uff0c\u7dad\u7738\u751f\u7269\u6b63\u5728\u958b\u767cVVN539\u7528\u65bc\u6cbb\u7642\u9752\u5149\u773c\u6216\u9ad8\u773c\u58d3\u75c7\uff0cVVN461\u7528\u65bc\u6cbb\u7642\u975e\u611f\u67d3\u6027\u524d\u8461\u8404\u819c\u708e\u548c\u8853\u5f8c\u708e\u75c7\u3002\u7dad\u7738\u751f\u7269\u9084\u81f4\u529b\u65bc\u767c\u73fe\u548c\u958b\u767c\u7528\u65bc\u6cbb\u7642\u5176\u4ed6\u524d\u3001\u5f8c\u773c\u75be\u75c5\u7684\u65b0\u7642\u6cd5\u3002 \u95dc\u65bcAbsci Absci\u662f\u4e00\u5bb6\u751f\u6210\u578b\u4eba\u5de5\u667a\u80fd\u85e5\u7269\u958b\u767c\u516c\u53f8\uff0c\u5c07\u4eba\u5de5\u667a\u80fd\u8207\u53ef\u64f4\u5c55\u7684\u6fd5\u5be6\u9a57\u5ba4\u6280\u8853\u76f8\u7d50\u5408\uff0c\u66f4\u5feb\u5730\u70ba\u60a3\u8005\u5275\u9020\u66f4\u597d\u7684\u751f\u7269\u88fd\u54c1\u3002\u5176Integrated Drug Creation\u2122\u5e73\u53f0\u901a\u904e\u540c\u6642\u512a\u5316\u517c\u5177\u958b\u767c\u548c\u6cbb\u7642\u6548\u679c\u7684\u591a\u7a2e\u85e5\u7269\u7279\u6027\uff0c\u91cb\u653e\u4e86\u52a0\u5feb\u85e5\u7269\u4e0a\u5e02\u6642\u9593\u548c\u63d0\u9ad8\u6210\u529f\u6982\u7387\u7684\u6f5b\u529b\u3002\u901a\u904e\u6578\u64da\u5b78\u7fd2\u3001\u4eba\u5de5\u667a\u80fd\u5275\u9020\u548c\u6fd5\u6cd5\u5be6\u9a57\u5ba4\u9a57\u8b49\uff0cAbsci \u6bcf\u9031\u53ef\u7be9\u9078\u6578\u5341\u5104\u500b\u7d30\u80de\uff0c\u4f7f\u5176\u80fd\u5920\u5728\u77ed\u77ed\u516d\u9031\u5167\u5b8c\u6210\u5f9e\u4eba\u5de5\u667a\u80fd\u8a2d\u8a08\u6297\u9ad4\u5230\u6fd5\u6cd5\u5be6\u9a57\u5ba4\u9a57\u8b49\u5019\u9078\u85e5\u7269\u7684\u904e\u7a0b\u3002Absci\u7684\u9858\u666f\u662f\u70ba\u6bcf\u500b\u4eba\u4e00\u9375\u63d0\u4f9b\u7a81\u7834\u6027\u7684\u6cbb\u7642\u65b9\u6cd5\u3002\u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8acb\u8a2a\u554fwww.absci.com","og_url":"https:\/\/pingtungtimes.com.tw\/?p=222124","og_site_name":"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","article_publisher":"https:\/\/www.facebook.com\/pingtungnews","article_published_time":"2024-03-06T10:46:00+00:00","og_image":[{"url":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","type":"","width":"","height":""}],"author":"\u7f8e\u901a\u793e","twitter_card":"summary_large_image","twitter_image":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","twitter_misc":{"\u4f5c\u8005:":"\u7f8e\u901a\u793e","\u9810\u4f30\u95b1\u8b80\u6642\u9593":"1 \u5206\u9418"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/pingtungtimes.com.tw\/?p=222124#article","isPartOf":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=222124"},"author":{"name":"\u7f8e\u901a\u793e","@id":"https:\/\/pingtungtimes.com.tw\/#\/schema\/person\/683b937f29ec1537972f6c41e22a2cf3"},"headline":"\u7dad\u4e9e\u751f\u7269\u6295\u8cc7\u5b75\u5316\u516c\u53f8\u8fd1\u671f\u767c\u5c55\u52d5\u614b\u4e00\u89bd","datePublished":"2024-03-06T10:46:00+00:00","mainEntityOfPage":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=222124"},"wordCount":146,"publisher":{"@id":"https:\/\/pingtungtimes.com.tw\/#organization"},"image":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=222124#primaryimage"},"thumbnailUrl":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","articleSection":["\u7f8e\u901a\u793e"],"inLanguage":"zh-TW"},{"@type":"WebPage","@id":"https:\/\/pingtungtimes.com.tw\/?p=222124","url":"https:\/\/pingtungtimes.com.tw\/?p=222124","name":"\u7dad\u4e9e\u751f\u7269\u6295\u8cc7\u5b75\u5316\u516c\u53f8\u8fd1\u671f\u767c\u5c55\u52d5\u614b\u4e00\u89bd - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","isPartOf":{"@id":"https:\/\/pingtungtimes.com.tw\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=222124#primaryimage"},"image":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=222124#primaryimage"},"thumbnailUrl":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","datePublished":"2024-03-06T10:46:00+00:00","description":"\u9999\u6e2f2024\u5e743\u67086\u65e5 \/\u7f8e\u901a\u793e\/ -- \u9762\u5c0d\u4e0d\u65b7\u8b8a\u5316\u7684\u5c40\u52e2\uff0c\u6280\u8853\u5275\u65b0\u4f9d\u820a\u662f\u751f\u7269\u91ab\u85e5\u4f01\u696d\u9577\u9060\u767c\u5c55\u6c38\u6046\u7684\u4e3b\u65cb\u5f8b\uff0c\u70ba\u4f01\u696d\u6e90\u6e90\u4e0d\u65b7\u5730\u6ce8\u5165\u751f\u547d\u529b\uff0c\u6301\u7e8c\u63a8\u52d5\u7814\u767c\u300c\u5f9e0\u52301\u300d\u8f49\u5316\u4ee5\u53ca\u5546\u696d\u5316\u6210\u529f\u3002\u8fd1\u671f\uff0c\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u4f01\u696d\u53c8\u6709\u65b0\u7684\u52d5\u614b\uff1aAceLink\u3001\u7279\u79d1\u7f85\u7814\u767c\u9032\u5c55\u9806\u5229\uff1b\u535a\u81f4\u751f\u7269\u3001Basking\u3001\u7279\u79d1\u7f85\u3001\u8f3b\u806f\u79d1\u6280\u6210\u529f\u5b8c\u6210\u878d\u8cc7\uff1b\u7dad\u7738\u751f\u7269\u65ac\u7372\u6b8a\u69ae\uff1bAbsci\u9054\u6210\u91cd\u8981\u5408\u4f5c\u3002 \u535a\u81f4\u751f\u7269\u5b8c\u62101800\u842c\u7f8e\u5143A\u8f2a\u878d\u8cc7 \u8fd1\u65e5\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u535a\u81f4\u751f\u7269\uff08Proviva Therapeutics\uff09\u6b23\u7136\u5ba3\u4f48\u5b8c\u62101800\u842c\u7f8e\u5143\u7684A\u8f2a\u878d\u8cc7\uff0c\u4ee5\u63a8\u9032\u5176\u6838\u5fc3\u7522\u54c1PTX-912\u7684\u81e8\u5e8a\u958b\u767c\u3002\u9f8d\u78d0\u6295\u8cc7\uff0c\u6069\u7136\u5275\u6295\u548c\u4ed9\u77b3\u8cc7\u672c\u806f\u5408\u53c3\u52a0\u672c\u8f2a\u878d\u8cc7\u3002 \u535a\u81f4\u751f\u7269\u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\u7684\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u81f4\u529b\u65bc\u958b\u767c\u65b0\u4e00\u4ee3\u7d30\u80de\u56e0\u5b50\u6297\u816b\u7624\u514d\u75ab\u7642\u6cd5\u3002\u91dd\u5c0d\u7d30\u80de\u56e0\u5b50\u5916\u5468\u6bd2\u6027\u7684\u50b3\u7d71\u96e3\u984c\uff0c\u516c\u53f8\u81ea\u4e3b\u958b\u767c\u4e86\u300cCrossover\u300d\u7d30\u80de\u56e0\u5b50\u524d\u85e5\u6280\u8853\u5e73\u53f0\uff0c\u5be6\u73fe\u5728\u816b\u7624\u5fae\u74b0\u5883\u4e2d\u7279\u7570\u6027\u7684\u85e5\u7269\u6d3b\u6027\u91cb\u653e\u3002\u4f9d\u8a17\u300cCrossover\u300d\u6280\u8853\u5e73\u53f0\uff0c\u535a\u81f4\u6210\u529f\u7814\u767c\u51faPTX-912\u2014\u2014\u65b0\u4e00\u4ee3\u514d\u75ab\u7d30\u80de\u9776\u5411\u7684\u767d\u7d30\u80de\u4ecb\u7d20-2\uff08IL-2\uff09\u524d\u85e5\u878d\u5408\u86cb\u767d\u3002 AceLink Therapeutics\u767c\u4f48\u5065\u5eb7\u5fd7\u9858\u8005\u53c3\u8207\u8a55\u4f30AL01211\u7684I\u671f\u81e8\u5e8a\u8a66\u9a57\u6578\u64da \u7d10\u74e6\u514b\uff0c\u52a0\u5229\u798f\u5c3c\u4e9e\u5dde\u2014\u20142024\u5e742\u670826\u65e5\uff0cAceLink Therapeutics\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u3001\u4e00\u5bb6\u958b\u767c\u4e0b\u4e00\u4ee3\u53e3\u670d\u5e95\u7269\u6e1b\u5c11\u7642\u6cd5\uff08SRTs\uff09\u7684\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u88fd\u85e5\u516c\u53f8\u5ba3\u4f48\uff0c\u5176\u5728\u5065\u5eb7\u5fd7\u9858\u8005\u4e2d\u9032\u884c\u7684AL01211\u7684I\u671f\u7814\u7a76\u7684\u7d50\u679c\u5df2\u7d93\u767c\u8868\u5728\u540c\u884c\u8a55\u5be9\u7684\u7f8e\u570b\u81e8\u5e8a\u85e5\u5b78\u9662\u671f\u520a\u300aClinical Pharmacology in Drug Development\u300b\u4e0a\u3002AL01211\u662f\u4e00\u7a2e\u5f37\u5927\u7684\u53e3\u670d\u8461\u7cd6\u795e\u7d93\u91af\u80fa\u5408\u6210\u9176\uff08GCS\uff09\u6291\u5236\u5291\uff0c\u6b63\u5728\u958b\u767c\u7528\u65bc\u6cbb\u7642\u6cd5\u5e03\u745e\u6c0f\u75c7\u548cI\u578b\u9ad8\u96ea\u6c0f\u75c7\u3002 \u5728\u5df2\u767c\u8868\u7684I\u671f\u7814\u7a76\u4e2d\uff0c\u5c0dAL01211\u9032\u884c\u4e86\u55ae\u5291\u91cf\u905e\u589e\u548c\u591a\u5291\u91cf\u905e\u589e\u7684\u7814\u7a76\uff0c\u4ee5\u78ba\u5b9a\u5176\u5728\u5065\u5eb7\u5fd7\u9858\u8005\u4e2d\u7684\u5b89\u5168\u6027\u3001\u85e5\u4ee3\u52d5\u529b\u5b78\uff08PK\uff09\u548c\u85e5\u6548\u5b78\uff08PD\uff09\u6548\u61c9\u3002\u7e3d\u9ad4\u800c\u8a00\uff0cAL01211\u5177\u6709\u826f\u597d\u7684\u5b89\u5168\u6027\u548c\u8010\u53d7\u6027\uff0c\u7121\u56b4\u91cd\u4e0d\u826f\u4e8b\u4ef6\u3002\u572830mg\u5291\u91cf\u6c34\u5e73\u4e0b\uff0c\u8840\u6f3f\u8461\u7cd6\u57fa\u795e\u7d93\u91af\u80fa\u548c\u7403\u86cb\u767d\u4e09\u7cd6\u795e\u7d93\u91af\u80fa\u5206\u5225\u5f9e\u57fa\u7dda\u6c34\u6e96\u964d\u4f4e\u4e8678%\u548c52%\uff0c\u5f9e\u800c\u652f\u6301AL01211\u7684\u9032\u4e00\u6b65\u81e8\u5e8a\u7814\u7a76\u3002 Basking\u5ba3\u4f48\u5b8c\u6210\u7531ARCH\u9818\u6295\u76845500\u842c\u7f8e\u5143\u878d\u8cc7\uff0c\u52a0\u901f\u53ef\u9006\u6eb6\u6813\u5291\u7684\u81e8\u5e8a\u958b\u767c \u4fc4\u4ea5\u4fc4\u5dde\u54e5\u502b\u5e03\u2014\u20142024\u5e741\u670830\u65e5\uff0cBasking Biosciences\uff08\u4ee5\u4e0b\u7c21\u7a31\u300cBasking\u300d\uff09\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\uff0c\u4e00\u5bb6\u958b\u767c\u65b0\u578b\u6025\u6027\u6eb6\u6813\u7642\u6cd5\u6cbb\u7642\u5352\u4e2d\u7684\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u88fd\u85e5\u516c\u53f8\uff0c\u5ba3\u4f48\u5b8c\u62105500\u842c\u7f8e\u5143\u7684\u878d\u8cc7\u3002\u65b0\u6295\u8cc7\u8005ARCH Venture Partners\u9818\u6295\uff0c\u5176\u4ed6\u65b0\u6295\u8cc7\u8005Insight Partners\u3001Platanus\u3001Solas BioVentures\u548cRTW Investments\uff0c\u4ee5\u53ca\u73fe\u6709\u6295\u8cc7\u8005\u8ddf\u6295\u3002ARCH Venture Partners\u8463\u4e8b\u7e3d\u7d93\u7406Steven Gillis\u535a\u58eb\u5c07\u64d4\u4efbBasking\u8463\u4e8b\u6703\u4e3b\u5e2d\u3002\u6b64\u524d\u516c\u53f8\u66fe\u5b8c\u6210540\u842c\u7f8e\u5143\u7a2e\u5b50\u8f2a\u878d\u8cc7\uff0c\u6295\u8cc7\u8005\u5305\u62ecRev1 Ventures\u3001Broadview Ventures\u548c\u7dad\u4e9e\u751f\u7269\u3002 Basking\u5c07\u5229\u7528\u878d\u8cc7\u52a0\u901fBB-031\u7684\u81e8\u5e8a\u958b\u767c\u3002\u9019\u662f\u4e00\u7a2e\u9776\u5411von Willebrand\u56e0\u5b50\uff08vWF\uff09\u7684\u540c\u985e\u9996\u5275\u53ef\u9006RNA aptamers\uff0c\u5c08\u70ba\u5feb\u901f\u8d77\u6548\u548c\u77ed\u6301\u7e8c\u6642\u9593\u7684\u7642\u6548\u800c\u8a2d\u8a08\u3002 \u7279\u79d1\u7f85\u7372\u842c\u7269\u5275\u6295\u6578\u767e\u842c\u7f8e\u5143Pre-B\u8f2a\u878d\u8cc7\uff0c\u4e14\u5176\u6cbb\u7642\u96c4\u6fc0\u7d20\u6027\u812b\u9aee\u5168\u7403\u9996\u5275\u65b0\u85e5TDM-105795\u81e8\u5e8a\u4e8c\u671fa\u8a66\u9a57\u9806\u5229\u5b8c\u6210\u53ca\u5b8c\u6210\u91dd\u5c0d\u6fd5\u75b9\/\u76ae\u708e\u9069\u61c9\u75c7\u7684TDM-180935\u5291\u91cf\u905e\u589e\u7684\u4e00\u671f\u81e8\u5e8a\u8a66\u9a57 \u64da\u52d5\u8108\u7db21\u670815\u65e5\u6d88\u606f\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u3001\u4e00\u5bb6\u5c08\u6ce8\u76ae\u819a\u75be\u75c5\u65b0\u85e5\u7814\u767c\u7684\u81e8\u5e8a\u968e\u6bb5\u516c\u53f8\u7279\u79d1\u7f85\u751f\u7269\u79d1\u6280\uff08\u6210\u90fd\uff09\u6709\u9650\u516c\u53f8\uff08\u4ee5\u4e0b\u7c21\u7a31\u300c\u7279\u79d1\u7f85\u300d\uff09\uff0c\u5ba3\u4f48\u5df2\u65bc\u8fd1\u671f\u5b8c\u6210\u6578\u5343\u842c\u4eba\u6c11\u5e63\u7684Pre-B\u8f2a\u878d\u8cc7\uff0c\u672c\u8f2a\u878d\u8cc7\u6295\u8cc7\u65b9\u70ba\u842c\u7269\u5275\u6295\uff0c\u6240\u878d\u8cc7\u91d1\u5c07\u7528\u65bc\u6bdb\u9aee\u9805\u76ee\u7684\u5f8c\u7e8c\u81e8\u5e8a\u958b\u767c\u548c\u6fd5\u75b9\u76ae\u708e\u9805\u76ee\u4e2d\u7f8e\u96d9\u5831\u7684\u4e8c\u671f\u81e8\u5e8a\u8a66\u9a57\uff08\u4e2d\u7f8eIIa\u81e8\u5e8a\uff09\u3002\u96a8\u5f8c2\u67085\u65e5\uff0c\u7279\u79d1\u7f85\u5f88\u9ad8\u8208\u5730\u5ba3\u4f48\uff1a\u5916\u7528\u5857\u62b9\u88fd\u5291TDM-105795\u7528\u65bc\u6cbb\u7642\u96c4\u6fc0\u7d20\u6027\u812b\u9aee\uff08AGA\uff09\u7684\u9996\u500b\u81e8\u5e8a\u4e8c\u671f\u8a66\u9a57\uff08NCT05802173\uff09\u9806\u5229\u5b8c\u6210\u3002 \u6b64\u5916\uff0c2023\u5e7412\u67084\u65e5\uff0c\u7279\u79d1\u7f85\u5ba3\u4f48\u5df2\u7d93\u5b8c\u6210\u91dd\u5c0d\u7279\u61c9\u6027\u76ae\u708e\/\u6fd5\u75b9\u7684TDM-180935\u5916\u7528\u8edf\u818f\u7684\u4e00\u671f\u81e8\u5e8a\u8a66\u9a57\uff08NCT05525468\uff09\uff0c\u8a66\u9a57\u7d50\u679c\u5747\u9054\u5230\u9810\u671f\u3002 \u8f3b\u806f\u79d1\u6280\u5ba3\u4f48\u5b8c\u6210B\u8f2a\u7f8e\u5143\u878d\u8cc7\uff0c\u4e14\u5176\u6bd4\u5229\u6642GMP\u751f\u7522\u8a2d\u65bd\u5960\u57fa 2024\u5e741\u67084\u65e5\uff0c\u4e0a\u6d77\/\u8b93\u5e03\u76e7\/\u6d77\u5fb7\u5821\u2014\u2014\u7dad\u4e9e\u751f\u7269\u88ab\u6295\u4f01\u696d\u3001\u5168\u9762\u6574\u5408\u7684\u570b\u969b\u5316\u653e\u5c04\u6027\u85e5\u7269\u6cbb\u7642\u516c\u53f8\u8f3b\u806f\u79d1\u6280\u6709\u9650\u516c\u53f8\uff08\u4ee5\u4e0b\u7c21\u7a31\u300c\u8f3b\u806f\u79d1\u6280\u300d\uff09\uff0c\u5ba3\u4f48\u5b8c\u62106330\u842c\u7f8e\u5143\u878d\u8cc7\uff0c\u5176\u4e2d\u5305\u62ec4730\u842c\u7f8e\u5143\u7684B\u8f2a\u80a1\u6b0a\u878d\u8cc7\u548c1600\u842c\u7f8e\u5143\u7684\u6388\u4fe1\u984d\u5ea6\u3002\u672c\u6b21\u878d\u8cc7\u5c07\u5e6b\u52a9\u516c\u53f8\u5feb\u901f\u63a8\u9032\u5176\u653e\u5c04\u6027\u85e5\u7269\u7ba1\u7dda\u7684\u958b\u767c\u548c\u85e5\u7269\u751f\u7522\u80fd\u529b\u7684\u5efa\u8a2d\uff0c\u4e26\u512a\u5316\u5176\u5c08\u6709\u767c\u73fe\u5e73\u53f0UniRDC\u2122\u3002\u00a0\u96a8\u8457\u672c\u6b21\u878d\u8cc7\u7684\u5b8c\u6210\uff0c\u8f3b\u806f\u79d1\u6280\u81ea2021\u5e748\u6708\u6210\u7acb\u4ee5\u4f86\u5df2\u7d2f\u8a08\u878d\u8cc7\u8d85\u904e1.1\u5104\u7f8e\u5143\uff0c\u5305\u62ec\u80a1\u6b0a\u878d\u8cc7\u3001\u50b5\u6b0a\u878d\u8cc7\u548c\u653f\u5e9c\u88dc\u8cbc\u3002 \u6b64\u524d12\u67088\u65e5\uff0c\u8f3b\u806f\u79d1\u6280\u9084\u5ba3\u4f48\u4e86\u5728\u6bd4\u5229\u6642\u8b93\u5e03\u76e7\u5e02\u958b\u5de5\u5efa\u8a2d\u5176\u7b26\u5408\u751f\u7522\u8cea\u91cf\u7ba1\u7406\u898f\u7bc4\uff08\u300cGMP\u300d\uff09\u7684\u653e\u5c04\u6027\u85e5\u7269\u751f\u7522\u8a2d\u65bd\uff0c\u4ee5\u9032\u4e00\u6b65\u63a8\u9032\u653e\u5c04\u6027\u85e5\u7269\u7684\u5168\u7522\u696d\u93c8\u89e3\u6c7a\u65b9\u6848\u3002 \u7dad\u7738\u751f\u7269\u7372\u9999\u6e2f\u5275\u65b0\u79d1\u6280\u7f72\u300c\u4f01\u696d\u652f\u63f4\u8a08\u5283\u300d\u8cc7\u52a9\uff0c\u4e14\u69ae\u767b\u300a2023\u80e1\u6f64\u5168\u7403\u7375\u8c79\u4f01\u696d\u699c\u300b \u8fd1\u671f\uff0c\u7531\u7dad\u4e9e\u751f\u7269\u53c3\u8207\u6295\u8cc7\u5b75\u5316\u7684\u7dad\u7738\u751f\u7269\u7684\u9999\u6e2f\u5b50\u516c\u53f8\uff0c\u4e00\u5bb6\u805a\u7126\u5dee\u7570\u5316\u548c\u5168\u7403\u65b0\u958b\u767c\u7684\u773c\u79d1\u5275\u65b0\u85e5\u516c\u53f8\uff0c\u5ba3\u4f48\u5176\u5275\u65b0\u773c\u5e95\u85e5\u7269VVN481\u6210\u529f\u7372\u5f97\u9999\u6e2f\u5275\u65b0\u79d1\u6280\u7f72\u300c\u4f01\u696d\u652f\u63f4\u8a08\u5283Enterprise Support Scheme\u300d\uff08ESS\u2014Hong Kong-Israel R&amp;D Cooperation Programme\uff09\u00a0\u8cc7\u52a9\u3002\u6b64\u6b21\u8cc7\u52a9\u5c07\u7528\u65bc\u63a8\u9032\u8a72\u7ba1\u7dda\u7684\u81e8\u5e8a\u524d\u7814\u767c\u5de5\u4f5c\uff0c\u4ee5\u671f\u66f4\u5feb\u63a8\u9032\u5230\u81e8\u5e8a\u968e\u6bb5\u3002\u6b64\u5916\uff0c\u8fd1\u65e5\u7dad\u7738\u751f\u7269\u9084\u69ae\u767b\u300a2023\u80e1\u6f64\u5168\u7403\u7375\u8c79\u4f01\u696d\u699c\u300b\u3002 \u7dad\u4e9e\u751f\u7269\u88ab\u6295\u4f01\u696dAbsci\u5ba3\u4f48\u8207\u963f\u65af\u5229\u5eb7\u5408\u4f5c\u958b\u767c\u4eba\u5de5\u667a\u80fd\u9a45\u52d5\u7684\u816b\u7624\u5019\u9078\u85e5\u7269 \u83ef\u76db\u9813\u5dde\u6eab\u54e5\u83ef\uff0c2023\u5e7412\u67084\u65e5\u2014\u2014\u7dad\u4e9e\u751f\u7269\u88ab\u6295\u4f01\u696d\u3001\u751f\u6210\u5f0f\u4eba\u5de5\u667a\u80fd\u6297\u9ad4\u767c\u73fe\u9818\u57df\u7684\u9818\u5c0e\u8005Absci\u516c\u53f8\uff08NASDAQ:ABSI\uff09\uff0c\u5ba3\u4f48\u8207\u5168\u7403\u751f\u7269\u88fd\u85e5\u516c\u53f8\u963f\u65af\u5229\u5eb7\uff08AstraZeneca\uff09\u5408\u4f5c\uff0c\u91dd\u5c0d\u816b\u7624\u9776\u9ede\u63d0\u4f9b\u4eba\u5de5\u667a\u80fd\u8a2d\u8a08\u7684\u6297\u9ad4\u3002\u6b64\u6b21\u5408\u4f5c\u5c07Absci\u7684Integrated Drug Creation\u2122\u5e73\u53f0\u8207\u963f\u65af\u5229\u5eb7\u5728\u816b\u7624\u5b78\u9818\u57df\u7684\u5c08\u696d\u77e5\u8b58\u76f8\u7d50\u5408\uff0c\u65e8\u5728\u52a0\u901f\u767c\u73fe\u6f5b\u5728\u7684\u65b0\u578b\u764c\u75c7\u6cbb\u7642\u5019\u9078\u85e5\u7269\u3002\u64da\u6089\uff0c\u8a72\u5354\u8b70\u5305\u62ec\u9810\u4ed8\u6b3e\u3001\u7814\u767c\u7d93\u8cbb\u548c\u91cc\u7a0b\u7891\u6b3e\u9805\u7b49\uff0c\u7e3d\u91d1\u984d\u9ad8\u90542.47\u5104\u7f8e\u5143\u3002 \u95dc\u65bc\u535a\u81f4\u751f\u7269 \u535a\u81f4\u751f\u7269\u5275\u7acb\u65bc2019\u5e74\uff0c\u7531\u86cb\u767d\u8cea\u5de5\u7a0b\u548c\u816b\u7624\u514d\u75ab\u9818\u57df\u7684\u9802\u5c16\u5c08\u5bb6\u5718\u968a\u7d44\u5efa\uff0c\u81f4\u529b\u65bc\u958b\u767c\u65b0\u4e00\u4ee3\u7d30\u80de\u56e0\u5b50\u6297\u816b\u7624\u514d\u75ab\u7642\u6cd5\u3002\u516c\u53f8\u81ea\u4e3b\u7814\u767c\u4e86\u300cCrossover\u300d\u524d\u85e5\u6280\u8853\u5e73\u53f0\uff0c\u80fd\u5be6\u73fe\u7d30\u80de\u56e0\u5b50\u5728\u816b\u7624\u5fae\u74b0\u5883\u4e2d\u7279\u7570\u6027\u91cb\u653e\uff0c\u6709\u6548\u89e3\u6c7a\u4e86\u7d30\u80de\u56e0\u5b50\u7684\u5916\u5468\u6bd2\u6027\u554f\u984c\u3002\u4f9d\u8a17\u8a72\u5e73\u53f0\u6280\u8853\uff0c\u516c\u53f8\u6210\u529f\u958b\u767c\u4e86\u81e8\u5e8a\u5019\u9078\u85e5\u7269PTX-912\uff0c\u5df2\u7d93\u555f\u52d5\u7f8e\u570b1\u671f\u81e8\u5e8a\u8a66\u9a57\u3002 \u95dc\u65bcAceLink Therapeutics AceLink Therapeutics\u6210\u7acb\u65bc2018\u5e74\uff0c\u662f\u4e00\u5bb6\u5275\u65b0\u578b\u751f\u7269\u88fd\u85e5\u521d\u5275\u516c\u53f8\uff0c\u5c08\u6ce8\u65bc\u958b\u767c\u5b89\u5168\u6709\u6548\u7684\u85e5\u7269\uff0c\u4ee5\u6eff\u8db3\u5b58\u5728\u9ad8\u5ea6\u672a\u6eff\u8db3\u7684\u81e8\u5e8a\u9700\u6c42\u7684\u907a\u50b3\u6027\u75be\u75c5\u3002\u516c\u53f8\u6700\u521d\u7684\u91cd\u9ede\u662f\u958b\u767c\u6cd5\u5e03\u745e\u6c0f\u75c7\u7684\u65b0\u578b\u6cbb\u7642\u65b9\u6cd5\u3002\u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8acb\u8a2a\u554f www.acelinktherapeutics.com \u95dc\u65bcBasking Biosciences Basking Biosciences\u662f\u4e00\u5bb6\u8655\u65bc\u81e8\u5e8a\u968e\u6bb5\u7684\u516c\u53f8\uff0c\u65e8\u5728\u89e3\u6c7a\u7f3a\u8840\u6027\u8166\u5352\u4e2d\u6cbb\u7642\u7684\u6700\u5927\u9700\u6c42\u2014\u2014\u4e00\u7a2e\u5feb\u901f\u8d77\u6548\u7684\u77ed\u6548\u6eb6\u6813\u85e5\u7269\uff0c\u80fd\u5920\u63d0\u4f9b\u6bd4\u73fe\u6709\u7642\u6cd5\u5927\u5927\u5ef6\u9577\u7684\u6cbb\u7642\u7a97\u53e3\uff0c\u4e26\u91cd\u65b0\u758f\u901a\u963b\u585e\u7684\u52d5\u8108\uff0c\u4e26\u4e14\u5728\u51fa\u8840\u6642\u53ef\u4ee5\u8fc5\u901f\u88ab\u9006\u8f49\u6d3b\u6027\u3002\u516c\u53f8\u6b63\u5728\u958b\u767c\u7684\u85e5\u7269BB-031\uff0c\u5373\u662f\u9019\u7a2efirst -in-class RNA\u9069\u914d\u9ad4\uff0c\u9776\u5411\u8840\u6813\u7684\u91cd\u8981\u7d50\u69cb\u6210\u5206\u548c\u51dd\u8840\u904e\u7a0b\u7684\u9a45\u52d5\u56e0\u7d20\u8840\u7ba1\u6027\u8840\u53cb\u75c5\u56e0\u5b50\uff08von Willebrand Factor\uff0cvWF\uff09\u3002 \u95dc\u65bc\u7279\u79d1\u7f85\u751f\u7269\u79d1\u6280\uff08\u6210\u90fd\uff09\u6709\u9650\u516c\u53f8\u00a0 \u7279\u79d1\u7f85\u751f\u7269\u79d1\u6280\uff08\u6210\u90fd\uff09\u6709\u9650\u516c\u53f8\u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\u7684\u751f\u7269\u91ab\u85e5\u516c\u53f8\u3002\u516c\u53f8\u524d\u8eab\u70ba\u5609\u8208\u7279\u79d1\u7f85\u751f\u7269\u79d1\u6280\u6709\u9650\u516c\u53f8\uff0c\u65b0\u8fd1\u65bc2023\u5e743\u6708\u642c\u9077\u81f3\u56db\u5ddd\u7701\u6210\u90fd\u5929\u5e9c\u570b\u969b\u751f\u7269\u57ce\u3002 \u516c\u53f8\u76ee\u524d\u7684\u6838\u5fc3\u7814\u767c\u9805\u76ee\u5305\u62ec\u91dd\u5c0d\u6cbb\u7642\u96c4\u6fc0\u7d20\u6027\u812b\u9aee\u3001\u7279\u61c9\u6027\u76ae\u708e\/\u6fd5\u75b9\u3001\u9280\u5c51\u75c5\u548c\u7d05\u6591\u72fc\u7621\u7b49\u75be\u75c5\u7684\u5275\u65b0\u85e5\u7269\u3002\u516c\u53f8\u5168\u7403\u9818\u5148\u7684\u6cbb\u7642\u96c4\u6fc0\u7d20\u6027\u812b\u9aee\u7684\u5c0f\u5206\u5b50\u5019\u9078\u85e5\u7269TDM-105795\u5373\u5c07\u5b8c\u6210\u4e8c\u671fa\u968e\u6bb5\u81e8\u5e8a\u8a66\u9a57\uff0c\u91dd\u5c0d\u7279\u61c9\u6027\u76ae\u708e\/\u6fd5\u75b9\u7684\u5275\u65b0\u578bJAK1\/TYK2\u6291\u5236\u5291\u4e5f\u5df2\u7d93\u5b8c\u6210\u4e00\u671f\u81e8\u5e8a\u8a66\u9a57\uff0c\u5373\u5c07\u958b\u5c55\u81e8\u5e8a\u4e8c\u671fPOC\u8a66\u9a57\u3002\u516c\u53f8\u5177\u6709\u591a\u500b\u81e8\u5e8a\u524d\u6216\u81e8\u5e8a\u968e\u6bb5\u7684\u5019\u9078\u85e5\u7269\uff0c\u5728\u7814\u7ba1\u7dda\u7522\u54c1\u90fd\u662f\u91dd\u5c0d\u6cbb\u7642\u5404\u7a2e\u76ae\u819a\u9069\u61c9\u75c7\u3002 \u95dc\u65bc\u8f3b\u806f\u79d1\u6280 \u8f3b\u806f\u79d1\u6280\u6709\u9650\u516c\u53f8\uff08\u300c\u8f3b\u806f\u79d1\u6280\u300d\uff09\u662f\u4e00\u5bb6\u5168\u9762\u6574\u5408\u7684\u570b\u969b\u5316\u653e\u5c04\u6027\u85e5\u7269\u6cbb\u7642\u516c\u53f8\uff0c\u5728\u6bd4\u5229\u6642\u3001\u5fb7\u570b\u548c\u4e2d\u570b\u5747\u8a2d\u6709\u8fa6\u4e8b\u8655\u3002\u6211\u5011\u81f4\u529b\u65bc\u6253\u9020\u64c1\u6709\u653e\u5c04\u6027\u85e5\u7269\u7814\u767c\u3001\u751f\u7522\u548c\u5546\u696d\u5316\u7684\u5168\u7522\u696d\u93c8\u7684\u6838\u85e5\u516c\u53f8\u4ee5\u9020\u798f\u5168\u7403\u60a3\u8005\u3002\u6211\u5011\u8a08\u5283\u901a\u904e\u91dd\u5c0d\u672a\u4f86\u6cbb\u7642\u65b9\u6cd5\u7684\u5275\u65b0\u7814\u7a76\u4f86\u89e3\u6c7a\u76ee\u524d\u5f71\u97ff\u653e\u5c04\u6027\u85e5\u7269\u7814\u767c\u7684\u6838\u5fc3\u554f\u984c\u3002\u6211\u5011\u5718\u968a\u4e2d\u4e0d\u4e4f\u7d93\u9a57\u8c50\u5bcc\u7684\u4f01\u696d\u5bb6\u548c\u79d1\u5b78\u5bb6\uff0c\u4ed6\u5011\u65e2\u64c5\u9577\u7ba1\u7406\u751f\u7269\u91ab\u85e5\u516c\u53f8\uff0c\u4e5f\u6df1\u8af3\u653e\u5c04\u6027\u540c\u4f4d\u7d20\u7684\u7814\u7a76\u548c\u81e8\u5e8a\u958b\u767c\u65b9\u6cd5\u3002 \u95dc\u65bc\u7dad\u7738\u751f\u7269 \u7dad\u7738\u751f\u7269\u662f\u4e00\u5bb6\u5c08\u6ce8\u65bc\u773c\u79d1\u5275\u65b0\u85e5\u7814\u767c\u9818\u57df\u7684\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u64c1\u6709\u570b\u969b\u4e00\u6d41\u7684\u773c\u79d1\u5275\u65b0\u85e5\u7814\u767c\u5718\u968a\u548c\u6280\u8853\u5e73\u53f0\uff0c\u4f9d\u8a17\u81ea\u4e3b\u7814\u767c\u5df2\u7d93\u5efa\u7acb\u8d77\u5177\u6709\u5168\u7403\u7af6\u722d\u529b\u7684\u7522\u54c1\u7ba1\u7dda\u3002\u9664VVN001\u9805\u76ee\u5916\uff0c\u7dad\u7738\u751f\u7269\u6b63\u5728\u958b\u767cVVN539\u7528\u65bc\u6cbb\u7642\u9752\u5149\u773c\u6216\u9ad8\u773c\u58d3\u75c7\uff0cVVN461\u7528\u65bc\u6cbb\u7642\u975e\u611f\u67d3\u6027\u524d\u8461\u8404\u819c\u708e\u548c\u8853\u5f8c\u708e\u75c7\u3002\u7dad\u7738\u751f\u7269\u9084\u81f4\u529b\u65bc\u767c\u73fe\u548c\u958b\u767c\u7528\u65bc\u6cbb\u7642\u5176\u4ed6\u524d\u3001\u5f8c\u773c\u75be\u75c5\u7684\u65b0\u7642\u6cd5\u3002 \u95dc\u65bcAbsci Absci\u662f\u4e00\u5bb6\u751f\u6210\u578b\u4eba\u5de5\u667a\u80fd\u85e5\u7269\u958b\u767c\u516c\u53f8\uff0c\u5c07\u4eba\u5de5\u667a\u80fd\u8207\u53ef\u64f4\u5c55\u7684\u6fd5\u5be6\u9a57\u5ba4\u6280\u8853\u76f8\u7d50\u5408\uff0c\u66f4\u5feb\u5730\u70ba\u60a3\u8005\u5275\u9020\u66f4\u597d\u7684\u751f\u7269\u88fd\u54c1\u3002\u5176Integrated Drug Creation\u2122\u5e73\u53f0\u901a\u904e\u540c\u6642\u512a\u5316\u517c\u5177\u958b\u767c\u548c\u6cbb\u7642\u6548\u679c\u7684\u591a\u7a2e\u85e5\u7269\u7279\u6027\uff0c\u91cb\u653e\u4e86\u52a0\u5feb\u85e5\u7269\u4e0a\u5e02\u6642\u9593\u548c\u63d0\u9ad8\u6210\u529f\u6982\u7387\u7684\u6f5b\u529b\u3002\u901a\u904e\u6578\u64da\u5b78\u7fd2\u3001\u4eba\u5de5\u667a\u80fd\u5275\u9020\u548c\u6fd5\u6cd5\u5be6\u9a57\u5ba4\u9a57\u8b49\uff0cAbsci \u6bcf\u9031\u53ef\u7be9\u9078\u6578\u5341\u5104\u500b\u7d30\u80de\uff0c\u4f7f\u5176\u80fd\u5920\u5728\u77ed\u77ed\u516d\u9031\u5167\u5b8c\u6210\u5f9e\u4eba\u5de5\u667a\u80fd\u8a2d\u8a08\u6297\u9ad4\u5230\u6fd5\u6cd5\u5be6\u9a57\u5ba4\u9a57\u8b49\u5019\u9078\u85e5\u7269\u7684\u904e\u7a0b\u3002Absci\u7684\u9858\u666f\u662f\u70ba\u6bcf\u500b\u4eba\u4e00\u9375\u63d0\u4f9b\u7a81\u7834\u6027\u7684\u6cbb\u7642\u65b9\u6cd5\u3002\u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8acb\u8a2a\u554fwww.absci.com","breadcrumb":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=222124#breadcrumb"},"inLanguage":"zh-TW","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pingtungtimes.com.tw\/?p=222124"]}]},{"@type":"ImageObject","inLanguage":"zh-TW","@id":"https:\/\/pingtungtimes.com.tw\/?p=222124#primaryimage","url":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","contentUrl":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","width":"3000","height":"1990"},{"@type":"BreadcrumbList","@id":"https:\/\/pingtungtimes.com.tw\/?p=222124#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u9996\u9801","item":"https:\/\/pingtungtimes.com.tw\/"},{"@type":"ListItem","position":2,"name":"\u7dad\u4e9e\u751f\u7269\u6295\u8cc7\u5b75\u5316\u516c\u53f8\u8fd1\u671f\u767c\u5c55\u52d5\u614b\u4e00\u89bd"}]},{"@type":"WebSite","@id":"https:\/\/pingtungtimes.com.tw\/#website","url":"https:\/\/pingtungtimes.com.tw\/","name":"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","description":"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831PingtungTimes\uff0c\u6700\u95dc\u5fc3\u5728\u5730\u7684\u5a92\u9ad4","publisher":{"@id":"https:\/\/pingtungtimes.com.tw\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pingtungtimes.com.tw\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-TW"},{"@type":"Organization","@id":"https:\/\/pingtungtimes.com.tw\/#organization","name":"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","url":"https:\/\/pingtungtimes.com.tw\/","logo":{"@type":"ImageObject","inLanguage":"zh-TW","@id":"https:\/\/pingtungtimes.com.tw\/#\/schema\/logo\/image\/","url":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","contentUrl":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","width":150,"height":150,"caption":"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831"},"image":{"@id":"https:\/\/pingtungtimes.com.tw\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/pingtungnews"]},{"@type":"Person","@id":"https:\/\/pingtungtimes.com.tw\/#\/schema\/person\/683b937f29ec1537972f6c41e22a2cf3","name":"\u7f8e\u901a\u793e","image":{"@type":"ImageObject","inLanguage":"zh-TW","@id":"https:\/\/secure.gravatar.com\/avatar\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g","caption":"\u7f8e\u901a\u793e"},"url":"https:\/\/pingtungtimes.com.tw\/?author=16"}]}},"_links":{"self":[{"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/222124","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=222124"}],"version-history":[{"count":0,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/222124\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/media\/199219"}],"wp:attachment":[{"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=222124"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=222124"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=222124"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}